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CHAPTER 1:  
Introduction and Aims 
 
 
1.1 Cell Membranes 
1.1.1 Common Properties and Functions 
Living cells need to be connected with and protected from the outer 
environment. Membranes confer the main protection against the different 
environmental conditions for survival. Plasma membrane surrounds the cytoplasm of 
living cells and physically separates the intracellular components from the extracellular 
ones. Membranes constitute a selective barrier that regulates the exchange of 
molecules between defined compartments. Unlike prokaryotes, eukaryotic cells have 
not only a plasma membrane but also intracellular membranes surrounding various 
organelles. All of these membranes are part of an extensive endomembrane system. 
The plasma membrane is composed of a thin layer of lipid molecules with large 
amounts of embedded proteins (Singer & Nicolson, 1972; Goñi, 2014). Both lipids and 
proteins participate in anchoring the membrane to the cytoskeleton thus providing a 
shape to the cell, and interact with the extracellular matrix to maintain tissue 
organisation. Furthermore, many other processes such as cell signalling, cell adhesion, 
ion conductivity, nutrient uptake or disposal of unwanted material are regulated by 
membrane components and take place either within or in the membrane vicinity.  
Cell membrane is selectively permeable and facilitates the transport of materials 
needed for survival. Due to this selective transport property membranes can maintain 
the cell potential. The movement of solutes across the membrane is controlled by some 
mechanisms that often involve proteins. Small molecules such as carbon dioxide and 
oxygen can move across the membrane by simple diffusion. In contrast, charged 






Figure 1.1. Schematic diagram of a lipid bilayer 
 
 















Membrane lipids are amphipatic molecules containing a hydrophobic tail and a 
polar head group, and can self-assembly into lipid bilayers (Figure 1.1). When exposed 
to a water solvent, these lipids can be spontaneously arranged so that the hydrophilic 
head groups interact with the water molecules isolating the hydrophobic tails from the 
water environment (Israelachvili et al., 1980). Thus, lipids in cell membranes 
characteristically adopt a bilayer structure with the hydrophobic tails facing each other 
and the polar heads interacting with the cytoplasm or extracellular medium. Proteins, 
the other main component, accommodate along the membrane extension up to 50% of 









Figure 1.2. Lipid and protein “fluid mosaic” 
model of biomembrane structure by Singer-








In this context, Singer and Nicholson proposed the current view of cell 
membranes as a fluid mosaic model, in which lipids and proteins can rotate and diffuse 
easily along the plane of the membrane (Figure 1.2). Thus, the membrane would be 
asymmetric as a consequence of the restricted transbilayer movement.  Membrane 
proteins are usually classified as peripheral or integral proteins. Integral (also called 
intrinsic) proteins have one or more segments embedded in the phospholipid bilayer. 
Most integral proteins contain hydrophobic residues that interact with the fatty acyl 
chains of phospholipids in order to anchor the protein to the membrane. However, the 
polypeptide chain does not always enter the phospholipid bilayer, as it is the case of 
proteins anchored by covalent binding to fatty acids. On the other hand, peripheral 














However, subsequent adjustments and evolutions of this model have emerged 
in the following decades (Jacobson et al., 1995; Engelman, 2005; Goñi, 2014). Now, 
the intrinsic membrane proteins are considered to be very abundant, and distributed 
inhomogeneously along the membrane (Figure 1.3). Even some proteins are not 
always in contact with the membrane, existing part-time in the cytosol and part-time 
docked to a membrane. Moreover, biological membranes present lateral heterogeneity. 
It can be divided into subdomains composed of specific proteins or lipids, allowing 
spatial segregation of biological processes associated with membranes such as ion 
and metabolite transport, signalling, cell adhesion, and migration. Additionally, in 
practice the membrane bilayer is not flat. Local curvature of the membrane can be 
caused by the asymmetry and non-lamellar organization of lipids. Some non-bilayer 
lipid structures can transiently occur, with important biological functions, as is the case 
Figure 1.3. An amended and updated 
version of the Singer-Nicolson model. 






of membrane fusion events or cell division. Lipid asymmetry in the membrane has been 
discovered to be controlled by flippase or scramblase proteins. Lipid flip-flop motion is 
of great importance for instance during the apoptotic response in a cell, in which an 
externalisation of phosphatidylserine (PS), a phospholipid present only in the cytosolic 
leaflet of plasma membranes, is promoted to potentiate macrophage cell recognition 
and death (Fadok et al., 2000). 
 
1.1.2 Membrane Lipids 
Lipids include a heterogeneous group of molecules, with important biological 
functions. In the cell, they are involved in the formation of cellular membranes. But 
largest amounts of lipids are used for energy storage, principally as triacylglycerols and 
sterol esters, in lipid droplets. Also, lipids can act as first and second messengers in 
signal transduction and molecular recognition processes (Bartke & Hannun, 2009; van 
Meer, 2005; van Meer et al., 2008).  
In this thesis, lipids are considered mainly as related to membrane formation. 
Cellular membranes are formed by polar lipids, which consist of a hydrophobic and a 
hydrophilic area. The propensity of the hydrophobic moieties to self-associate, and the 
tendency of the hydrophilic moieties to interact with the aqueous environment are the 
physical basis of the spontaneous formation of membranes. Regarding the head group 
charge, all these lipids can be either neutral (zwitterionic) or electrically (usually 
negatively) charged. From the head group, generally one or two fatty acyl hydrophobic 
tails emerge. These can contain from 2 to 28 carbon atoms and also can be saturated 
or unsaturated with one or more cis or trans double bounds (Berg et al., 2002). 
 
1.1.2.1 Classification of Membrane Lipids 




Glycerolipids are the major structural lipids in eukaryotic membranes. There are 
two classes of glycerolipids, glycerophospholipids and glyceroglycolipids. 






Figure 1.4. General structure of glycerophospholipids. 
 
are bound via ester linkages to the carbons in sn-1 and sn-2 positions of glycerol. To 
the carbon in the glycerol sn-3 position a phosphate group is attached, and a polar 
residue is esterified to the phosphate group (Figure 1.4). Depending on the length and 
saturation of the acyl chains attached to the glycerol, and on the polar group bound to 









The other class of glycerolipids, glyceroglycolipids, are less abundant in animal 
cell membranes but are present in huge quantities in plant and some bacterial 
membranes. They lack a phosphate group, but contain a mono- or oligosaccharide 
group linked through a glycosyl linkage to carbon sn-3 of glycerol. 
 
B) Sphingolipids 
Sphingolipids can be sorted into phosphosphingolipids and glycosphingolipids. 
Their hydrophobic backbone is sphingosine, a long chain unsaturated amino octadecyl 
alcohol. N-hexadecanoyl-D-erythro-sphingosine, ceramide, an important sphingolipid in 
cell signalling, is originated by a fatty acyl chain attached through an amide linkage to 
sphingosine (Figure 1.5). Binding of a phosphorylcholine polar residue to ceramide 
originates sphingomyelin, an abundant phosphosphingolipid in the external leaflet of 
cell plasma membrane. 
The binding of complex sugar structures gives rise to a class of sphingolipids 
named glycosphingolipids, which can be classified into cerebrosides and gangliosides, 






Figure 1.5. General structure of sphingolipids. Sphingosine in a red square, fatty acid in 












The third class of lipids that integrate cell membranes are sterols. These lipids 
are the major non-polar lipids in cell membranes. Sterols have a hydrophobic four-
membered fused ring rigid structure, and a small polar head group. In general, sterols 
are synthesized via the mevalonate pathway of isoprenoid metabolism. The most 
abundant sterol in mammals is cholesterol (Figure 1.6), whereas ergosterol 
predominates in yeast.  
 
1.1.2.2 Lipid Distribution and Asymmetry 
Eukaryotic cells contain well over 1000 different lipid species in the membranes. 
Variation in headgroups and aliphatic chains of each kind of lipid generates this 
enormous lipid diversity. Interestingly phospholipids, sphingolipids and sterols are not 
 







Figure 1.7. Lipid compositions of different membranes within the cell. [Taken from van 
Meer et al. (2008)]. 
 
distributed homogeneously throughout the main organelles of mammals, conferring 
special characteristics to them (Figure 1.7). This segregation reflects the different 
physiological role, local lipid metabolism of each lipid in the cell and specific 
physicochemical membrane properties generated by differences in lipid composition. 
For example, sphingomyelin and cholesterol are principally found in the plasma 

























Furthermore, lipid heterogeneity is not only present between different 
membranes in the cell, but also within single membranes. Lipids can be asymmetrically 
distributed between the two monolayers of a lipid bilayer. This characteristic is named 
lipid transversal asymmetry (Figure 1.8). The Golgi, plasma membrane and endosomal 
membranes display an asymmetric distribution with sphingomyelin (SM) and 






(PS) and phosphatidylethanolamine (PE) enriched in the cytosolic leaflet. The main 
reason of lipid composition differences between both monolayers is the asymmetric 
synthesis of certain lipids or the presence of transporters that allow unidirectional lipid 
translocation. 
In model membranes the rate of spontaneous polar lipid movement between 
bilayer leaflets is slow [hours to days for Phosphatidylcholine (PC)] and is governed by 
the size, charge and polarity of the headgroup. The half time for translocation is days 
for complex GSLs but seconds for Ceramide (Cer), Diacylglycerol (DAG) and sterols. 
Hence, in cell membranes some proteins (flippases, floppases, scramblases), facilitate 











In addition, lipids are not homogeneously located even along one leaflet of the 
membrane. Lipids display certain lateral asymmetry. Membrane fluidity is connected to 
the lipid motion, and regulates the capacity of free lateral movement. In this context, 
lipid domains and rafts are related to this lateral heterogeneity. 
 
1.1.2.3 Lipid Polymorphism 
Morphological plasticity of biological membranes is critical for cellular life, as 
cells need to quickly reorganise their membranes for a proper response to a given 
stimulus. Cell membranes are basically organised in a unidimensional lamellar 
structure. However, some crucial events are characterised by the formation of more 
Figure 1.8. Asymmetric phospholipid 







Figure 1.9. Lamellar gel-fluid phase transition and its associated height and chain order 
transformation. S represents de order parameter of the acyl chains. Redrawn from van Meer 
et al., (2008). 
 
Gel phase Fluid phase
S = High S = Low
complex non-lamellar structures, such as the inverted hexagonal or cubic phases. 
From macromolecule transversal motion across the membrane to cell division, many 
processes require the generation of these unstable structures (Epand, 1998). 
Membrane fusion and fission processes, that include virus infection, vesicular transport 
from the Endoplasmic reticulum (ER) to the Golgi or endocytic and exocytic transport, 
are good examples of energetically unfavourable events that require the transient 
formation of non-lamellar structures (Basañez, 2002; Burger, 2000). However lipid 
polymorphism is not only associated to two-dimensional structural changes. For 
instance, the formation of laterally segregated structures within a membrane, where 
protein complexes can adopt a more stable conformation is dependent on 
unidimensional alterations of lipid order or rigidity.  
A lipid phase is a thermodynamic concept corresponding to different structural 
patterns that a lipid or a lipid mixture adopt in aqueous solution. Biological membranes 
under equilibrium conditions are composed of a lipid bilayer in a lamellar configuration, 
where the most significant phases are: fluid or liquid-disordered or liquid-crystalline 
(Lα), gel or solid-ordered (Lβ) and a phase with intermediate properties between fluid 
and gel denoted as liquid-ordered (Lo). In a Lα phase, lipids are free to diffuse laterally 
or rotationally, and display their acyl chains in a disordered state with high flexibility, 
and at least one of the acyl chains is normally unsaturated. Lipids in the Lβ phase have 
highly ordered acyl chains and display high proportions of trans C-C conformers, being 
almost immobile and not allowing lateral or rotational motion (Marsh, 1980). The Lβ to 








Other lamellar phases include Lβ´, in which acyl chains are tilted with respect to 
the plane of the membrane, the interdigitated LβI where acyl chains from the two 













chain), and the rippled Pβ´ phase, which can be adopted by a few saturated 
phosphatidylcholines and phosphatidylglycerols, and characterised by the ripples seen 
by electron microscopy in freeze-fractured surfaces of lipid samples in this phase.   
 
1.1.2.4 Lipid Geometry 
The formation of some non-lamellar structures is strongly influenced by the lipid 
molecular geometry. Differences in the cross-sectional areas between the polar 
headgroup and the hydrophobic tail could determine the overall structure of the lipid 
aggregates (Israelachvili et al., 1980). From this point of view, lipids are mainly 
classified into three groups: lipids with cone, cylindrical or inverted-cone shapes 
(Figure 1.10). These shapes could be summarized by the morphological parameter S: 
S = V/AoLc 
Equation 1. Morphological parameter S. 
 
where: 
V = is the volume of the lipid molecule, 
Ao = is the area of the molecule in the lipid-water interface and  
Lc = the length of the extended acyl chain.  
Taking into account these parameters and the lipid cross-sectional area in the 
hydrophobic tail “AH”, which would reflect a volume of V = AHLc for a lipid displaying 
cylindrical shape, we can review the different morphological geometries as:  
 A0 = AH (S = 1): The molecule presents a cylindrical shape  
 A0 < AH (S > 1): The molecule presents a cone shape  











Figure 1.11. Molecular shape, curvature and overall structure adopted by some lipids from 
biological membranes. Redrawn from Suetsugu et al., (2014) 
 
Cylindrical lipids Conical lipids Inverted conical lipids
Pure lipids in aqueous solutions will self-aggregate into different structures 
depending on their molecular geometry. Cylindrical shapes displaying lipids as PC or 
SM will become organised in the form of lamellar bilayers. Cone shaped lipids as PE, 
DAG or sterols will tend to form “hexagonal” (tubular) arrangements, while inverted-
cone-shaped lipids as is the case of lysophospholipids (LPC) will aggregate into 
micelles (Figure 1.11). However, these non-cylindrical lipids could be part of a lipid 
bilayer structure whenever lipids such as PC, SM or PS are present. For instance, a 20 
to 50 mol % of cylindrical lipids are necessary when mixed with conical lipids in order to 
have an overall lamellar structure (Cullis et al., 1986). 
Thus, it could be summarised that lipid polymorphism reflects the lipid 
behaviour under specific physical conditions in which long-range ordered structures are 













1.1.3 Membrane Fusion 
Fusion processes imply that the membrane bilayers of two vesicles merge and 
their aqueous contents connect. When it occurs, the lamellar structure is transiently 
altered in a regulated manner. These fusion events are observed in many biological 





infection and exocytosis in higher organisms. All these processes are controlled by the 
protein machinery of the cell, but they are highly dependent on the lipid composition of 
membranes. Despite the important events that involve fusion, many mechanistic and 
molecular features are still unknown.   
The first step in membrane fusion is to bring membranes together in close 
proximity, in order to remove the water in between the two membranes. Once this step 
has been accomplished, the membrane is destabilised, and undergoes changes 
leading to the mixing of aqueous contents within the resulting single vesicle (Siegel, 
1986). Previous work has related the destabilisation of the membrane to lipid 
polymorphism (transition from lamellar to non-lamellar phase) (Gilbert, 2015). 
Moreover, the presence of a common intermediate for leakage and fusion has been 
suggested (Siegel et al., 1994). 
The stalk hypothesis is currently the most accepted fusion model. It involves the 
formation of a lipid intermediate with a semi-toroidal shape, termed stalk, that is formed 
from the two membranes that are about to fuse (Chernomordik & Kozlov, 2008; 
Chernomordik et al., 1987; Kozlov & Chernomordik, 2015). The stalk enables mixing of 
the two outer monolayers, a process known as hemifusion. This intermediate is 
transient, and is rapidly converted into a more stable structure that connects the two 
membranes. It is proposed to be a non-lamellar structure with a high curvature. Model 
membranes have helped to study this process and it has been possible to explain 
certain stages of the stalk model (Figure 1.12). 
 
I. Membranes are brought together into a close apposition, for this electrostatic 
forces need to be overcome. 
 
II. Hemimembrane fusion of the outer monolayers, when the stalk structure is 
formed. 
 





























The first step when the two membranes come in contact requires overcoming 
the highest energetic barrier, because both surfaces are hydrated and repel each 
other. This step is facilitated by lipids that induce localised negative curvature, such as 
cholesterol or DAG, the latter is mostly produced by phospholipase C (PLC) (Goñi et 
al., 2012). These lipids are known to induce non-lamellar structures because of their 
cone shape, and diminish the energetic barrier of repulsion favouring the stalk 
formation (Khattari et al., 2015), but no the stalk expansion (Risselada et al., 2014). X-
ray studies have revealed changes in the water layer thickness (dw) in between 
apposed bilayers, depending on the lipid composition (Aeffner et al., 2012). Moreover, 






1.1.4 Protein-lipid Interactions   
Membrane proteins are associated in different ways with membranes and 
enable them to carry out their distinctive activities. Each particular bilayer contains a 
specific pool of proteins that confers to it some particular properties. 
As it was said in section 1.1.1, membrane proteins are commonly classified as 
peripheral or integral proteins. Integral (also called intrinsic) proteins contain one or 
more segments embedded in the phospholipid bilayer. Most integral proteins contain 
hydrophobic residues that interact with the fatty acyl chains of phospholipids in order to 
anchor the protein to the membrane. However, the polypeptide chain does not always 
enter the phospholipid bilayer, as is the case of proteins anchored by covalent binding 
to fatty acids. On the other hand, peripheral (also called extrinsic) proteins usually 
interact with the lipid polar head groups or intrinsic proteins. 
Moreover, a large amount of membrane proteins do not spend their whole life 
attached to the membrane. Some of them contact the lipid bilayer only under certain 
conditions, thereby remaining membrane bound (either as integral or as peripheral 
proteins) or returning promptly to the aqueous medium (non-permanent membrane 
proteins).  
In this regard, these non-permanent proteins can be classified according to the 
reversibility of the membrane contact or to the nature of the interaction. The first 
criterion assumes that there are some proteins that interact reversibly with the 
membrane and others with very long-lived (irreversible) contacts. The second one sorts 
the proteins into groups depending of the strength of the interaction, considering weak 
or strong associations, either in a transient or a permanent way, with the membrane 
(Goñi, 2002). 
Protein-membrane association can also rely on specific protein domains that 
recognize some pecularities of the membrane (Hurley, 2006; Lemmon, 2008; 
Moravcevic et al., 2010). At least ten different types of protein domains bind 
phospholipids at the membrane surface. These interactions can fall into two classes: 
highly specific, involving the recognition of a particular phospholipid in the membrane, 
or non-specific, implying a physical property of the membrane surface (Lemmon, 
2008). For instance, C1, C2, PH, PX, FYVE or PROPPINs domains belong to the first 
type. In contrast, BAR domains, ALPS motifs or N-terminal amphiphatic α-helices 
recognize physical properties such as membrane curvature (Antonny, 2011). More 







Autophagy (from the Greek auto-, "self" and phagein, "to eat") is a general 
biological process conserved among eukaryotes that allows the regulated degradation 
of unnecessary or dysfunctional cellular materials. This event occurs under normal 
conditions of cell development, but it can be highly active in the context of disease to 
promote survival, or in some cases cell death, or under starvation conditions when 
autophagy promotes the maintaining of cellular energy levels. However, autophagy 
does not only provide nutrients to maintain vital cellular functions under amino-acid 
limiting conditions, but also plays an important role in a wide range of physiological 
processes, such as development, differentiation or immunity. Not surprinsingly, 
impaired autophagy underlies a wide range of pathological conditions. 
 
1.2.1 Origin 
The process of autophagy was observed by Keith R. Porter and his postdoctoral 
student Thomas Ashford at the Rockefeller Institute, New York. In January 1962 they 
reported an increased number of lysosomes in the liver cells of rat after addition of 
glucagon, and that some displaced lysosomes towards the centre of the cell contained 
other cell organelles such as mitochondria. This was the first reported evidence in the 
English literature of intracellular digestion of cell organelles. In early 1963, the 
American Journal of Pathology published a detailed ultrastructural description of focal 
cytoplasmic degradation, which referenced a 1955 German study of injury-induced 
sequestration. Z. Hruban and colleagues recognised three continuous stages of 
maturation of the sequestered cytoplasm to lysosomes, and noted that the process was 
not limited to injury states, but also functioned under physiological conditions for 
reutilization of cellular materials (Hruban et al., 1963). Inspired by this discovery, the 
term "autophagy" was invented by Christian de Duve (de Duve, 1963), the Nobel Prize-
winning discoverer of lysosomes and peroxisomes. Unlike Porter and Ashford, de Duve 
conceived the term as a part of lysosomal function while describing the role of 
glucagon as a major inducer of cell degradation in the liver. With his postdoctoral 
student Russell L. Peter, he subsequently established that lysosomes are indeed 
responsible for glucagon-induced autophagy. This was the first time that lysosomes 





1.2.2 Types of Autophagy 
Three different types of autophagy have been described in mammalian cells 
(Figure 1.13) (Okamoto, 2014):  
a) Macroautophagy is the main pathway, occurring mainly to eradicate damaged 
cell organelles or unused proteins. This involves the formation of a double 
membrane around cytoplasmic substrates resulting in the organelle known as 
autophagosome. The autophagosome travels through the cytoplasm of the cell 
to a lysosome, and the two organelles fuse; intersection with endosomal 
pathways also occurs. Within the lysosome, the contents of the autophagosome 
are degraded via acidic lysosomal hydrolases. This pathway is conserved from 
yeast to humans. 
 
b) Microautophagy, on the other hand, involves the direct engulfment of 
cytoplasmic material by the lysosome. This occurs by invagination, meaning the 
inward folding of the lysosomal membrane, or cellular protrusion. It is also 
conserved from yeast to humans. 
 
c) Chaperone-mediated autophagy refers to the chaperone-dependent selection of 
soluble cytosolic proteins that are then targeted to lysosomes and directly 
translocated across the lysosome membrane for degradation. It is found only in 
mammals (Bejarano & Cuervo, 2010). 
 
Autophagy can also be classified into selective or non-selective autophagy, 
depending on whether there are signals to degrade a specific cellular component or 
else it is a bulk process. This is particularly important for the cell when only some 
specific organelles are damaged. In this context, the word organellophagy arises. 
Different organelles could be specifically selected to be degraded using the 
macroautophagy or microautophagy pathways. In the last years almost every cell 
organelle has been suggested to be a candidate for this selective mode of autophagy. 
For instance, mitochondria (Mitophagy), peroxisome (Pexophagy), lipid droplets 
(Lipophagy), nucleus (Nucleophagy), lysosome (Lysophagy), ER (reticulophagy) or 
ribosomes (Ribophagy) (Okamoto, 2014). 
In this thesis, we are interested in the biogenesis of the autophagosome, so in 
the context of this work, autophagy is to be understood as macroautophagy, the most 






Figure 1.13. Scheme of the three types of autophagy in mammalian cells. Macroautophagy, 















1.2.3 Molecular Machinery of Macroautophagy 
The landmark event in autophagy is the formation of a double-membrane 
structure called autophagosome (AP) (Noda & Inagaki, 2015). The first step for this 
process is the generation of an isolation membrane. The origin of that initial membrane 
is not yet known, but some evidences suggest as possible sources the ER, plasma 
membrane or even mitochondria (Hamasaki et al., 2013; Mari et al., 2011; Mizushima 
et al., 2011). 
Hereafter, the adhesion and fusion of membrane structures is necessary for 
autophagosome elongation. While membrane material, in the form of vesicles, is 
reaching the pre-autophagosome, new selected or non-selected cellular contents start 
to come into this preformed structure. In a final step, the autophagosome closes and 
upon fusion with a lysosome, the inside contents are degraded by lysosomal 
hydrolases (Figure 1.14) (Tooze & Yoshimori, 2010). Regarding the last step in 
autophagosome formation, a new study suggest that the autophagosome closure 






Figure 1.14. Scheme of the current working model of autophagosome formation. Four main 
steps are distinguished in the process: Membrane or vesicle nucleation, phagophore elongation 
and closure, autophagosome-lysosome fusion and a final degradation of the contents. [Taken 
from Meléndez A. et al (2009)] 
publications in autophagy field sustain (Knorr et al., 2015). Autophagosome sealing 
comprise the process in which one bilayer splits-up into two separate ones, generating 
two aqueous compartments, one of which is enclosed by the other. Thus, the correct 











To date at least 35 autophagy-related (ATG) genes (Table 1.1), divided into 
several groups depending on the timing of their participitacion during AP biogenesis, 
have been identified and related to the process (Lamb et al., 2013). Among them, the 
Atg8 family of ubiquitin-like proteins, studied in this thesis, are late autophagosome-


















Alternative name and function 
ULK1 and ULK2 ULK complex 
Atg1 orthologues; Ser/Thr kinases that mediate 
mTOR signalling and ATG9 cycling 
ATG13 ULK complex 
ULK1 and ULK2 substrate that also modulates the 
activity of the ULK complex 
FIP200 ULK complex 
Atg17 orthologue; ULK1 and ULK2 substrate that 
also modulates the activity of the ULK complex 
ATG101 ULK complex Interacts with ULK1 and ATG13 
Beclin 1 PI3K complex 
Atg6 orthologue; part of the PI3K complex and also 
has a role in autophagy during initiation, formation 
and maturation 
VPS34 PI3K complex Catalytically active subunit of the PI3K complex 
p150 PI3K complex 
Vps15 orthologue; recruits the PI3K complex to 
membranes 
ATG14L PI3K complex 
Atg14 orthologue; directs the PI3K complex to the 
omegasome; also known as Barkor 
WIPI1 and WIPI2 
PtdIns(3)P-binding 
protein 





Similar to the E2 ubiquitin conjugating enzyme; 




Cys protease that cleaves carboxy-terminal Gly 
residues from LC3 homologues and is also required 





Similar to E1 ubiquitin activating enzymes; activates 
ATG12 and LC3 homologues 







Atg8 homologues; ubiquitin-like proteins that recruit 









Similar to E2 ubiquitin conjugating enzyme; links 




Ubiquitin-like protein conjugated to ATG5 that 




Binds to the ATG5–ATG12 conjugate and directs 
LC3 conjugation at the isolation membrane 
ATG9A and ATG9B 
Integral membrane 
proteins 
Atg9 orthologues; required for autophagosome 
formation 
ATG2A and ATG2B 
Localize to 
omegasome 
Atg2 orthologues; required for closure of isolation 





1.2.4 Autophagy Signalling Cascade 
Autophagy induction is controlled by a complex regulatory mechanism involving 
different input signals that include nutrients, growth factors, hormones, ATP levels, and 
various others. Many signals converge at the level of the mammalian target of 
rapamycin complex 1 (mTORC1). mTORC1 consists of mTOR, regulatory associated 
protein of mTOR (raptor), DEP-domain-containing mTOR-interacting protein (Deptor), 
proline-rich AKT substrate 40 kDa (PRAS40) and G-protein β-subunit-like protein (GβL) 
(Wirawan et al., 2012). When amino acids and growth factors are present, class I 
phosphatidylinositol-3-kinase (PIK3C1) activates mTORC1, which suppresses 
autophagic signalling. Active mTORC1 inhibits autophagy by binding and 
phosphorylating uncoordinated-51 (unc-51)-like kinase 1 or 2 (ULK1 or ULK2) and 
Atg13 within the ULK complex. This complex is composed of ULK1 or ULK2, atg13, 
focal adhesion kinase family interacting protein 200 kDa (FIP200) and Atg101 (Noda & 
Inagaki, 2015). Consequently, repression of mTORC1 by nutrient deprivation or 
rapamycin treatment is commonly used to activate autophagy. Thus, when mTORC1 is 
inactivated, it dissociates from the ULK complex, allowing ULK activity (Figure 1.15) 
(Noda & Fujioka, 2015). In yeast, Atg17, Atg29 and Atg31 are also components of the 
Atg1 complex and participate in the recruitment of Atg9 vesicles to the PAS, through an 
Atg1-dependent interaction of Atg17 with Atg9 (Ragusa et al., 2012; Stanley et al., 
2014). This aspect represents an important difference between the yeast and 
mammalian pathway. 
During starvation, ULK1 plays an important role in regulating mATG9 trafficking, 
the unique multispanning transmembrane protein, that cycles between the trans-Golgi 
network and the endosomal compartment in basal conditions. Upon autophagy 
induction, mATG9 is recruited to the growing autophagosome, where it might supply 
lipids needed for membrane elongation (Orsi et al., 2012; Webber et al., 2007). 
After autophagy induction, several protein complexes participate in the isolation 
membrane elongation to build the mature autophagosome. This process can be divided 
into three stages: vesicle nucleation, elongation and maturation. In order to develop 
these actions, proteins take part each one in a specific step. 
In the first step, a huge number of different proteins are recruited to the site of 
autophagosome formation, in a process called autophagosome nucleation. PIK3C3, 
p150, Ambra1 and Bcl-2-interacting protein (Beclin-1) form the core of the PIK3C3 
complex, which can also bind the product of UV-radiation resistance associated gene 






Figure 1.15. Macroautophagy signaling pathway. From top to bottom, different signals act 
as upstream inhibitors of mTOR. ULK and PI3KC3 complex participate and recruit more 
proteins for membrane nucleation. Both, Atg8 and Atg5 UBL systems work in collaboration in 
autophagosome elongation and closure. [Taken from Green & Levine, (2014)] 
 
regulators of PIK3C3 bind in order to modulate the generation of phosphatidylinositol-3-
phosphate (PI3P). This phospholipid plays the role of recruiting more Atg proteins to 
the nucleation site. Among the PI3P interacting proteins, WD repeat domain 
phosphoinositide interacting 1 (WIPI1) and 2 (WIPI2) (Dooley et al., 2014; Polson et al., 
2010), mAtg2 and double-FYVE containing protein-1 (DFCP1) are the most well known 
even if their exact role needs to be further studied.  
Afterwards two ubiquitin-like (UBL) conjugation systems participate in 
autophagosome membrane elongation, shaping and closure. These two systems are 
interconnected and need to act together for a proper autophagosome growing in vivo. 
The first UBL system is composed of Atg5, Atg12, Atg10 and Atg16L1. Initially, Atg12 
is activated by Atg7 (E1-like enzyme), transferred to Atg10 (E2-like enzyme) and finally 
covalently bound to Atg5. Atg12-Atg5 interacts also with Atg16L1 to create a complex 
that homodimerizes forming a multimeric complex (Figure 1.15). The final action of this 
complex is to interact with the outer autophagosomal membrane and to act as the E3 
ligase enzyme of the second UBL conjugation system (Romanov et al., 2012; Walczak 

















This second UBL system is constituted by ATG4, ATG7, ATG3 and LC3 
(Figure 1.15). First of all, LC3 is cleaved in its C-terminal end by ATG4, exposing a 
glycine. Next, LC3 is associated with ATG7 and then transferred to ATG3 in an ATP 
dependent transthioesterification process. Once bound to ATG3, the latter directs LC3 
to the autophagosomal membrane, and in collaboration with the E3-ligase complex 
catalyzes the conjugation of LC3 to phosphatidylethanolamine (PE) to produce LC3-PE 
(Nakatogawa et al., 2007; Noda et al., 2011; Tanida et al., 2004).   
The final product, LC3-PE, is considered as the main autophagy-specific marker 
in cells, and is also the best known effector in autophagosome elongation. Moreover 
LC3 in the preautophagosomal membrane recruits partner proteins, through its LC3-
interacting motif (LIR), involved in autophagy regulation and autophasome growth 
(Hurley & Schulman, 2014; Noda et al., 2010a). Once the autophagosome is formed 
and closed with the corresponding material to degrade, ATG4 participates again 
removing LC3-PE from the outer autophagosomal membrane in the recycling of LC3. 
Nevertheless, LC3 associated to the inner autophagosomal membrane will be 
degraded by the lysosomal enzymes. More about the Atg8 UBL system will be 
explained in section 1.2.7. 
In the last step of autophagy and regarding the enclosured material 
degradation, autophagosome travels along the cytoplasm through microtubules and 
fuses with the lysosomes. The outer autophagosomal membrane fuses with the 
lysosomes so that the inner autophagosomal membrane and their contents come into 
contact with the lysosomal hydrolases and lipases. Many proteins take part in the 
autophagosome-lysosome fusion event such as LAMP2, Ras-related GTP-binding 
protein (Rab), homotypic fusion and protein sorting (HOPS), SNAREs, LC3, ESCRT, 
FYCO1 and UVRAG-C-Vps tethering complex (Wirawan et al., 2012). 
The result of the autophagy process is the generation of recycled amino acids, 
fatty acids and nucleosides that will come back to the cytosol for new anabolic 
reactions. 
 
1.2.5 Autophagy is a Lipid-modulated Process 
In the autophagy network, the main object of study in this thesis, there are 
several proteins that associate with different cell membranes. Those proteins may 





inositol (GPI) anchor, an amphipathic alpha helix, a domain such as FYVE (that binds 
PtdIns 3-phosphate), or a PH domain (that binds PtdIns 3,4-bisphosphate). Unusually, 
Atg8 and mammalian Atg8 protein family associate with autophagosomal membranes 
through PE that is covalently attached to the C-terminal glycine residue. This type of 
modification is so far unique to the Atg8 family. Peripheral membrane proteins known 
to be involved in autophagosome formation include for example ULK1 and ULK2, 
known to be present in a salt- and detergent-resistant membrane fraction, and DFCP1, 
that contains a FYVE domain (Tooze, 2010). 
The initiation of the autophagic signalling under starvation conditions starts in 
the plasma membrane where phosphoinositides are recognized by proteins 
(Phosphatidylinositol-3-kinase or phosphoinositide phosphatases). In addition, from the 
beginning to the end of autophagosome formation a huge amount of membrane 
material is constantly moving through different cell localizations with many proteins 
transiently associated, such as Atg9, Atg5-12-16 complex, Atg3, Atg14 or WIPI 
proteins. 
 
1.2.6 Autophagy in Health and Disease 
Autophagy is activated as an adaptive catabolic process in response to different 
forms of metabolic stress, including nutrient deprivation, growth factor depletion and 
hypoxia. Generation of free amino acids and fatty acids as a result of autophagy are 
further used for de novo synthesis of cellular building blocks and energy production 
essential for stress adaptation. 
The repertoire of housekeeping actions performed by autophagy covers the 
removal of defective proteins, organelles, abnormal protein aggregates and intracellular 
pathogens. These functions make autophagy a critical process involved in the 
protection against cancer, infection, neurodegenerative diseases and aging (Galluzzi et 
al., 2016; Levine & Kroemer, 2008; Rubinsztein et al., 2011). 
Autophagy may have a multifactorial influence on the initiation and progression 
of cancer, as well as being a valuable target in its treatment (Choi et al., 2013). The 
regulation mechanism of autophagy overlaps with signalling pathways of 
tumorigenesis, as is the case of the tumour suppressor genes upstream of TOR 
signalling such as PTEN, TSC1 and TSC2. However Akt, an oncogene product of this 





autophagy may allow the continuous growth of precancerous cells, but conversely 
when tumours grow, cancer cells need autophagy to survive under nutrient-limiting 
conditions. A good example of the involvement of autophagy in cancer is beclin 1. This 
protein is monoallelically deleted in a high percentage of breast, ovarian and prostate 
cancers. Stable transfection of beclin 1 in MCF7 cells promotes autophagic activity and 
reduces tumorigenic capacity, which suggests a possible tumor suppressor role of the 
autophagic protein beclin 1 (Liang et al., 1999; Shintani & Klionsky, 2004). 
Furthermore, some reports show evidences of the involvement of autophagy in 
neurodegenerative diseases (Menzies et al., 2015; Wong & Cuervo, 2010; Wong & 
Holzbaur, 2015). An accumulation of autophagosomes has been observed in many 
disorders such as Parkinson´s, Alzheimer´s and Huntington´s diseases. These 
illnesses share the accumulation of protein aggregates of α-synuclein, tau or 
polyglutamine-rich proteins, respectively (Lynch-Day et al., 2012; Martinez-Vicente et 
al., 2010; Nixon et al., 2005). In order to fix the critical situation, cells highly increase 
their autophagic activity to eliminate these protein aggregates (aggrephagy), but 
nevertheless the presence of this kind of aggregates impairs autophagy. Thus, 
autophagy represents an important target in the treatment of these disorders. 
Moreover, the homeostatic functions of autophagy in the long-lived protein 
turnover and removal of damaged organelles are thought to act as an anti-aging 
process. Analysis of autophagy related genes (BECN1, Atg7 or Atg5) showed an 
important down-regulation in old people compared to the younger ones, which is 
correlated with a reduction in autophagy rate (Lipinski et al., 2010). This could explain 
why a caloric restriction might induce autophagic activity, representing a possible 
mechanism for life-span extension (Jia & Levine, 2007). In addition to the above 
discussed implications of autophagy, pathogen infection, muscular disorders, immunity, 
cardiovascular, pulmonary and metabolic diseases are partly regulated by the 
autophagic pathway (Jiang & Mizushima, 2014; Levine & Kroemer, 2008). 
 
1.2.7 Atg8 Conjugation System 
The autophagosome elongation and sealing process involves two UBL systems, 
Atg8 and Atg5. Both of them work together in vivo, although in vitro the presence of the 
second one is not strictly necessary for their main goal, Atg8 lipidation. Since the main 
work in this thesis is focused on the Atg8 UBL system, a detailed description of its 





Atg8, a crucial protein in the autophagic process of autophagosome elongation 
in yeast, is the central player and also the final effector of the UBL system. At least 
eight Atg8 orthologs have been identified in mammals, divided into two subfamilies, 
LC3 and GABARAP. LC3A, LC3B, LC3B2 and LC3C constitute LC3 subfamily, 
whereas GABARAP, GABARAPL1, GABARAPL2/GATE-16 and GABARAPL3 
comprise the GABARAP one (Weidberg et al., 2010). In the context of this thesis, 
LC3B, GABARAP and GATE-16 will be studied. LC3B (MAP1LC3B; Microtubule 
associated protein 1 light chain 3 B) is the most extensively studied ortholog in 
mammals and it participates in autophagosome biogenesis as it does Atg8 in yeast. 
GATE-16 (Golgi-associated ATPase enhancer of 16 kDa) and GABARAP (γ-
aminobutyric acid type A receptor associated protein) were identified as an intra-Golgi 
vesicular transport factor and a protein that facilitates clustering of GABAA receptors in 
combination with microtubules, respectively (Tanida et al., 2004). Both of them are the 
most recently but less characterized orthologs in terms of their role in autophagosome 
formation.  
LC3B, GABARAP and GATE-16, as well as the other Atg8 orthologs, share a 
strong structural similarity with ubiquitin, despite the lack of similarity in amino acid 
sequence (Shpilka et al., 2011). The C-terminal ubiquitin core is mainly conserved, and 
the larger differences are located in the regions surrounding it (Figure 1.16). 
Atg8 UBL system contains three other proteins, ATG4, ATG7 (E1- like enzyme) 
and ATG3 (E2-like enzyme). ATG4 is a cysteine protease responsible for the post-
translational cleavage of LC3 last five amino acids to expose a C-terminal glycine 
(G120) (Kirisako et al., 2000). This glycine is essential for the final conjugation to PE.   
 
Figure 1.16. Crystal structures of 3 different mammalian orthologs of Atg8, and ubiquitin. 







Figure 1.17. Yeast Atg7 crystal structure. AD in red, ECTD in violet and NTD and CTD 







After that cleavage, LC3 (125 aa, 14.6 kDa) interacts with the E1-like enzyme of 
the system, ATG7. ATG7 (703 aa, 77.9 kDa) is a symmetric homodimer with two 
catalytic cysteine residues that allow it to activate two different UBL proteins, LC3 and 
Atg12 (Hong et al., 2011; Kaiser et al., 2013). Each Atg7 monomer is comprised of two 
globular domains, the C-terminal domain (CTD) and the N-terminal domain (NTD), 
connected by a short linker (Figure 1.17). The CTD includes an Adenylation domain 
(AD), the cysteine-containing domain and a final homodimerization motif (ECTD), 
whereas the NTD just recognizes the E2-like enzyme Atg3 or Atg10 (Noda et al., 
2011). Among these domains, the ECTD is suggested to be responsible for Atg7 
homodimerization and interaction with LC3, the cysteine-containing domain 
accommodates the catalytic cysteine (C572) which is critical for UBLs activation, and 
the AD binds the MgATP molecule necessary for the subsequent formation of thioester 
bonds between the proteins. In contrast, the NTD is unique in E2 enzymes, and it is 













ATG3, the E2-like enzyme of this system, receives LC3 from ATG7 and is 
thought to be engaged in bringing LC3 to the membrane for its final lipidation. Atg3 has 
mainly two characteristic regions, a handle region (HR) for interaction with LC3 and a 






Figure 1.18. Schematic representation of Atg8 UBL system.  [Taken from 
http://ruo.mbl.co.jp/g/product/protein/autophagy/autophagy.html] 
2007). Additionally, a predicted N-terminal α-helix is suggested to recognize the 
autophagosomal membrane (Nath et al., 2014). 
Taking this into consideration, the operation of the Atg8 UBL system is as 














I. First, ATG4 cleaves the last 5 amino acids of LC3, exposing a final Glycine 
(G120) to which PE can then be coupled during the following steps. 
II. Next, ATG7 binds both MgATP in its AD and LC3 in the ECTD. After moving 
LC3 from ECTD to AD, ATG7 catalyzes the adenylation of LC3 in its C-terminal 
Glycine. Subsequently, ATG7 catalytic cysteine (C572) attacks the LC3-acyl 
adenylate intermediate to generate a thioster bond between ATG7-LC3 
(Taherbhoy et al., 2011).  
III. Then, ATG3 associates with ATG7 NTD and a transthiolation reaction occurs 
whereby LC3 is transferred from ATG7 C572 to ATG3 C264 in a trans manner. 






Figure 1.19. Yeast Atg3 crystal structure. FR and HR domains indicated with dotted lines 
(left). Conserved α-helices and β-strands are coloured red and cyan, respectively, and non-
conserved α-helices, β-strands, and loop regions are coloured gray. The two unique inserted 
regions of Atg3, FR and HR, are coloured yellow (right). Regions lacking defined electron 
density are indicated with dotted lines (right).  
IV. Finally, ATG3 redirects LC3 to the autophagosomal membrane where the latter 
one will be transferred from ATG3´s catalytic cysteine to the amine head group 
of PE via an amide bond. This final reaction is stimulated by the other UBL 
system participating in autophagy, Atg5-Atg12-Atg16 complex. This complex 
acts as the E3-ligase enzyme of this sophisticated reaction. 
 
1.2.8 ATG3, the E2-like Enzyme in the Atg8 Conjugation System 
LC3 lipidation requires the approach of this protein to a PE-enriched membrane. 
This approach would be catalyzed by ATG3, the E2-like enzyme of the UBL system. 
ATG3 and canonical E2 enzymes have similar structures, despite having little 
sequence homology. Human ATG3 (314 aa, 35.8 kDa) has a partially conserved core 
region with two unique and large insertions, the FR and HR regions (Figure 1.19). 
These two regions participate in the interaction of ATG3 with the E1-like (ATG7) and 
the UBL (LC3) enzymes of the system, respectively. HR domain consists of a long α-
helix F and a loop, whereas the FR is a highly acidic, 80-100 residue long, very mobile 
domain situated between strands 2 and 3 (Yamada et al., 2007). Aditionally, ATG3 
interaction with membranes was proposed to be directed by the N-terminal region of 
the protein. In yeast, Atg3 first seven amino acids are essential to the recognition of 
PE-containing membranes and also to Atg8-PE formation (Hanada et al., 2009; Oh-oka 















In contrast, mouse ATG3, practically identical to human (97.5% identity), was 
suggested and demonstrated to insert into membranes through an N-terminal 
amphipathic helix comprising the first 26 amino acids of the protein (Nath et al., 2014). 
This helix would present a large hydrophobic moment and an amphipathic distribution. 
There are two hydrophobic and polar faces clearly separated by two lysines, one in 
each border and probably defining the surface of the bilayer. The hydrophobic face is 
mainly composed of small hydrophobic residues such as valine and leucine, just as the 
polar face contains small polar and anionic residues. These characteristics suggest a 
weak interaction with stable bilayers. Recently it has been proposed ATG3 N-terminal 
helix as a membrane curvature sensor, more specifically sensing membrane defects 
created in highly PE-enriched membranes. They demonstrated that ATG3 interacts 
more strongly with very small liposomes and that the lipidation reaction is most efficient 
in these small-sized vesicles (Nath et al., 2014). 
Taking this into consideration and comparing with other examples of curvature 
sensors and amphipathic helices containing proteins such as ADP-ribosylation factor 
GTPase-activating protein 1 (ArfGAP1) and Beclin 1-associated autophagy-related key 
regulator (Barkor) (Fan et al., 2011), or α-synuclein (Antonny, 2011; Bartels et al., 
2010; Jo et al., 2000), Atg3 shares some characteristics of both groups. It contains two 
lysines important for the interaction with the polar groups of phospholipids, but also a 
mildly hydrophobic face. So ATG3 ability to bind to membranes would rely on both 
properties. In this context, human ATG3 interaction with model membranes has been 
studied in this thesis. 
 
1.2.9 ATG9: the Only Transmembrane Atg Protein 
In yeast there is just one transmembrane protein involved in autophagy up to 
date: Atg9. It possesses 6 transmembrane helices, in addition to both N-terminus and 
C-terminus ends oriented to the cytosol (Figure 1.20). 
Atg9 has been well characterized in yeast, where it was demonstrated that in 
contrast to most of the Atg proteins, Atg9 does not localize to the preautophagosomal 
structure (PAS) (Mari & Reggiori, 2007). Atg9 seems to be located in some vesicles 
distributed around the cytosol. Its function is not yet known, but it was suggested to 
move cyclically to the PAS in order to deliver some membrane portions for 
autophagosome elongation. It is also thought that these vesicles are the membrane 






Figure 1.20. Schematic representation of Atg9. It consist of 6 transmembrane helices and two 
N- (68 aa) and C- terminal (342 aa) domains exposed to the cytosol. A glycosilation site is 
located in the first luminal loop. 
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autophagosomes, so it is thought that it is previously removed from there by the Atg1-
Atg13 complex, the PI3K complex, Atg2 and Atg18. Atg1 and PI3K complex would 
associate with the PAS and the Atg9 removal would start by recruiting at the same time 
Atg2 and Atg18 to the autophagosomal membrane (He et al., 2006; Reggiori et al., 
2004). Despite the no incorporation to the mature autophagosome, Atg9 has been 
demonstrated to be transiently embedded in the autophagosomal outer membrane 
(Yamamoto et al., 2012). Atg17-Atg29-Atg31 protein complex is suggested to bind to 
Atg9 vesicles through the interaction of Atg17 with Atg9. This complex would bind two 
Atg9 vesicles in order to carry out the tether and fusion of these vesicles and generate 

















From all the hypothesis about Atg9 trafficking, it could be extracted that if Atg9 
trafficking is increased then the autophagosome would grow. Some Atg9 intermolecular 
interactions would facilitate fusion of small vesicles that deliver membrane material for 
PAS elongation. 
In mammals, ATG9 (829 aa, 94.4 kDa) is also a multispanned protein with 6 
transmembrane helices, and both N and C terminal domains are exposed to the 
cytosol. However, there are some characteristics in these domains that confer specific 
properties to the mammalian homologue. In HEK293 cells, mATG9 is localised to the 
trans-Golgi region and to peripheral endosomes when cells are grown in complete 





autophagy is induced and mATG9 moves away from these regions, and colocalizes 
with Rab7 and GFP-LC3 (Longatti et al., 2012; Orsi et al., 2012). Comparing with the 
Atg9 behaviour in yeast, there is no evidence of proteins that interact with Atg9 in order 
to fuse Atg9 vesicles as in the case of Atg17-Atg29-Atg31 complex in yeast. Therefore 
further efforts must be done in this context to establish the basic molecular mechanism 
of autophagy initiation. 
Taking this into account and considering that there is no data about hATG9 
function in vitro, an important contribution in this area must be done. The continuous 
movement of the hATG9 vesicles in the cytoplasm might contribute to the regulation of 
autophagosome size. The delivery of these vesicles to the forming autophagosome 
might provide lipid material for its growth. Thus recombinant hATG9 purification has 
been tried in order to know the presence of lipids associated to the protein and to 















 The present work is focused on a better understanding of how autophagosome 
elongates and of the proteins involved in the process. Atg8 lipidation is proposed to 
engage in vesicle-phagophore fusion events along the nascent autophagosome 
growth. The involvement of lipid-lipid and protein-lipid interactions in this process 
constitutes the basis of our interest in the autophagy pathway. Biophysical approaches 
applying model membrane techniques, well established in our laboratory, have been 
used to progress in the knowledge of this aspect of cell molecular biology. 
 
The specific aims of this thesis are the following: 
 
- To in vitro reconstitute the autophagosome elongation process with a minimal 
protein ensemble constituted by the human Atg8/ATG3/ATG7 UBL system. 
 
- To investigate the interaction of ATG3 with model membranes and its possible 
role in the human Atg8 lipidation process. 
 
- To express and purify the transmembrane protein ATG9 in order to explore its 









































 Experimental Techniques  
 
2.1 Molecular Biology Methods 
Molecular biology techniques make possible to isolate, purify and modify DNA 
sequences encoding the protein of interest (Sambrook & MacCallum, 2001). In this 
work, we have applied standard recombinant DNA techniques in order to clone cDNAs 
of several Atg proteins into bacterial and insect expression vectors as well as to 
perform mutations in their sequences for analyzing the implication of selected residues 
in the overall protein function.  
 
2.1.1 DNA Amplification and Cloning  
In order to clone the cDNA of interest, a DNA fragment is PCR-amplified and 
inserted into a self-replicating genetic element, generally a plasmid, usually called the 
vector. The process can be divided in: 1) PCR Amplification, 2) Digestion, 3) DNA 
purification, 4) Ligation, 5) Transformation in E.coli, 6) Extraction, and 7) Confirmation 
the presence of the insert in the vector (Figure 2.1). 
 
1. PCR Amplification and Purification:  
cDNA of interest was PCR-amplified using a MastercyclerPro 
Thermocycler (Eppendorf AG, Hamburg, Germany) with PfuTurbo DNA 
Polymerase (Agilent Technologies, Santa Clara, CAL, U.S.A) using the indicated 
general PCR conditions. Forward and reverse primers, carrying the appropriate 
restriction sites allowing ligation in the target vectors, were synthesized by Sigma 
Aldrich (Madrid, Spain). The PCR product was subjected to purification using 








Figure 2.1. General cloning steps. (1) PCR amplification, (2) Digestion, (3) Purification, (4) 
Ligation, (5) Transformation in E.coli, (6) DNA isolation and (7) Checking for the presence of 









Both PCR product and target vector were digested with the same 
restriction enzymes (New England Biolabs, Canada) for 1 hour at 37 ºC. To avoid 
self-ligation, the vector was subjected to dephosphorylation using shrimp alkaline 
phosphatase (USB Corp, Cleveland, OH, U.S.A) for 1 hour at 37 ºC. Restriction 














3. Purification of Digestion Products: 
Digestion products were diluted in Loading Dye Solution (Thermo 
Scientific, Waltham, MA, U.S.A); loaded on 1-2% agarose gels and then gel 
purified using the QIAquick Gel Extraction Kit (Qiagen, California, U.S.A.).  
 
4. Ligation: 
Ligations were performed at 16 ºC overnight using T4 DNA ligase 







5. Transformation in E.coli: 
For transformation of ligation products, ligation mixture was added 
to 50 μl of XL10-Gold Ultracompetent Cells (Agilent Technologies, Santa Clara, 
CAL, U.S.A). Cells were first incubated on ice for 15 min, and then heat-shocked 
for 90 s in a bath at 42 ºC. The mixture was immediately transferred to an ice 
bucket and incubated for 2 min to allow cell recovery. Next the mixture was placed 
in a tube with 1 ml Luria Broth (LB) medium and incubated with gentle stirring at 37 
ºC for 45 min. Finally, cells were spun down in a benchtop centrifuge at 8,000 xg 
for 1 min. The pellet was resuspended in 50 μl LB, plated in an agar plate with the 
appropriate antibiotic and incubated at 37 ºC overnight. 
 
6. Confirmation the Presence of the Insert in the Vector: 
If present, several colonies were randomly picked from the agar 
plate and grown overnight at 37 ºC in 5 ml LB medium containing the appropriate 
antibiotics. For isolation of plasmidic DNA, cells were subjected to alkaline lysis 
followed by DNA purification using a miniprep spin kit (Qiagen, California, U.S.A) 
following the manufacturer’s instructions. DNA concentration was determined by 
measuring the absorbance of the sample at 260 nm (A260), and its purity from the 
A260/A280 ratio in a NanodropTM spectrophotometer (Thermo Scientific, Waltham, 
MA, U.S.A). DNAs were digested with appropriate restriction enzymes at 37 ºC for 
1 h and subjected to electrophoresis to check that the insert was present. Any 
mutation introduced during PCR amplification was discarded by sequencing 
(Secugen S.L, Madrid, Spain).  
 
2.1.2 Site-directed Mutagenesis  
In vitro site-directed mutagenesis is an invaluable technique for determining the 
contribution of individual amino acids to the structure and function of a given protein. 
Over the past two decades, highly effective simple methods for making site-directed 
mutations without subcloning have been developed (Fisher & Pei, 1997). In this work, 
we have used Stratagene Quikchange Site-Directed Mutagenesis Kit (Agilent 
Technologies, Santa Clara, CAL, U.S.A) to perform point mutations in ATG3.  
The basic procedure utilizes an initial template double-stranded DNA (dsDNA) 
and two synthetic oligonucleotide primers containing the desired mutation (Table 2.1). 
The oligonucleotide primers, each complementary to opposite strands of the vector, are 





Protocol 1. Site-directed Mutagenesis  
1. Mutagenic primers are designed using Stratagene´s web-based primer design 
program (http://www.stratagene.com/cprimerdesign.com) which basically 
designs primers with a melting temperature (Tm) of at least 78 ºC and centers 
the mutation in the middle. 
2. Mix: 
 0.5 μl Forward primer (2.5 pmoles/μl)  
 0.5 μl Reverse primer (2.5 pmoles/μl)  
 0.5 μl template DNA (10 ng/μl) 
 0.5 μl 40 mM dNTP mix (10 mM each) 
 0.5 μl Pfu Turbo Polymerase (2.5 U/μl) 
 5 μl Polymerase buffer (5X) 
 17.5 μl sterilized H2O 
3. PCR program: 
o 5 min 95 ºC 
o Repeat x18 
 30 s 95 ºC 
 1 min 55 ºC 
 2 min 72 ºC 
o 7 min 72 ºC 
(Agilent). Incorporation of the oligonucleotide primers generates a mutated plasmid 
containing staggered nicks. Following temperature cycling, the product is treated with 
DpnI. The DpnI endonuclease (target sequence: 5´-Gm6ATC-3´) is specific for 
methylated and hemimethylated DNA and is used to digest the parental DNA template 
and to select for mutations containing synthesized DNA. The nicked vector containing 
the desired mutations is then transformed into XL10-Gold Ultracompetent Cells 
(Agilent).  
 In the following protocol (Protocol 1), the general procedure used in this work 
to perform point mutations in ATG3 is shown. However, for particular cases where the 
reaction failed, the protocol was modified by dropping the primer concentration, 




























2.2 Recombinant Protein Expression and Purification 
2.2.1 Protein Expression  
Plasmids of LC3, GATE-16, GABARAP, ATG3 and their corresponding mutant 
forms were transformed onto E. coli BL21 (DE3) cells. Information about bacterial 
strains used for hATG9 expression are detailed in Chapter 5. Proteins were expressed 
as Glutathione S-transferase (GST)-tagged fusion proteins. First, cells were picked 
from a E.coli BL21 (DE3) glycerol stock into a 100 ml flask containing LB-Ampicillin 
(Amp) medium, and were incubated in an orbital shaker at 37 ºC overnight. The culture 
was escalated by adding 10 ml of the overnight saturated culture to 1 l LB-Amp 
medium, and the mixture was incubated at 37 ºC to 0.6-0.8 Optical Density (OD600), 
then Isopropil-β-D-1-tiogalactopiranósido (IPTG) was added to start the induction of the 
recombinant protein expression. Due to differences in protein expression levels and 
susceptibility to proteolysis, different induction and expression times were optimized for 
each protein (Table 2.2). After IPTG addition, samples were incubated in an orbital 
shaker for the indicated times and bacteria were collected by centrifugation (5000 xg 
for 20 min, 4 ºC) in a Beckman Coulter centrifuge using a JLA-9.100 rotor (Beckman 
Coulter, Fullerton, California, U.S.A). The supernatant was discarded and the pellet 





Protein Expression Conditions 
LC3/GATE-16 3 h at 37 ºC 
GABARAP 4 h at 20 ºC 
ATG3 18 h at 18 ºC 
Table 2.2. Conditions for expression of recombinant proteins. 
4. DpnI digestion is performed by adding 0.25 μl of DpnI (20 U/μl) to the reaction 
mixture, and incubating at 37 ºC for 1 h. 
5. The final reaction product is transformed into competent cells. Generally, 1 μl is 
added into 50 μl of XL10-Gold Ultracompetent cells. 
6. Finally a colony is picked, the DNA is amplified by miniprep and sequenced to 






2.2.2 Purification of GST-tagged Proteins (LC3, GATE-16, GABARAP and 
ATG3) 
In order to start with the purification procedure, cells were subjected to the 
disruption and lysate clearance steps. Bacterial pellets were resuspended in 
appropriate Lysis buffer [10 mM PBS, 20 mM Tris-HCl pH 7, 150 mM NaCl, 
supplemented with freshly prepared 1 mg/ml lysozyme (Sigma- Aldrich), 1 mM 
Dithiothreitol (DTT)(Sigma-Aldrich), bacterial protein inhibitors (Roche, Basel, 
Switzerland) and 2.5 μg/ml DNAase ( igma-Aldrich)]. The mixture was then incubated 
at 4 ºC in an orbital shaker for 40 min to allow disruption of the bacterial cell wall by 
lysozyme. Samples were then subjected to sonication on ice, to avoid overheating, 10 
s on/10 s off 40 cycles twice. After cell disruption, the resultant suspension was 
centrifuged at 30000 xg for 30 min at 4 ºC in a Beckman Coulter centrifuge using JA-
25-50 rotor (Beckman Coulter, Fullerton, California, U.S.A). The pellet was discarded 
and the supernatant was filtered through 0.45 μm and 0.2 μm filters, and finally kept on 
ice for subsequent purification steps. 
GST-tagged LC3, GATE-16, GABARAP and ATG3 were purified by affinity 
chromatography using Glutathione Sepharose 4B beads (GE Healthcare). For each 4 l 
bacterial culture, 1 ml beads was required. Beads were first washed three times with 
ten bed volumes of distilled water and then five times with Lysis buffer by 
centrifugation. The bacterial supernatant was mixed with washed beads and the 
mixture was incubated for 3 h in an orbital rotator at 4 ºC to allow binding of 
Glutathione S-Transferase to glutathione. The beads with bound proteins were packed 
in a gravity flow column (Biorad), and the Flow-Through (FT) was removed. After that 
the column is washed with 10 bed volumes of each buffer described in Table 2.3. 
Then, 50 μl (Stock: 2000 units/ml) PreScission protease (GE Healthcare, Waukesha, 
WI, USA) were added to the beads in a 2 ml final volume. The mixture was transferred 
to a 15 ml falcon tube and incubated for 4 h in an orbital rotator at 4 ºC to allow efficient 
protease cleavage. The cleaved protein was eluted from the gravity flow column with 
Prescission buffer and two fractions of 4 ml were collected. After that another 4 ml 
Prescission buffer were added to the column with the beads and it was stored 
overnight at 4 ºC. Finally, the next day two more 4 ml fractions were eluted and 
subjected to SDS-PAGE analysis and Coommassie Blue staining. Protein enriched 








2.3 Baculovirus Expression Vector System  
Microbial expression systems have been widely used for recombinant protein 
production. Well-known examples are the production of insulin, using Escherichia coli 
and the production of bovine growth hormone using Saccharomyces cerevisiae 
(Swartz, 2001). Many complex proteins, such as functional monoclonal antibodies or 
highly glycosylated proteins require post-translational processing for which the 
metabolic machinery is only available in higher eukaryotic or mammalian cells (Butler, 
2006). While mammalian cells are the best to produce these proteins, they are also 
more costly for large scale production and can lead to immune reactions when used in 
therapeutic production. Another way of getting proteins is by extracting them from 
plants or animals directly, but that makes the process very expensive and leads to the 
sacrifice of many animals. Also, this method of production requires the often very 
difficult protein isolation from a plant or animal. The baculovirus expression vector 
system (BEVS) was developed in the 1980s. This system can be used to express 
proteins in insect cell lines and produce valuable and functional proteins that are similar 
to mammalian cell proteins. Proteins produced by BEVS can reduce the production 
time, as it takes a relatively short time to obtain a recombinant Autographa californica 
multiple nucleopolyhedrovirus (AcMNPV) for expressing a protein. Thus, the BEVS 
provides an intermediate approach between microbial and mammalian expression 
systems that is cost- and quality-effective. However a major problem with BEVS is the 
production of excess reactive oxygen species (RO ) e.g. superoxide radical (O2 •-) 
and hydroperoxide radical (•OH) resulting in oxidative stress following viral infection of 
the cell. These oxidative stresses result in earlier cell death that reduces protein 
production.  
 
Buffer  Buffer composition 
Washing buffer 
1 PBS1x pH 7.4 + 1 mM DTT 
2 PBS1x/TRIS 50 mM pH 8.7 + 1 mM DTT 
3 PBS1x/TRIS 50 mM, NaCl 500 mM pH 8.7 + 1 mM DTT 
Prescission buffer  50 mM TRIS, 150 mM NaCl, 1 mM EDTA, pH 7.5 + 1 mM DTT. 





2.3.1 Baculovirus as Expression Vector  
The Baculovirus (BV) infection in cell culture can be divided into three phases, 
namely early phase, or the reprogramming of the cells for virus replication, followed by 
the late phase for BV production, and then the very late phase for Occluded Virus (OV) 
production. The early phase lasts for about the first six hours post infection (hpi). 
During this time the cells undergo significant changes, e.g., cytoskeleton re-
arrangements, host chromatin dispersion within the nucleus and cell enlargement. 
These changes occur primarily due to new proteins expressed following viral infection. 
The late phase lasts from 6 hpi to approximately 20-24 hpi. This stage mainly accounts 
for Baculovirus production. The very late phase begins at approximately 20 hpi. The 
production of OVs mainly occurs in this phase and can be marked by the presence of 
occlusion bodies in the nucleus. Polyhedra occlusion bodies have a crystalline nature 
and tend to give a highly refractive appearance to the group of infected cells or 
plaques.  
The two most commonly used BV are Bombyx mori nucleopolyhedrovirus 
(BmNPV) and Autographa californica multiple nucleopolyhedrovirus (AcMNPV). Both of 
these viruses have a genome of approximately 130 kbp. The polyhedrin gene (polh) is 
expressed at very high levels during a separate and final phase of infection and this 
gene product is found to be non-essential for virus replication in cell culture (Smith et 
al., 1983a). Thus, the first recombinant baculovirus was developed by replacing the 
polh gene with a heterogeneous gene under the control of the polh promoter (Miller et 
al., 1983; Pennock et al., 1984; Smith et al., 1983b) and this is still used for most 
baculovirus expression vectors. This is also due to the fact that the polyhedron gene 
has a very strong promoter, leading to the accumulation of recombinant protein to 
levels as high as 50 % of the total cell protein. Also, expression vectors have been 
developed with multiple copies of this promoter that can be used to simultaneously 
express several recombinant proteins (Belyaev et al., 1995).  
Moreover, the rod shape of the nucleocapsids of Baculovirus can accommodate 
large viral DNA genomes, thereby allowing for DNA insertions at least as large as 15 
kbp. BV vectors are relatively simple to use as they are independent of helper-virus. 
Construction of recombinant Baculovirus is easier than cloning and isolating stable cell 







2.3.2 Insect Cell Lines 
Insect cell lines have intermediate properties between mammalian cell lines and 
bacterial cell lines. Insect cells can perform post-translational protein folding like 
mammalian cells. However, it has been recognized that the protein processing 
pathways of insect cell lines differ from mammalian cell lines. For instance, the N- and 
O-linked glycosylations happen in a fundamentally different manner. Furthermore, 
protein production is dependent on the insect cell line, some insect cell lines just may 
not be able to produce a functional protein, while others can successfully carry out the 
protein processing (Harrison & Jarvis, 2007). The three most commonly used insect 
cell lines for BV expression are BTI-TN-5B1-4 (H5; High Five cells), which are derived 
from the eggs of Trichoplusia ni, Sf-21 cells, which were heterogeneously derived from 
pupal ovarian tissue of Spodoptera frugiperda, and Sf-9 cells, which were cloned from 
the Sf-21 cell line to maximize β-galactosidase production during BV expression. The 
Sf-21 and Sf-9 cell lines are most commonly used for transfection, viral amplification 
and protein expression while H5 are primarily used for protein expression (Murhammer, 
2007). 
 
2.3.3 Recombinant Protein Expression Using the Baculovirus-Insect Cell 
System 
For the expression of recombinant hATG9 and hATG7 using the Baculovirus 
expression system the following cell lines, vectors and general procedures are 
required. 
 
A) Eukaryotic Cells 
In order to generate, amplify and express the recombinant Baculoviruses (rBV) 
the cell line High Five TM (H5) (BTI-TN-5B1-4) (Invitrogen) was used. This cell line is 
an isolated cell clon of Trichoplusia ni. H5 cells were cultured in TC-100 medium 
(GIBCO) supplemented with 10% Fetal Calf Serum (FCS), penicillin (100 U/ml), 







B) pFastBacHTa and pFastBac1 
These plasmids were used to generate the hATG7 and hATG9 CT, and the 
hATG9 FL rBVs respectively. Heterologous genes (hATG7 and hATG9) cloned in this 
plasmid are under control of the polyhedrin gene promotor, and are flanked by specific 
sites for the recombinant gene transposition into the bacmid. Recombinant proteins 
produced through this vector contain a 6xHis sequence in their N-terminal end and a 
16-aminoacid linker that includes a Tobacco Etch Virus nuclear-inclusion-a 
endopeptidase (TEV protease) cleavage site. 
 
C) Baculovirus 
This virus was generated through genetic manipulation of an isolated 
Autographa californica polyhedrovirus (AcPHV). Production of the recombinant 
baculoviruses was achieved from BV FastBac strain (Invitrogen). The produced rBV 
express the corresponding proteins (hATG7 or hATG9) fused to an N-terminal 6xHis 
tag. 
 
D) Bac to Bac System 
rBV were generated with a Bac-to-Bac system (Invitrogen) following the 
manufacturer´s instructions. This method is based on the transposition of the 
recombinant genes into the infective genome of the Baculovirus, which is present in a 
vector (called bacmid) multiplied in the E. coli DH10Bac strain (Luckow et al., 1993). 
Once the relevant sequence is cloned in the donor plasmid (pFastBacHTa), this 
plasmid will be used to transform DH10Bac bacteria where the recombinant gene 
transposition into the bacmid will take place. Then, the recombinant bacmid containing 
the relevant gene is selected, and the rBV are generated by H5 cell transfection with 
these bacmids. Finally, rBV are amplified through H5 cell infection with the bacmid-








2.3.4 hATG7 Protein Cloning 
A plasmid containing human ATG7 (hATG7-PGEX-6P-2) sequence was kindly 
provided by Dr. Isei Tanida (National Institute of Infectious Diseases, Tokyo, Japan).  
hATG7 sequence was amplified using the designed oligonucleotides, hATG7 
cloning forward and hATG7 cloning reverse (Table 2.4), and subsequently digested 
with the restriction enzymes EcoRI and SalI to clone the fragment into a pFastBac-HTa 
vector. 
Thereupon the ligation product was used to transform E. coli DH5α cells to keep 
the DNA and check the reaction efficiency. The presence of the correct sequence was 
checked by agarose gel and sequencing.  
DH10Bac cells contain the required bacmid for the next insect cell infection and 
are used to select the correct transposition of the hATG7 gene from the donor plasmid 
to the bacmid. Hence, DH10Bac cells were transformed with the hATG7-pFastBac-HTa 
plasmid. Blue-white screening was performed to select the white colonies that contain 
the bacmid with the hATG7 sequence inside. Next the bacmid was isolated, purified 
and finally the presence of the corresponding sequence was confirmed by PCR. 
hATG7-containing bacmid was stored at 4 ºC. 
 
 















2.3.5 hATG9 Protein Cloning 
A plasmid containing human ATG9 (ATG9 FL 441) sequence was kindly 
provided by Dr. Sharon Tooze (Cancer Research UK, London Research Institute, 
London, UK). 
Two different constructs were amplified (hATG9 FL and hATG9 CT) using 
specific oligonucleotides (Table 2.5). The resulting fragments were subsequently 
digested with the restriction enzymes NcoI and SalI (hATG9 CT), and BamHI and SalI 
(hATG9 FL) to clone the fragment into a pFastBac-HTa and pFastBac1 vectors 
respectively. Thereupon the ligation products were used to transform E. coli DH5α cells 
to keep the DNA and check the reaction efficiency. The presence of the correct 
sequence was checked by agarose gel and sequencing.  
DH10Bac cells contain the required bacmid for the next insect cell infection and 
are used to select the correct transposition of the hATG9 FL and hATG9 CT genes 
from the donor plasmid to the bacmid. Hence, DH10Bac cells were transformed with 
the hATG9 CT-pFastBac-HTa or hATG9 FL-pFastBac1 plasmid. Blue-white screening 
was performed to select the white colonies that contain the bacmid with the correct 
sequence inside. Next the bacmid was isolated, purified and finally the presence of the 
corresponding sequence was confirmed by PCR. hATG9-containing bacmids were 










Oligonucleotide  Sequence 
hATG9 CT cloning 
Forward 5´-CGCGCCATGGCCCGGGCCCTGGAGATTATAGACTTC-3´ 
Reverse 5´-GCGCGTCGACTATACCTTGTGCACCTGAGGG-3´ 
hAT9 FL Fragment 1 
Forward 5´-GGCTCCCTTATCACCATCCTGG-3´ 
Reverse 5´-GCGCGTCGACTATACCTTGTGCACCTGAGGG-3´ 





2.3.6 Transfection with Recombinant Bacmid 
A 75% confluent p60 plate of H5 insect cells was transfected following the 
steps: 4 μg hATG7-pFastBac-HTa, hATG9 CT-pFastBac-HTa or hATG9 FL-pFastBac1 
were incubated with 30 μl lipofectine in a 1:2.5 lipofectine:vector proportion for 30 min 
at RT. Then, the mixture was added over the cell culture and incubated for 5 h at 28 
ºC. Finally, the lipofectine:vector mix was removed and replaced by TC-100 medium 
supplemented with 5% FCS. Transfected cells were incubated for 5-6 days at 28 ºC 
until cytophatic effect was observed. 
At this stage, the culture supernatant was collected, centrifuged for 10 min at 
3000 rpm and 4 ºC, and then stored as 1st Recombinant Baculovirus stock (P1) at 4 
ºC. It contains the first population of viruses with the recombinant gene incorporated in 
their genome. In addition, the pellet fraction was used to analyze the recombinant 
protein expression by SDS-PAGE and Western Blot. 
Once it was known that hATG7, hATG9 CT and hATG9 FL were being 
expressed, the next action was to amplify the P1 stock to get a 2nd Recombinant 
Baculovirus Stock (P2) that contains a higher virus titer. Two 80% confluent p150 
plates were infected with a Multiplicity of Infection (MOI) 1-5 PFU/cell (20 μl of P1 
stock), and incubated for 4-5 days at 28 ºC until the cytophatic effect was evident. As in 
the case of P1 stock, the supernatant was stored at 4 ºC. This P2 stock is used for the 
next steps of H5 cells infection to produce the proteins on a large scale. 
For the purpose of determining the optimal quantity of virus and time of infection 
to get the best protein expression, virus and time titration were performed. Different 






quantities of P2 stock were used to infect confluent wells of a M6 plate and also some 
infection times were tested. hATG7, hATG9 CT and hATG9 FL expression quality was 
checked by SDS-PAGE. 
 
2.3.7 Purification of 6xHis-tagged Human ATG7 and ATG9-CT 
48 h after hATG7 or hATG9-rBV infection, H5 cells were collected and 
centrifuged at 500 xg for 5 min at 4 ºC. Then the supernatant was removed and the cell 
pellet washed with cold PBS and subjected to a new centrifugation. The pellet was 
stored at -80 ºC for the following protein purification steps.  
Cell pellets were resuspended in ATG7 Lysis buffer  [50 mM Tris-HCl pH 8, and 
150 mM NaCl supplemented with freshly prepared 1 mM TCEP (Sigma-Aldrich) and 
EDTA-free protein inhibitors (Roche, Basel, Switzerland)]. The mixture was incubated 
at 4 ºC on ice for 30 min to allow cell disruption. Samples were then subjected to 
sonication on ice, to avoid overheating, 5x 40 s on/60 s off cycles. After cell disruption, 
the resultant suspension was centrifuged at 30000 xg for 30 min at 4 ºC in a Beckman 
Coulter centrifuge using a JA-25-50 rotor (Beckman Coulter, Fullerton, California, 
U.S.A). The pellet was discarded and the supernatant was finally kept on ice.  
6xHis-tagged full-length hATG7 or hATG9-CT were purified by affinity 
chromatography using “Talon Metal Affinity Resin” (Clontech). For each 10 p150 plates 
of insect cell culture, 1 ml beads was required. Beads were first washed three times 
with 10 bed volumes of distilled water and then 5 times with 10 bed volumes of ATG7 
Lysis buffer followed by centrifugation for 5 min at 1000 xg. The cell supernatant was 
mixed with washed beads and the mixture was incubated for 3 h in an orbital-rotator at 
4 ºC to allow binding of 6xHis-tagged proteins to cobalt-containing beads. The beads 
with bound proteins were collected by centrifugation (1000 xg, 5 min, 4 ºC), the 
supernatant was removed and the beads with bound proteins were subjected to a 
washing step. The cobalt resin was washed 5 times with 10 bed volumes of Washing 
buffer (50 mM Tris-HCl pH 8, 150 mM NaCl, 1 mM TCEP and 5 mM Imidazole). The 
protein was eluted using Elution buffer (50 mM Tris-HCl pH 8, 150 mM NaCl, 1 mM 
TCEP and 500 mM imidazole supplemented with EDTA-free protein inhibitors) and 10 
fractions of 0.5 ml were collected for SDS-PAGE analysis and Coomassie-Blue 
staining. Fractions enriched in hATG7 protein were concentrated in Amicon Ultra 
Centrifugal Filter Units (Millipore) up to a 500 μl-volume, and they were loaded into a 





in Superdex Elution buffer (50 mM Tris-HCl pH 8, 150 mM NaCl and 1 mM DTT 
supplemented with protein inhibitors). Sample elution was performed at a 0.3 ml/min 
flow-rate at 4 ºC. Protein elution was followed by monitoring UV absorbance at 280 nm, 
and 0.5-ml fractions were collected. Peak protein fractions were analyzed by SDS-
PAGE and Coomassie-Blue staining. Finally, fractions containing pure hATG7 were 
concentrated in Amicon Ultra Centrifugal Filter Units (Millipore) up to the desired 
concentration. 
 
2.4 Membrane Lipid Model Systems  
Numerous model membrane systems have been developed for studying the 
properties of pure lipids, lipid mixtures, and reconstituted lipid-protein systems. A 
variety of model membrane systems is required as no single system is suitable for all 
the techniques used in their study. These model systems can be grouped as (1) 
monolayers, (2) planar bilayers, and (3) liposomes or vesicles (Gennis, 1989). In the 
present work two of them have been used: i) lipid vesicles or liposomes, and ii) lipid 
monolayers. A detailed explanation of their principal applications and their preparation 
procedures is given.  
 
2.4.1 Lipid Vesicles (Liposomes)  
A lipid structure in a bilayer configuration enclosing an aqueous solution is 
called a liposome. Liposomes are spontaneously generated when dispersing 
cylindrical-shaped lipids in aqueous solutions, thus they constitute a convenient source 
of lipidic model membranes. Depending on the treatment, liposomes can be prepared 
to have a single or several bilayers or lamellae, being unilamellar vesicles the principal 
system used in this work (Figure 2.3). However, research with both kinds of vesicles 
and various biophysical techniques provides essential information for our 
understanding of most membrane processes.  
Liposomes have been extensively used for measuring fusion, fission, 
solubilisation, leakage, lipid flip-flop, lipid-protein binding, protein-protein binding and 
many more events. An interesting application is the use of liposomes for drug 






Figure 2.3. Outline of the phospholipid organization in vesicles of various sizes (SUV, 
LUV, GUV and MLV). 
< 60 nm
side effects can be reduced and a more specific and gradual drug release within the 
target area can be achieved (Gregoriadis, 1978, 2008). Nowadays, liposomes as drug 
carriers are largely been tested in anticancer therapies [See (Allen & Cullis, 2013; 
Dass, 2008; Noble et al., 2014) for recent reviews on the methodology and liposome 












2.4.2 Multilamellar Vesicles (MLVs) 
In the early 60´s, the British haematologist Alec Bangham and collaborators 
characterised the first known liposomes in Cambridge by looking at lecithin dispersions 
under electron microscopy (Bangham & Horne, 1964). As he pointed out, some 
“spherulites” containing concentric lamellae were formed. Vesicles were formed either 
by hand-shaking or by sonication, the latter inducing the formation of vesicles with 
fewer lamellae. These vesicles are nowadays commonly known as multilamellar 
vesicles (MLVs) and mostly used in lipid biophysical studies for the characterization of 
lipid phases either by differential scanning calorimetry (DSC), nuclear magnetic 
resonance (NMR) or x-ray diffraction techniques. After lipid hydration and sample 
shaking, MLVs are spontaneously formed usually containing between 7 and 10 





heterogeneous in size, displaying an average diameter of around 700 nm but ranging 
from 100 to 5000 nm (Figure 2.3).  
MLV generation is the simplest and fastest of all liposome formation methods. A 
detailed protocol for multilamellar vesicle preparation used in the present work is 
described (Protocol 2). 
 
 
2.4.3 Large Unilamellar Vesicles (LUVs)  
MLVs are easy and fast to prepare, but they have an important drawback. 
When treating vesicles with a solubilising agent, or when looking at a protein effect 
upon binding to the vesicle, only the effects of interaction with lipids on the external 
bilayer can be achieved, thus making difficult data analysis and interpretation. To 
overcome this issue, unilamellar vesicles are generally used (Figure 2.3). Unilamellar 
vesicles are classified according to their size, those with an average diameter of less 
Protocol 2. Multilamellar Vesicles (MLVs) 
1. Pure lipid stocks are prepared by dispersing lipids in powder in chloroform/methanol 
(2:1 v/v) to the desired concentration.  
2. The desired amount of lipid is pipetted from the stock in organic solution into a glass 
test tube.  
3. The organic solvent is evaporated under a nitrogen gas flow.  
4. To completely remove any traces of organic solvent, the sample is placed into a high 
vacuum desiccator for 2 h to obtain a solvent-free dried lipid film at the bottom of the 
test tube. 
5. Finally the lipid is hydrated by pipetting the desired amount of an aqueous solution at 
a temperature above the lipid main phase transition temperature and the suspension 
is shaken by vigourous vortexing for lipid detachment from the bottom of the test 
tube. By increasing temperature, the lipid is hydrated faster and, when preparing 
vesicles with a mixture of lipids, a more homogeneous lipid composition through the 
vesicles can be expected by maintaining every lipid in the fluid phase state. This 






than 60 nm being named SUVs (small unilamellar vesicles), those with an average 
diameter between 100 and 500 nm are LUVs (large unilamellar vesicles) and those 
with larger, micrometer-ranged diameters, are GUVs (giant unilamellar vesicles). Apart 
from their size, they differ from each other in the method of preparation.  
Large unilamellar vesicles present, in contrast to small vesicles, low curvature 
stress and so, when preparing LUVs containing a mixture of lipid species, a 
homogeneous lipid distribution through both monolayers in stable lipid vesicles is 
generally obtained. In this way, LUVs represent a very good model system for most 
studies. LUVs are generally prepared by mechanical extrusion of MLV suspensions 
through polycarbonate porous filters of the desired pore size (Mayer et al., 1986). A 












2.4.4 Small Unilamellar Vesicles (SUVs) 
Due to their small diameter (smaller than 60 nm) SUVs present a high curvature 
stress, which induces a lipid enrichment in the external monolayer as compared to the 
Protocol 3. Large Unilamellar Vesicles (LUVs) 
1. Steps 1-5 of MLV preparation protocol (Protocol 1) 
2. The MLV solution is subjected to 10 freeze/thaw cycles in order to reduce the number 
of lamellae in the vesicles. This is obtained as a result of placing the vesicles in liquid 
nitrogen for 1 min, then placing these vesicles in a water bath at a temperature above 
that of the lipid with the highest main transition temperature. Finally the suspension is 
vortexed before starting the next cycle.  
3. Vesicles are extruded 10 times through polycarbonate filters of the desired diameter 
(usually between 0.1 and 0.4 μm), using a high-pressure extruder (nitrogen gas flow). 
The extruder can be connected to a water bath in order to maintain the vesicles at a 
high temperature if necessary.  
4. The concentration of the vesicle suspension is assayed using the Fiske method 
(Protocol 6), because some lipid can be lost in the process. 
5. Finally it is important to check vesicle size using dynamic light scattering (DLS) (see 






inner one (Szoka & Papahadjopoulos, 1980). Their curvature stress makes these 
vesicles good model membranes for the study of membrane fusion and/or fission 
related processes (Nieva et al., 1989), because they may be subjected to such stress 
conditions in vivo. Small unilamellar vesicles are usually prepared by sonication of MLV 
suspensions. This is basically done either by bath sonication or probe tip sonication, in 
the latter case probes are immersed in the MLV suspension for sonication. In this way, 
large MLV are broken down into small unilamellar vesicles. In the present work, small 
unilamellar vesicles have been prepared by probe tip sonication. Thus, the protocol for 
SUV generation is that of the MLV but with final sonication of the vesicles for 20 min 
(10 s on/ 10 s off). Finally, SUV preparation is centrifuged at 14500 rpm, 10 min to 
remove aggregates and traces of the sonicator tip. SUV generation can be directly 
observed as the vesicle solution becomes transparent. 
 
2.4.5 Giant Unilamellar Vesicles (GUVs)  
Giant unilamellar vesicles are nowadays one of the most promising model 
systems in the study of membrane heterogeneity. Their size, in the order of 5-100 
micrometers as prepared by electroformation, i.e. comparable to a cell, allows 
performing direct microscopy on individual vesicles. The generation of giant vesicles 
was first described in 1969 by John P. Reeves and Robert M. Dowben exposing dry 
lipid films to aqueous solutions at temperatures above that of the lipid main phase 
transition temperature for 24 hours (Reeves & Dowben, 1969). Giant vesicles were 
spontaneously generated but with very low total lipid yield and a very heterogeneous 
size distribution. 
 In 1986, Miglena I. Angelova and Dimiter S. Dimitrov developed a new method 
for the generation of giant vesicles based on the exposure of dry lipid films to an 
aqueous solution under electric fields, which is the most generally applied procedure in 
the present (Angelova & Dimitrov, 1986; Angelova et al., 1992) (Figure 2.4). As in the 
initial procedure, the aqueous solution is kept at temperatures higher than that of the 
lipid with the highest main phase transition, but the method is much faster and a higher 
amount of homogeneous size vesicles can be obtained. Vesicle generation under 
electric fields is strongly dependent on the lipid composition, aqueous solution ionic 
strength and pH, and on the electric voltage and frequency conditions (Bagatolli, 2003). 






Figure 2.4 Outline of GUV electroformation. The electric field makes the lipid films (A) to 
grow/fuse (B) and detach (C) yielding GUV. [Adapted from Angelova and Dimitrov (1986)]  
A B C
under this procedure. However, the approach has considerably evolved and nowadays 
even the generation of giant vesicles from erythrocyte membranes in physiological salt 














Regarding the present work, an important application for giant vesicles is the 
study of lipid lateral segregation by direct confocal microscopy of individual vesicles. 
With this aim two vesicle generation procedures have been applied to obtain: i) giant 
vesicles in solution, or ii) giant vesicles attached to a platinum wire for direct 
microscopy measurements. A general overview for both procedures is given. For a 
detailed specification on buffer, electric field or microscopy conditions in a particular 
assay see Materials & Methods in the corresponding chapter.  
2.4.5.1 GUV in Solution 
 
GUV in solution are formed and subsequently translated to visualization 
chambers (Protocol 4). To enable their visualization, a high density sucrose solution is 
encapsulated in vesicles so that when transferred to chambers with an iso-osmotic 





Protocol 4. Giant Unilamellar Vesicles in solution 
1. Pure lipid stocks are prepared by diluting commercially available lipids in powder into 
a chloroform/methanol (2:1 v/v) organic solution to a 0.2 mM concentration.  
2. 3 μl of the appropriate stock solution are added onto the surface of different platinum 
electrodes in a specially designed chamber (Industrias Técnicas ITC, Bilbao, Spain) 
containing four holes with two platinum electrodes each.  
3. The chamber is introduced into a high vacuum desiccator for 2 h to remove any 
remaining solvent traces.  
4. The chamber is then equilibrated for 15 min at the desired temperature by an 
incorporated water bath.  
5. Next, the platinum wires are covered with a 300 mM sucrose solution previously 
equilibrated at the desired temperature.  
6. The chamber holes are covered with a glass held in place with vacuum grease to 
avoid evaporation during electroformation. 
7. The platinum electrodes are connected to a generator and the desired electric field 
(870 mV) is applied for approximately 2 h. Vesicles are then generated enclosing 
sucrose. Temperature during preparation is always higher than that of the lipid with 
the highest main phase transition temperature.  
8. The applied frequency (10 Hz) is decreased for 1 h 30 min to induce vesicle 
detachment from the electrodes.  
9. The electric field and water bath are disconnected and the vesicles left 30 min for 
equilibration. 
10. The vesicle solution is then transferred to microscopy chambers, which have been 
pre-treated with BSA (10 mg/ml) and contain an iso-osmotic aqueous solution or 
buffer without sucrose. In this way, vesicles sediment due to the higher density of the 
enclosed sucrose, and this allows direct fluorescent confocal microscopy 








Protocol 5. GUVs attached to a platinum wire for direct microscopy 
1. Pure lipid stocks are prepared by diluting commercially available lipids in powder into 
a chloroform/methanol (2:1 v/v) organic solution to a 0.2 mM concentration. The 
desired percentage of a fluorescent dye (approximately 0.2%) is added to the lipid 
stock to allow the direct visualization of vesicles in a confocal fluorescence 
microscope.  
2. 3 μl of the appropriate stock solution are added onto the surface of different platinum 
electrodes attached to specially designed polytetrafluoroethylene (PTFE) circular 
wells.  
3. The round units containing the wires are introduced into a high vacuum desiccator 
for 2 h to remove any remaining solvent traces. 
2.4.5.2 GUV for Direct Microscopy 
 
GUV for direct microscopy measurements are formed in home-made chambers 
and remain attached to a platinum wire where they are formed (Figure 2.5). The 
chamber is directly placed under the microscope. 
The procedure for the generation of GUVs attached to a platinum wire is very 
similar to that for giant vesicles in solution but with two main variants: A) A special 
chamber for direct microscopy supplied by Luis A. Bagatolli (Odense, Denmark) has 
been used for this purpose, and B) vesicles are prepared in the desired aqueous or 


















Figure 2.5. Homemade chamber and PTFE circular wells for 





4. Then, the units are fitted into specific holes within a specially designed homemade 
chamber (Figure 2.5) to which a glass cover slide has been previously attached by 
the use of epoxy glue. Once fitted, the platinum wires stay in direct contact with the 
glass cover slide.  
5. The chamber is then equilibrated to the desired temperature for 15 min by an 
incorporated water bath.  
6. Then the platinum wires are covered with the buffer solution, previously equilibrated 
at the desired temperature, and closed with perfectly fitting caps to avoid 
evaporation during electroformation.  
7. The chamber is connected to a generator through the platinum electrodes and the 
desired electric field is applied for 2 h following a detailed protocol of voltage and 
frequencies e.g: 6 min 0.22 V/ 20 min 1.9 V/ 90 min 5.3 V.  
8. After this step, the electric field and water are disconnected and vesicles are left to 
equilibrate for 30 min.  
9. The chamber is finally moved to the microscope and direct confocal fluorescence 














2.4.6 Lipid Monolayers  
Another model system for the study of lipid-lipid and/or lipid-protein interactions 
are monomolecular films at the air-water interface, the so-called lipid monolayers. An 
important advantage of this system compared to vesicles is that neither curvature nor 
fluctuation effects are present, and furthermore, there is a complete control of the 
surface pressure, lipid composition and molecular packing at any time. Its main 
detriment is the uncertainty of applying of data from lipid monolayers to biological 
membrane bilayers. However, very precise information about lipid-lipid interaction 
behaviour can be obtained, a virtually impossible task using in vivo measurements in 






Lipid monolayers can be prepared in a fast and easy way. A monolayer is 
generated by spreading a lipid solution, previously prepared by diluting lipids in highly 
volatile organic solutions such as pure chloroform or chloroform/methanol mixtures, on 
top of an aqueous solution. Due to their amphipathic nature, lipids self-organize with 
their hydrophilic headgroups in contact with the water environment and their acyl 
chains towards the air. Once generated, different measurements within the monolayer 
are performed based on the accurate control of its surface pressure by the use of a 
Langmuir balance. This is commonly done by the Wilhelmy method, using a suspended 
probe located at the air-water interface that measures any deviation from water surface 
tension, e.g. those induced by the presence of the monolayer (Figure 2.6).  
 
A special section in the current chapter (Section 2.7) has been introduced for a 
detailed overview on Langmuir balance-based approaches on lipid monolayers, 
applications and their methodological aspects.  
 
2.5 Phospholipid Assay (FISKE Assay) 
A well-established method has been applied for phospholipid assay based on 
the quantitation of inorganic phosphorous, an approach based on the initial procedure 
developed in 1925 by Cyrus H. Fiske and Yellapragada SubbaRow (Fiske & Subbarow, 
 
 
Figure 2.6. A lipid monolayer at the air-water interface of a Langmuir 
trough. Zoomed area: contact angle on the Wilhelmy plate at the interface. 






Protocol 6. Phospholipid assay (FISKE assay) 
1. A phosphorous calibration curve must be set up from which the exact lipid sample 
concentration will be determined. 0, 25, 50, 75 and 100 nmol phosphorous are 
respectively pipetted into duplicate separate test tubes from a 1 mM NaH2PO4 
standard solution, which will be used to construct the calibration curve. 
2. The sample is then pipetted into separate tubes (at least triplicate) to contain 
theoretically 50 nmol lipid phosphorous, which will be in the centre of the calibration 
curve. When pipetting samples in organic solution, Hamilton syringes are used.  
3. To each tube, 500 μl of a 60% perchloric acid (HClO4) are pipetted. The tubes are 
vigourously vortexed and introduced into a heating block at 205 ºC for 45 min. In this 
way phospholipid hydrolysis is achieved leaving free inorganic phosphate.  
4. Tubes are collected, cooled down to room temperature and the following solutions 
are pipetted:  
 4 ml 1X ammonium heptamolybdate solution [(NH4)6Mo7O24.4H2O]. 
 500 μl 10% (v/v) ascorbic acid (added while vortexing).  
The inorganic phosphate reacts with molybdate, which subsequently reacts with the 
ascorbic acid giving a yellow-coloured solution. 
5. The tubes are introduced into a boiling water bath and left for 6 min. During that 
period, the solution colour is blue-shifted depending on the amount of phosphorous.  
6. Finally, tubes are cooled in water and absorbance at 812 nm measured for each of 
the samples. In the present work a Ultrospec 500 pro spectrophotometer from 
Amersham Biosciences (Piscataway, NJ, USA) was used for this purpose. 
7. To obtain the sample phospholipid concentration, the standard absorbance is plotted 
against the phosphorous concentration and adjusted to a straight line. The slope of 
the curve and the sample absorbance are used to find out the sample concentration. 
1925) and later modified (Bartlett, 1959 and Böttcher et al., 1961). Briefly, the approach 
consists of hydrolysing the phospholipids until the lipid phosphate group is free to 
interact with specific reagents that will colour the solution in a concentration-dependent 































2.6 Vesicle Size Measurement by Dynamic Light Scattering 
(DLS)  
 
Vesicle size measurements were performed using the quasi-elastic light 
scattering (QELS) technique, commonly known as dynamic light scattering (DLS), that 
is related to the Brownian motion of particles in solution. By the use of a laser beam 
focused within a small area in the solution, a measurement of the intensity fluctuations 
from the scattered light of sample particles crossing through the focused area is 
performed. The particles, vesicles in our case, scatter the light and this is recorded and 
related to the hydrodynamic radius (Rh) of the vesicle by the Stokes-Einstein equation:  
 
D = kBT/6πρRh 
 
Equation 2.  Stokes-Einstein equation. 
 
where: D is the diffusion coefficient,  kB is the Boltzmann constant = 1.38 x 10
-23 m2 kg 
s-2 K-1, T is temperature, ρ is viscosity of the medium and Rh is the hydrodynamic 
radius of spherical particles  
The scattered light provides a correlation function from which, by the use of 
several algorithms, a vesicle size distribution in solution can be obtained (Figure 2.7). 
This value is accompanied by a polydispersity index (PDI), which gives information on 
the size heterogeneity of the sample. The PDI varies between 0 and 1, where values 





Figure 2.7. Size distribution plot of an egg PC vesicle population prepared using 100 






The present measurements have been performed in a Malvern Zeta-Sizer Nano 
ZS (Malvern, Instruments, UK) with a detection range for sizes between 0.6 nm to 6 
μm. We placed 50 μl of the sample (around 0.4 mM in lipid) in standard acryl cuvettes 
at room temperature with a He-Ne laser beam of 5 mW (λ = 633 nm) as the light 
source. The light scattered by the vesicles was detected with a photomultiplier placed 
at 173º to the beam and the results were analyzed by the commercial software of the 
instrument. 
 
2.7 Langmuir Balance  
Due to their amphipathic character, lipids spread on top of a water surface 
orient their polar headgroups in close contact with the water surface while moving their 
hydrophobic acyl chains towards the air. In this simple way, a monomolecular lipid film 
at the air/water interface is generated, in other words, a lipid monolayer. The terms 
“Langmuir films” and “Langmuir balance” refer to the preparation and characterization 
of such structures, named after the intensive studies of the American chemist and 
physicist Irving Langmuir in this field (Langmuir, 1917). For his work in surface 
chemistry Langmuir was awarded the Nobel Prize in chemistry in 1932. 
Langmuir balance measurements represent an important source for the 
characterisation of lipid-lipid and lipid-protein interactions. In contrast with the use of 
vesicles or lipid bilayers, Langmuir balance approaches have the advantage of 
precisely controlling lateral pressure, molecular packing and lipid composition. There 
are no curvature or fluctuation effects if they are compared to vesicles. Furthermore, 
the current development of the technique allows for instance direct microscopy 
measurements by incorporation of fluorescent probes within the monolayer, or transfer 
of lipid monolayer to solid supports for its analysis under atomic force microscopy, 
among others. In the present work, Langmuir balance-based approaches have been 
applied to the study of lipid-protein interaction.  
 
2.7.1 Surface Pressure Measurements 
Langmuir balance approaches are based on the measurement of the water 





“Wilhelmy plate” with regard to Ludwig Wilhelmy, who first provided a way for 
measuring surface tension in 1863 (Wilhelmy, 1863). The Wilhelmy plate is very thin 
and usually made of platinum or filter paper, but other materials have been as well 
used: quartz, glass or mica. As explained, the Wilhelmy plate measures surface 
tension, which is the excess of free cohesive energy present at a gas-liquid interface. 
Water molecules are exposed to forces from surrounding molecules, which are 
balanced in the bulk of a water solution due to the equal attraction in every direction. 
However, at a gas-liquid interface, water molecules in the interface are not subjected to 
attractive forces in every direction, and thus, an excess cohesive energy is generated 
which is called the surface free energy. This excess energy can be related to surface 
tension as force/length by means of the forces detected by the plate (probe) partly 
introduced into the gas-liquid interface as depicted in Figure 2.8, which can be further 
related with surface pressures. The overall forces detected by the solid probe are:  
 
Total force = Weight of the probe + probe buoyancy + surface tension 
Equation 3. Overall forces detected by the Langmuir balance solid probe. 
 
Before measurement, the pressure detected by the probe is adjusted to zero, 
thus discarding the weight force. The probe´s buoyancy reflects the applied force of 
displaced water molecules upon probe immersion acting upwards, and is as well 
discarded as the probe is maintained at a constant depth during the measurement. 
Thus, the overall force can be reduced to surface tension, which is described on the 
 
 
Figure 2.8. Schematic representation of the process of protein insertion into a lipid 
monolayer. Experimental set-up for lipid monolayers experiment. Before adding the protein, 
the initial pressure of the monolayer is adjusted to the desired value (πi). The protein inserts 





























following equation:  
F = 2(w + t)(γ)(cos ϴ) 
Equation 4. Reduced equation of the overall force. 
where:  w,t = width and thickness of the probe, γ = surface tension, ϴ = contact angle. 
When introducing the probe in the aqueous solution, a meniscus is formed, 
resulting in a contact angle of zero degrees as shown in Figure 2.6. In this way, the 
equation can be reduced to:   
γ = Force/Perimeter 
Equation 5. Surface tension. 
or force/length which is given in the following units (dynes/cm = mN/m).  
Water molecules give rise to one of the highest surface tensions due to their 
high intermolecular attractive forces, 72.8 mN/m at 22 ºC and 1 atm. The presence of 
amphipathic molecules at the air-water interface disrupts the cohesive energy of water 
molecules, decreasing the water surface tension, this reduction being known as the 
surface pressure (π) with same units but opposite sign.  
π = γo –γ 
Equation 6. Surface pressure.  
In conclusion, all the Langmuir balance measurements are performed following 
changes of surface pressure. Typically, a lipid solution in a highly volatile organic 
solvent (usually pure chloroform or chloroform/methanol (2:1 v/v)) is spread onto the 
surface of an aqueous solution (the air-liquid interface). As the solvent is evaporated, 
lipids organise themselves with the polar headgroup towards the aqueous solution and 
the hydrophobic chain towards the air. As the lipid spreads over the available surface 
area it decreases the water surface tension, i.e. increases the surface pressure. In this 
way, for instance for lipid-protein interaction studies, a lipid monolayer is prepared by 
spreading the desired amount of lipid into an air-water interface at a controlled surface 
pressure. Protein is subsequently incorporated into the subphase and lipid-protein 





adsorption of the protein into the monolayer (Figure 2.8). In this respect, it is to be 
stressed that cell membranes are proposed to have a surface pressure of around 30 
mN/m (Janmey & Kinnunen, 2006; Marsh, 1996), although this value can vary largely. 
 
A methodological overview on the preparation of Langmuir films can be found in 
Cruz & Pérez-Gil, (2007). Precise methodological conditions for each of the 
experiments carried out in the present work will be specifically found in the Materials & 
Methods section of the corresponding chapter.  
 
2.8 Equilibrium Sucrose Gradient Centrifugation of Liposomes 
Liposome floatation assays are widely applied for studying the affinity and lipid 
specificity of proteins binding to membranes (Landeta et al., 2011; Yethon et al., 2003). 
In the liposome float-up experiment, the vesicles and bound proteins are enriched by 
density gradient centrifugation. In general, large unilamellar or multilamellar vesicles 
are the best model membrane systems for these studies. Another commonly used and 
more sensitive technique is the vesicle sedimentation, but many membrane-interacting 
proteins have a tendency to aggregate or oligomerize, which results in their 
sedimentation in the absence of liposomes. In this situation, membrane binding of such 
proteins cannot be reliably examined by vesicle sedimentation assays and liposome 
floatation assays, which are not that sensitive to protein oligomerization/aggregation, 
can be used instead. 
Liposome floatation assay starts with the incubation of the proteins with 
liposomes at 37 ºC. Then the sample is adjusted to 1.4 M sucrose using a sucrose 
stock solution prepared in prescission buffer and loaded at the bottom of a 
discontinuous sucrose gradient (medium layer of 0.8 M, upper layer of 0.5 M sucrose). 
The sample is centrifuged at 4 ºC for 3 h at 100000 rpm in a Beckman Optima TLX 
benchtop ultracentrifuge, using a TLA 120.2 rotor. During ultracentrifugation, due to 
their lower density, liposomes and liposome-bound proteins float up to the top fraction 
of the gradient whereas free protein remains at the bottom of the tube (Figure 2.9). 
Aliquots of 250 μl were taken starting from the bottom (a total of 4 samples) and added 
to 50 μl 6X Loading Buffer (LB). Then the samples (25 μl) were analyzed by 10-15% 






Protocol 7. Vesicle Aggregation Assay 
1. LUV or SUV at the desired lipid composition are prepared as previously described 
(Protocol 3). 
2. A Fiske assay is performed to determine the exact lipid concentration (Protocol 6). 
3. In 1 ml quartz cuvettes, 600 μl final volume of buffer (previously equilibrated at the 
desired temperature) containing 0.4 mM liposomes is added under continuous stirring 
at 37 ºC. 
4. After 5 min stabilization, the corresponding amount of protein is added to the cuvette 
in the smaller possible volume. 
5. Absorbance at 400 nm is recorded to obtain the aggregation time course. 
 
Figure 2.9. Schematic representation of an equilibrium sucrose gradient 
centrifugation assay. Before centrifugation (left side) a sucrose gradient is generated and 
the sample is in the bottom of the test tube. After centrifugation, liposomes and protein 










2.9. Vesicle Aggregation Measurements 
Lipid vesicles are found to aggregate under a variety of conditions. Aggregation 
is usually assayed as an increase in turbidity (A400) of the vesicle suspension that can 
be followed spectrophotometrically (Figure 2.10). The vesicle aggregation may be a 
first step for vesicle-vesicle fusion so turbidity measurements can be used as a first 
approach in the study of fusion events. This assay has been performed in a 
spectrophotometer Uvikon 922 (Kontron, Augsburg, Germany) as described in the 
















Figure 2.10. Schematic overview of a time-course of an aggregation assay. Initially 
vesicles scarcely scatter light. Upon protein addition, aggregation occurs and turbidity 




























2.10 Protein Analysis 
2.10.1 Protein Concentration Measurements 
Protein concentration was quantified using either the biscinchoninic acid (BCA) 
protein assay (Thermo Scientific) or absorbance measurements at 280 nm.  
 
2.10.1.1 Biscinchoninic Acid Assay (BCA) 
The reaction that leads to BCA color formation is strongly influenced by four 
amino acid residues (cysteine or cystine, tyrosine, and tryptophan) in the amino acid 
sequence of the protein. However, the universal peptide backbone also contributes to 
color formation, helping to minimize variability caused by protein compositional 
differences. In the first step, known as the biuret reaction, the chelation of copper with 
protein in an alkaline environment takes place to form a light blue complex. In the 






The BCA/copper complex is water-soluble and exhibits a strong linear 
absorbance at 562 nm with increasing protein concentrations. The assay was 
performed using the standard test tube protocol and a set of prediluted bovine serum 
albumin (BSA) protein assay standards.  
 
2.10.1.2 Absorbance at 280 nm  
Proteins in solution absorb ultraviolet light with absorbance maxima at 280 nm, 
due to the presence of amino acids with aromatic rings. Secondary, tertiary, and 
quaternary structure all affect absorbance, therefore factors such as pH or ionic 
strength can alter the absorbance spectrum. Following the Lambert-Beer equation with 
a theoretically calculated extinction coefficient, the protein concentration can be 
estimated.  
A = ε c l 
Equation 7. Lambert-Beer equation. 
where A is absorbance, ε is the molar extinction coefficient, c is the concentration and l 
is the path length.  
 
2.10.2 Protein Electrophoresis  
Protein separation was achieved by SDS-PAGE in 10-15% (w/v) acrylamide 
gels. Samples were mixed with Laemmli loading buffer (6x) supplemented with β-
mercapthoethanol and heated at 90 ºC for 10 min. Broad-range and precision 
(unstained and pre-stained) standards (Bio-Rad) were used as molecular weight 
markers. Electrophoresis was performed at 150 V in running buffer (3.028 g Tris, 14.41 
g glycine, 1 g SDS and H2O to 1 L). For quick protein visualization, the gel was stained 
for at least 10 min in a solution containing 0.1% (v/v) Coomassie Brilliant Blue R-250, 
40% (v/v) methanol and 10% (v/v) acetic acid. Background staining was eliminated by 
washing with 10% (v/v) acetic acid solution and images were taken on a Gel DocTM 







2.10.3 Western Blotting  
Transfer of proteins from an SDS-PAGE gel to nitrocellulose membranes (Bio-
Rad) was performed with a Trans-Blot® (Bio-Rad) equipment. A gel sandwich with 
Trans-Blot filter papers and a nitrocellulose membrane was prepared and hydrated with 
transference buffer (2.25 g Glycine, 5.81 g Tris pH 8, 0.375 g SDS, 200 ml MetOH and 
H2O to 1L). Protein transfer was performed at 22 V for 30 min at room temperature. 
After protein transfer, membranes were blocked with 5% skim milk in PBS and 
incubated with the specific primary (1:1000) and secondary (1:2000) antibodies, the 
latter tagged with a horse-radish peroxidase (HRP). Membrane washing was followed 
by protein detection in a Curix 60 processor with the  uper ignal™ West Pico 
Chemiluminescent Substrate (Thermo Scientific). The intensity of the sample signal 
was quantified in a GS-800 densitometer (Bio-Rad). 
 
2.11 Circular Dichroism  
Circularly polarised light can be understood as a combination of two 
electromagnetic radiation components of equal magnitude that rotate counter-
clockwise (left-handed) and clockwise (right-handed), respectively. When a sample is 
irradiated with light, an absorption process is produced. If both components are equally 
absorbed by the sample, the transmitting light will be polarised circularly. However, if 
there is a differential absorption of the left- and right- handed components, the resulting 
light will be elliptically polarised. Circular dichroism (CD) spectroscopy measures the 
differences in the absorption of the left- and right- handed components of circularly 
polarised light (Martin & Schilstra, 2008). This technique is used to study molecules of 
all types and sizes but it is in the analysis of the secondary structures of 
macromolecules where it finds its main application. The peptide bond is the primary 
chromophore contributing to the absorption of light in the far-UV spectra (from 170 to 
250 nm). Moreover, the specific organization of the peptide bonds in the protein gives 
rise to isolated absorbing units that present unique spectral features. Thus, alpha-helix, 
beta-sheet and random-coiled structures produce each a characteristic shape and 
magnitude in the CD spectrum (Figure. 2.11). CD spectroscopy in the far-UV was used 
to obtain a quantitative estimate of the average secondary structure of Atg8 






2.12 Fluorescence Spectroscopy Techniques  
2.12.1 Lipid Mixing Assay 
Fluorescence energy transfer (FRET) is a distance-dependent interaction 
between the electronic excited states of two dye molecules in which excitation is 
transferred from a donor molecule to an acceptor molecule without emission of a 
photon. The efficiency of FRET is dependent of the inverse sixth power of the 
intermolecular separation, thus it can only occur when fluorophores are very close to 
each other. 
In order to study vesicle-vesicle fusion, lipid mixing between vesicles was 
monitored using a FRET pair of fluorescently labeled lipids, a methodology developed 
by Struck et al. (Struck et al., 1981). 7-nitrobenz-2-oxa-1,3-diazol-4-yl (NBD) was used 
as the energy donor and rhodamine (Rho) as the energy acceptor. The energy transfer 
takes place because the emission spectra of the donor (465 nm) and the acceptor 
excitation (560 nm) spectra are overlapped. Each of the two fluorophores is coupled to 
the free amino group of a phosphatidylethanolamine to provide an analogue that can 
be incorporated into a lipid vesicle bilayer. When both fluorescent lipids are in LUV at 
 
 
Figure 2.11. Far-UV spectra associated with various types of secondary 
structure. Different secondary structure elements display characteristic CD spectra: α-
helical proteins have negative bands at 222 nm and 208 nm and a positive band at 193 
nm. Proteins with well defined antiparallel β-pleated sheets have negative bands at 218 
nm and positive bands at 195 nm. Finally, disordered proteins have very low ellipticity 





Protocol 8. Total Lipid Mixing Assay 
1. Prepare two LUV populations, population 1 with no fluorescent probes and population 2 
with 1.5 mol% NBD and 1.5 mol% Rho (Protocol 3) 
2. Determine the lipid concentration with the lipid phosphorous assay (Protocol 6). 
3. In 1 ml quartz cuvettes, the two populations are mixed in a 1:4 (population 1: population 
2) ratio to a 0.4 mM total concentration. 
4. After 5 min stabilization, proteins are added and NBD fluorescence was recorded at 
530nm.  
 
Protocol 9. Inner Lipid Mixing Assay 
1. Prepare two LUV populations, population 1 with no fluorescent probes and population 2 
with 1.5 mol% NBD and 1.5 mol% Rho (Protocol 3). 
2. Prepare a fresh 100 mM stock solution of sodium dithionite (keep in the dark at 4 ºC) in 
the same buffer than the vesicles. 
3. Place population 2 in a 1 ml quartz cuvette and add small amounts (1 – 3 ul) of 
dithionite to the sample until the fluorescence is quenched to half of initial value. 
4. The vesicle suspension is immediately passed through a Sephadex G-25 column to 
remove dithionite. Steps 3 and 4 should be done as quickly as possible because some 
dithionite can penetrate the vesicles. 
the appropriate surface densities (ratio of fluorescent lipid to total lipid), efficient energy 
transfer is observed. When such vesicles are fused with a population of unlabelled 
vesicles by the addition of a fusion inducing agent, the two probes mix with the other 
lipids present to form a new membrane. This mixing reduces the surface density of the 
fluorophores and the energy transferred between molecules decreases, thus the fusion 
can be measured as an increase of NBD (donor) fluorescence (Figure 2.12) (Protocol 
8).  
Using this system, the lipid mixing induced by the Ubiquitin Like System (UBL) 
















5. Determine the lipid concentration with the lipid phosphorous assay (Protocol 6). 
6. In 1ml quartz cuvettes, the two populations are mixed in a 1:4 (population 1: population 
2) ratio to a 0.4 mM total concentration. 
7. Add proteins and record NBD fluorescence at 530 nm.  
Fluorescence is followed in an AmincoBowman Series 2 spectrofluorimeter under the 
following conditions: 
λex = 465 nm  
λem = 530 nm  
Interference filter at 515 nm  
0% fusion = Initial fluorescence of vesicles with maximum NBD-Rho 
energy transfer. 
100% release = Fluorescence after complete vesicle solubilisation with   1 
mM n-octyl--D-glucopyranoside (OG) detergent. 
 To calculate the amount of lipid mixing the following equation is used: 
Lipid mixing % = [(F – F0)/(F100 – F0)]* 100 
Equation 8. Lipid Mixing % calculation. 
 Where:  F = Fluorescence at equilibrium 
   F0 = Fluorescence of vesicles at time zero 





















2.12.2 Aqueous Contents Mixing Assay 
Intervesicular contents mixing was monitored using the 8-aminonapthalene-
1,3,6 trisulfonic acid (ANTS)/ p-xylene-bis-pyridinium bromide (DPX) assay. ANTS 
emission was monitored at 530 nm with the excitation wavelength set at 360 nm (slits, 
2 nm). A 470 nm cut-off filter was placed between the sample and the emission 
monochromator to avoid scattering interference. 0% vesicle contents mixing was set by 
using a 1:1 mixture of ANTS and DPX liposomes. 100% mixing of contents 
corresponded to the fluorescence of the vesicles containing coencapsulated ANTS and 
DPX. Details for the intervesicular lipid mixing and contents mixing assays can be 
found in Goñi et al, 2003. (Figure 2.13) 
 
 
Figure 2.12. Schematic overview of an inter-vesicle lipid mixing assay. 
Initially there are two populations of vesicles, one with and the second without the 
FRET pair. Upon protein addition, when fusion occurs lipids are mixed and 
rhodamine cannot quench NBD. Triton X-100 is added to achieve vesicle 


































2.12.3 Vesicle Contents Efflux Measurement (Leakage) Assay  
This technique measures the ability of particular molecules to permeabilise the 
vesicle lipid bilayer. It is a simple approach in which vesicles are prepared enclosing 
fluorescent molecules. Upon specific molecule incubation, permeabilisation is followed 
by changes in fluorescence. If vesicles are incubated with a detergent, a possible 
permeabilisation could be followed by externalisation of entrapped fluorescent 
molecules through unstable solubilised vesicle regions. In the present study, the ability 
of ATG3 to produce vesicle leakage in the process of vesicle aggregation, and the 
possible leakage in vesicle fusion processes were tested by following the 
externalisation of the well-known low-molecular weight ANTS and its quencher DPX 
fluorescent molecules.  
 
Figure 2.13. Schematic overview of an inter-vesicular aqueous contents mixing 
assay.  Initially there are two populations of vesicles, one with ANTS and the second 
one with DPX. Upon protein addition, when complete fusion occurs the aqueous 
contents of the vesicles are mixed , and DPX can quench ANTS. 100% fusion value 
is obtained measuring the fluorescence of a vesicle population containing both 
































The basis of this approach is depicted in Figure 2.14. By entrapping both ANTS 
and DPX inside the vesicles, their close proximity allows DPX to interact with ANTS 
quenching its fluorescence. Upon externalisation, both molecules are diluted into the 
external medium and they hardly interact, inducing an increase of ANTS fluorescence. 
Thus, by following ANTS fluorescence, vesicle bilayer permeabilisation, or 
solubilisation in our case, can be followed. This approach was initially developed in 
1985 (Ellens et al., 1985) to measure vesicle fusion, a situation in which both 
molecules where entrapped into separate vesicle populations and their fusion followed 
in terms of ANTS fluorescence quenching upon fusion and ANTS-DPX interaction [see 
(Goñi et al., 2003; Nieva et al., 1989)]. A full description of the assay conditions is given 
in the Protocol 10.  
 
 
Figure 2.14. Schematic overview of the ANTS/DPX leakage assay. Upon incorporation of 
the protein into the membrane, vesicle-enclosed ANTS and DPX are externalised through 
membrane defects. An increase on ANTS fluorescence is observed. Triton X-100 is 
generally added for complete vesicle solubilisation into mixed vesicle lipid/surfactant/Triton 



































Protocol 10. Vesicle Contents Efflux Measurement (Leakage) Assay 
1. 100 nm large unilamellar vesicles (LUVs) are prepared as previously described 
(Protocol 3) in the following buffer containing both ANTS and DPX. 
 For experiments with ATG3: 20 mM ANTS, 70 mM DPX, 40 mM NaCl, 50 
mM Tris-HCl (pH 7.5). 
 For experiments with UBL System: 20 mM ANTS, 70 mM DPX, 1 mM MgCl2, 
40 mM NaCl, 50 mM Tris-HCl (pH 7.5). 
A high DPX/ANTS ratio is used to ensure complete quenching inside vesicles. 
Samples are covered with aluminium foil to protect fluorescent molecules from 
bleaching.  
2. The vesicle suspension is passed through a Sephadex G-25 column to remove non-
entrapped ANTS and DPX. A previously adjusted isosmotic buffer solution is used for 
this process:  
 For leakage experiments with ATG3: 50 mM Tris-HCl, 175 mM NaCl, 1 mM 
DTT (pH 7.5) for leakage experiments with Atg3.  
 For UBL system experiments: 50 mM Tris-HCl, 150 mM NaCl, 1 mM MgCl2, 1 
mM DTT (pH 7.5) for UBL system experiments.  
3. Lipid concentration is determined as previously described (Protocol 6).  
4. The permeabilizing agent is added to 0.4 mM vesicles in 1 ml quartz cuvettes with 
continuous stirring and leakage is followed in terms of ANTS fluorescence in a 
QuantaMaster spectrofluorometer (Photon Technology International, Birmingham, 
New Jersey) under the following conditions:  
λex = 355 nm  
λem = 520 nm  
Interference filter at 450 nm  
0% release = Initial fluorescence of intact vesicles.  
100% release = Fluorescence after complete vesicle solubilisation with   1 
mM Triton X-100. 
  To calculate the amount of leakage the following equation is used: 
Leakage % = [(F – F0)/(F100 – F0)]* 100 
Equation 9. Leakage % calculation. 
  Where: F = Fluorescence at equilibrium 
   F0 = Fluorescence at time zero 






2.13 Cryo-electron Microscopy 
Cryo-electron microscopy (cryo-EM), is a form of transmission electron 
microscopy (EM) where the sample is studied at cryogenic temperatures (generally 
liquid nitrogen temperatures). Nowadays, cryo-EM is gaining users in structural biology.  
The main advantage of cryoelectron microscopy stems from the fact that this 
technique allows the observation of specimens that have not been stained or fixed in 
any way, showing them in their native form. This is in contrast to X-ray crystallography, 
which requires crystallizing the specimens, which can be a difficult task, and placing 
them in non-physiological environments, which can occasionally lead to functionally 
irrelevant conformational changes. 
In this electron microscopy derived technique, the way in which sample is 
prepared is one of the main advantages. The sample could be frozen from its native 
conditions, generally in an aqueous environment (aqueous buffer). The biological 
material is spread on an electron microscopy grid and is preserved in a frozen-hydrated 
state by rapid freezing, usually in liquid ethane near liquid nitrogen temperature. By 
maintaining samples at or below liquid nitrogen temperature, they can be introduced 
into the high-vacuum of the electron microscope column. Most biological samples are 
extremely radiation-sensitive, so they must be imaged with low-dose techniques. 
Usefully, the low temperature of cryo-electron microscopy provides an additional 
protective factor against radiation damage. 
For our observations the samples were placed in the controlled environment of 
the vitrification chamber of Vitrorobot (FEI) at room temperature, where the relative 
humidity was kept close to saturation to prevent water evaporation form the sample. A 
5 μl drop of the aqueous solution was placed on carbon-coated holey film supported by 
a TEM copper grid. Most of the liquid was removed by careful blotting with absorbent 
filter paper to create a thin liquid film. The sample was then rapidly plunged into liquid 
ethane and cooled by liquid nitrogen to its melting temperature to obtain a vitrified film. 
The vitrified specimen was stored under liquid nitrogen and transferred into the electron 
microscope (Jeol JEM-2200FS) operating at 200 kV. Images were collected under low-
dose conditions with a CCD camera (UltraScan 4000, Gatan) with an underfocus in the 
range of 3-5 μm at magnifications of 40000-60000 x. This technique was performed in 








Figure 2.15. Components of fluorescence confocal microscope. 
 
2.14 Fluorescence Confocal Microscopy  
The development of confocal microscopy during the late 70´s resulted in one of 
the major advances in optical microscopy.  pecifically, fluorescence confocal 
microscopy allows analysing the fluorescence coming from an individual thin in-focus 
plane of the sample, and this enables the construction of real three-dimensional (3D) 
images. To discard fluorescence coming from out-of-focus planes, and in contrast to 
common epifluorescence microscopy, confocal imaging is achieved by introducing a 
pinhole next to the detector that allows only fluorescence coming from the in-focus 
plane to reach the detector. Figure 2.15 shows a schematic picture of the central 
components of a fluorescence confocal microscope. Essentially, a laser beam is used 
as the excitation light, which is focused into a dichroic mirror, that selects the light to be 
directed through an objective into a small spot within the sample. However, this is not 
enough to build a 3D image of the specimen being measured. For this purpose, special 
mirrors are introduced to scan the laser beam on the x-y plane, thus building a special 
confocal microscopy known as laser scanning confocal microscopy. In this way, by 
precisely controlling the z sample movement, three dimensional images can be 
constructed.  
In the present work, laser scanning confocal microscopy has been applied to 
observe the binding of protein to GUV and for immunofluorescent localization of 
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Macroautophagy, “autophagy” in this context, is an intracellular degradation 
pathway conserved in all eukaryotes (Mizushima & Komatsu, 2011). This process does 
not only provide nutrients to maintain vital cellular functions under amino-acid limiting 
conditions, but also plays an important role in a wide range of physiological processes 
(Boya et al., 2013). Not surprinsingly, impaired autophagic function seems to underlie a 
wide range of pathological conditions (Choi et al., 2013). During autophagy portions of 
the cytosol and even entire organelles are sequestered by double-membrane structures 
called autophagosomes (AP). Eventually, AP fuse with the lysosomal system where the 
inner membrane and the cargo are degraded. One outstanding question is how the AP 
membrane is formed and elongated. The most widely accepted hypotheses propose 
the formation of a core pre-autophagosomal structure, named isolation membrane or 
phagophore, upon which adhesion and fusion of further membrane structures would 
occur (Hamasaki et al., 2013; Rubinsztein et al., 2012; Shibutani & Yoshimori, 2014).  
To date, at least 35 autophagy-related genes (ATG) have been identified and 
related to the process (Homma et al., 2011; Xie & Klionsky, 2007). Among them, the 
Atg8 family of ubiquitin-like proteins are among the late autophagosome-specific 
proteins to bind the AP (Suzuki et al., 2001). Conjugation of Atg8 to PE at the 





al., 2008) but the underlying mechanism of AP growth remains essentially unknown.  
While most studies have been focused on the Atg8 conjugation system derived 
from S. cerevisiae, the role of Atg8 homologues in higher eukaryotes is less well 
characterized (Yang & Klionsky, 2010). Remarkably, whereas yeast has a single Atg8 
gene, mammals have up to seven homologs (Shpilka et al., 2011), which can be 
divided into LC3 and GABARAP subfamilies. Members of both subfamilies have overall 
similar structures (Coyle et al., 2002; Kouno et al., 2005), are localized to 
autophagosomal membranes (Kabeya et al., 2000; Tanida et al., 2002a) and are all-
essential for the autophagic process (Sou et al., 2008; Weidberg et al., 2010). However, 
far from being simply redundant members of a protein family, specific members are 
suggested to act at different stages of AP biogenesis (Weidberg et al., 2010). 
Several authors have approached autophagy, and particularly the fusion 
processes leading to autophagosomal growth, using model membrane systems 
consisting of vesicles of defined lipid compositions and purified proteins. Nakatogawa et 
al. (Nakatogawa et al., 2007) showed in this kind of systems that yeast Atg8 can trigger 
liposome tethering and hemifusion, while Weidberg et al. (Weidberg et al., 2011) found 
that mammalian ortologues of Atg8 have the same activities. Furthermore Nair and 
coworkers (Nair et al., 2011) described how the in vitro fusion activity of Atg8-like 
proteins depended strongly on the presence of high amounts of 
phospatidylethanolamine (in the 50% mol range). These studies have elicited the 
interest of investigators on the role of specific lipids and their corresponding 
synthesizing enzymes in the process of AP formation. Because of the important role of 
PI3P in autophagy (Dooley et al., 2014; Noda et al., 2010b), this area of research has 
recently attracted considerable attention and a variety of other lipids have been 
involved (Chu et al., 2013; Dall’Armi et al., 2013; Vicinanza et al., 2015). However, how 
the various membrane lipid species modulate AP biogenesis, particularly at the level of 
autophagic membrane elongation, remains largely unexplored. The ever-increasing 
number of ATG proteins and the potential combinatorial interactions among them and 
with cellular factors make the autophagy network very complex and difficult to dissect 
and analyse in intact cells. In this regard, compositionally defined in vitro reconstituted 
systems are increasingly being used to reveal fundamental information concerning the 
mechanism of action of individual autophagy proteins and their regulatory factors (Zens 
et al., 2015). Here we used two minimal reconstituted systems, based on a minimal set 
of recombinant proteins together with synthetic vesicles of defined lipid compositions, to 
gain further insight into the the ability of human Atg8 homologues (LC3, GABARAP and 
GATE-16) to mediate membrane fusion. Our in vitro studies shed light on the role of the 




various human Atg8 proteins during AP elongation and identify selected lipids as potent 
modulators of the process.  
 
3.2 Materials and Methods 
3.2.1 Materials 
Egg phosphatidylcholine (PC), bovine liver phosphatidylinositol (bl-PI), heart 
cardiolipin (CL), 1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamine (DOPE), 
lysophosphatidylcholine (LPC), egg diacylglycerol (DAG), 1,2-dioleoyl-sn-glycero-3-
phosphatidylethanolamine-N-(lissamine rhodamine B sulfonyl) (Rho-PE), 1,2-dioleoyl-
sn-glycero-3-phosphatidylethanolamine-p-maleimidomethyl-cyclohexanecarboxamide 
(PEmal) and 1-oleoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-
glycero-3 phosphatidylethanolamine (NBD-PE) were purchased from Avanti Polar 
Lipids (Alabaster, AL). NaCl, Tris Base, MgCl2, Triton X-100 and n-octyl--D-
glucopyranoside were obtained from Calbiochem (Darmstadt, Germany). N-(7-
nitrobenz-2-oxa-1,3-diazol-4-yl)-1,2-dihexadecanoyl-sn-glycero-3-
Phosphatidylethanolamine (NBD-PE), (1,3,6 aminonaphtalene-trisulfonate (ANTS) and 
p-xilene-bisdipicolinic acid (DPX) were purchased from Molecular Probes (Eugene, 
OR). Dithiothreitol (DTT) and tris(2-carboxyethyl)phosphine (TCEP) were purchased 
from Sigma-Aldrich (St. Louis, MO).  
 
3.2.2 DNA Constructs and Site-directed Mutagenesis 
Plasmids for expression of human ATG7, human ATG3 and the various 
homologues of Atg8 (human LC3B, human GATE-16 and human GABARAP) were 
kindly provided by Dr. Isei Tanida (National Institute of Infectious Diseases, Tokyo, 
Japan). Note that each Atg8 homologue was a truncated form ending in the reactive C-
terminal glycine such that no ATG4-mediated pre-processing was necesary. Wild-type 
plasmids were mutated by site-directed mutagenesis to obtain LC3G120C, GATE-
16C15SG117C (GATEG117C for simplicity) and GABARAPG117C by TopGeneTech (Montreal, 







3.2.3 Expression and Purification of Recombinant Proteins 
Proteins were purified from soluble fractions of bacterial extracts obtained in the 
absence of detergents, and were >90% pure as evaluated by Coomassie-stained SDS-
PAGE. ATG7 was expressed by baculoviral infection of HighFive (H5) insect cells. 
ATG7 in pFASTBAC HTa plasmid DNA was used to transform DH10Bac E. coli for 
transposition into the bacmid. We used blue/white colony selection to identify colonies 
containing the recombinant bacmid and they were confirmed by PCR. The recombinant 
bacmid was then isolated and purified using Macherey Nagel endotoxin-free DNA 
purification kit. H5 insect cells were transfected with purified bacmid using 
Lipofectamine from Invitrogen (Waltham, MA) in TC-100 insect media (Sigma-Aldrich) 
supplemented with the appropiate antibiotics. When the transfected cells demonstrated 
signs of late stage infection (typically around 72 h), the medium containing the free 
virus was collected. We repeated cycles of transfection and virus collection to amplify 
the viral stock. Cells were collected after 48 h infection followed by centrifugation at 
5,000 xg for 10 min. The pellet was resuspended and sonicated in a breaking buffer 
consisting of 50 mM Tris pH 8, 150 mM NaCl and freshly prepared 1 mM TCEP and 
protease inhibitors. The lysate was cleared by 30 min centrifugation at 30,000 xg and 
loaded on cobalt resin (Clontech, Mountain View, CA) for 3 h at 4 ºC. Protein was 
eluted with 500 mM imidazole, concentrated up to 500 µl using YM-30 microcons 
(Millipore, Darmstadt, Germany) and loaded onto a Superdex TM200HR 10/30 size 
exclusion column (GE Healthcare, Buckinghamshire, UK) equilibrated in 50 mM Tris pH 
8, 150 mM NaCl, supplemented with freshly added 1 mM DTT and protease inhibitors. 
Purified protein was kept at 4 ºC. Plasmids of ATG3, LC3, GATE-16, GABARAP and 
their corresponding mutant forms were transformed onto E. coli BL21 (DE3) cells. 
Cells were grown to OD600=0.8 and induced with 0.5 mM IPTG for 3 h at 37 ºC in the 
case of GATE-16 and LC3, 4 h at 20 ºC in the case of GABARAP, and 18 h at 18 ºC in 
the case of ATG3. Following centrifugation at 5,000 xg for 10 min, the pellet was 
resuspended and sonicated in breaking buffer (PBS with protease inhibitors mixture 
and 1 mM DTT). The lysate was cleared by 30 min centrifugation at 30,000 xg, loaded 
on glutathione-agarose (Sigma-Aldrich) and incubated for 3 h at 4 ºC. Proteins were 
eluted by cleavage with PreScission Protease (GE Healthcare) in Precission Buffer (50 
mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA) with freshly added 1 mM DTT, for 4 h at 
4 ºC. In the case of cysteine C-terminal mutants 1 mM TCEP was used instead of DTT 
to avoid interference with the thiol-maleimide coupling. Proteins were aliquoted, flash-
frozen and stored at -80 °C until further use.  
 




3.2.4 Liposome Preparation 
The appropriate lipids were mixed in organic solution, and the solvent was 
evaporated to dryness under a stream of N2. The sample was then kept under vacuum 
for 2 h to remove solvent traces. The lipids were swollen in appropiate buffers. Small 
unilamellar vesicles (SUVs) were prepared from the swollen lipids by sonication with a 
probe tip sonicator (MSE Soniprep 150 (MSE, UK)) for 10 min (10 s on and off cycles) 
at 10-20 µm amplitude. The vials were kept on ice during the process to avoid 
overheating. When large unilamellar vesicles (LUVs) were required, swollen lipids were 
subjected to 10 freeze/thaw cycles and then extruded using 0.05 µm pore-size 
Nuclepore (San Diego, CA) filters, as described by Mayer et al (Mayer et al., 1986). 
Vesicle size was checked by quasielastic light scattering, using a Malvern Zeta-Sizer 4 
spectrometer (Malvern Instruments, Worcestershire, UK). LUVs had an average 
diameter of 80 nm and SUVs had an average diameter of 50 nm. Lipid concentration 
was determined by phosphate analysis (Fiske & Subbarow, 1925). 
 
3.2.5 Dynamic Light Scattering Measurements 
To determine size-distribution profiles of the liposomes, the samples were 
properly diluted with the conjugation reaction buffer and subjected to DLS 
measurements at 37 ºC using a Zetasizer Nano-S system (Malvern Instruments). 
 
3.2.6 In vitro Enzymatic Lipidation Reaction  
To recreate PE-conjugation in vitro, purified ATG7 (1 μM), ATG3 (1 μM), and 
LC3 or one of its homologues (10 μM) were mixed with liposomes (0.4 mM total lipid) in 
the presence of 1 mM DTT and 5 mM ATP in conjugation buffer (50mM Tris pH 7.5, 
150 mM NaCl and 1 mM MgCl2) and incubated at 37 °C for 90 min. The reaction was 
stopped with 6x SDS-PAGE sample buffer and heated at 90 °C for 5 min. Samples 
were run on SDS-PAGE gels and visualized with Coomassie Blue stain 
(Thermoscientific; Waltham, MA).  
 
3.2.7 Lipidation of LC3 and Homologues with PEmal 





PE, purified LC3G120C, GATE-16G117C or GABARAPG117C (10 μM each) were incubated 
with 15% PEmal-containing liposomes at a final lipid concentration of 0.4 mM in 
conjugation buffer. The reaction mixture was incubated at 37 ºC for 90 min and 
visualized by SDS-PAGE. 
 
3.2.8 Aggregation Assays 
Liposome aggregation was monitored in an Uvikon 922 (Kontron, Augsburg, 
Germany) spectrophotometer as an increase in turbidity (absorbance at 400 nm) of the 
sample. All assays were carried out at 37 ºC with continuous stirring.  
 
3.2.9 Lipid Mixing and Aqueous Contents Mixing Assays in Large Unilamellar 
Vesicles 
A fluorescence resonance energy transfer assay was used to monitor 
intervesicular membrane lipid mixing (Struck et al., 1981). The appropriate LUVs 
containing 1.5 mol% NBD-PE and 1.5 mol% Rh-PE were mixed with 9-fold excess of 
unlabeled LUVs. NBD-PE emission was monitored in a QuantaMaster 
spectrofluorometer (Photon Technology International, Birmingham, New Jersey) in a 
thermostatically controlled 1 cm path length cuvette with constant stirring at 37 °C. NBD 
emission was monitored at 530 nm with the excitation wavelength set at 467 nm (slits, 2 
nm). A 515 nm cut-off filter was placed between the sample and the emission 
monochromator to avoid scattering interference. Inner monolayer lipid mixing was 
measured using asymmetrically labeled membrane vesicles produced by the quenching 
of the outer leaflet NBD-PE fluorescence upon addition of sodium dithionite (Xu et al., 
2005). Dithionite was removed by gel filtration in Sephadex G-25M, using conjugation 
buffer for elution.  
Intervesicular content mixing was monitored by the ANTS/DPX assay (Ellens et 
al., 1985). ANTS emission was monitored at 530 nm with the excitation wavelength set 
at 360 nm (slits, 2 nm). A 470 nm cut-off filter was placed between the sample and the 
emission monochromator to avoid scattering interference. 0% vesicle content mixing 
was set by using a 1:1 mixture of ANTS and DPX liposomes. 100% mixing of contents 
corresponded to the fluorescence of the vesicles containing coencapsulated ANTS and 
DPX. Details for the intervesicular lipid mixing and contents mixing assays can be found 
in Goñi et al. (2003).  




3.2.10 Vesicle Contents Leakage Assay 
Leakage of vesicle contents was monitored by the ANTS/DPX assay (Ellens et 
al., 1985). ANTS emission was monitored at 530 nm with the excitation wavelength set 
at 360 nm (slits, 2 nm). A 470 nm cut-off filter was placed between the sample and the 
emission monochromator to avoid scattering interference. To establish the 100% 
leakage signal, Triton X-100 was added to a concentration of 1%. Details for the vesicle 
contents leakage assay can be found in Goñi et al., (2003).  
 
3.2.11 Cryo-electron Microscopy (Cryo-EM) 
For the Cryo-EM studies, conjugation reactions were performed as explained 
above. Grids were prepared following standard procedures and observed at liquid 
nitrogen temperatures in a JEM-2200FS/CR transmission electron microscope (JEOL 
Europe, Croissy-sur-Seine, France) operated at 200 kV. An in-column omega energy 
filter helped to record images with improved signal to noise ratio by zero-loss filtering. 
The energy selecting slit width was set at 9 eV. Digital images were recorded on 
UltraScan4000 CCD camera under low-dose conditions at a magnification of 55,058 
















Figure 3.1. Infection time and MOI optimization for ATG7 expression. ATG7 expression 
was followed by SDS-PAGE (A) and Western Blotting anti-His (B), under different infection 
times and MOI. ATG7 is observed as a band around 75 kDa. Molecular masses are shown in 
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3.3.1 Production of UBL System Proteins and Detection of UBL System Reaction 
Intermediates 
The Atg8 UBL conjugation system has been well studied in the past few years. 
Different steps in the conjugation reactions have also been characterized in yeast, and 
using both mammalian and yeast proteins jointly. Recently, a new study (Nath et al., 
2014) first reconstituted the system using only mammalian proteins, most of them from 
human origin. However, no reports about this system with the whole human set of 
proteins have been published. Thus, we tried to reconstitute and characterize the 
behaviour of the human UBL system. We used LC3B, GATE-16 and GABARAP as 
human Atg8 homologues, as well as human ATG7 and ATG3. 
Among these proteins ATG7, the E1-like enzyme, was expressed in bacteria, E. 
coli strains. Many different strains and as many different constructs with a variety of 
tags were tested to get protein expression but without success. Most of the references 
about ATG7 protein are related to the yeast homologue, because in higher organisms 
ATG7 seems to be very unstable and requires some modifications in the expression 
process. Thus in order to obtain the human full length ATG7, we decided to switch to a 
more sophisticated expression system, such as insect cells. Baculovirus expression 
system is closer to the mammalian expression and implements more post-translational 
modifications than bacteria to obtain better protein expression results. ATG7 was 




















Figure 3.2. ATG7 purification. (A) SDS-PAGE of cobalt affinity chromatography. (B) SDS-
PAGE of the size exclusion chromatography using Superdex 200 Increase column. (FT: Flow-
Through; W: Wash; R: Resin after elution; Inp: Input). Molecular masses are shown in kDa on 
the left-hand side. (C) Size exclusion calibration chromatogram. (D) Size exclusion ATG7 
chromatogram. ATG7 is indicated by a red rectangle in both A and B. Red arrows denote each 
chromatography peak.  
 
 



















Expression was optimized in terms of infection time and MOI (Figure 3.1), 
obtaining a satisfactory amount of polypeptide. Protein was purified using cobalt beads 
and size exclusion chromatography to clean the sample and verify the oligomeric state 
of the protein (Figure 3.2 A-B). Enough amount of protein in its dimeric state was 
obtained (Figure 3.2 D). Nevertheless, ATG7 was very unstable and tended to be 
proteolytically degraded in a short period of time. Freshly added protease inhibitors 



















Atg8 human homologues LC3B, GATE-16 and GABARAP were expressed and 

















expressed with the C-terminal Gly exposed in order to bypass the cleavage by ATG4. 
These versions are denoted with the original name of the proteins in the following 
experiments. Another version used as a negative control of the lipidation reaction was 
the deletion mutant of the exposed C-terminal Gly, called as LC3ΔG, GATE-16ΔG and 
GABARAPΔG. In addition, with the aim of mimicking the conjugation reaction of these 
proteins without the other components of the system, we designed mutants of the C-
terminal Gly to Cys (LC3G120C, GATE-16G117C and GABARAPG117C). In this 
manner, the protein could covalently bind a maleimide modified PE by itself. The set of 
the different protein versions (Figure 3.3) were expressed in their GST-tagged form in 
E. coli BL21 (DE3) and purified using Glutathione Sepharose beads (Figure 3.4 A-C). 
Human ATG3, the E2-like enzyme, was expressed, as well as Atg8 human 
homologues, in E. coli BL21 (DE3) with a GST tag, and purified in the same way 
(Figure 3.4 D).  
Next, circular dichroism (CD) was used to assess the secondary structure  and 
the correct folding of the recombinant purified Atg proteins. Results are shown in 
Figure 3.4 F.  As expected from previously reported data of these proteins, LC3, 
GATE-16, GABARAP and ATG3 gave rise to CD spectra with minima near 205 nm 
compatible with a mix of α-helix and intrinsically disordered structures. By contrast, the 












Figure 3.3. Schematic representation 
of the Atg8 homologue versions. From 
top to bottom, LC3 wild type, LC3 with 
the C-terminal Gly exposed the negative 
control without the C-terminal Gly, and 
finally the substitution mutant LC3 with a 
Cys in its C-terminal end. 






Figure 3.4. Expression and purification of human LC3, GATE-16, GABARAP and ATG3. 
(A-D), After elution from gluthatione beads, ATG proteins were subjected to size exclusion 
chromatography on a Superdex 75 10/300 GL column. (E) After SEC, all proteins were >90% 
pure as evaluated by Coomassie-stained SDS-PAGE. Molecular masses are shown in KDa 
on the left-hand side. (F) Circular dichroism (CD) analysis of ATG proteins in 50 mM 
Na2HPO4, 20 mM KCl, pH 7.0.  








































Figure 3.5. ATG7-LC3 intermediates. ATG7 (2 μM) and LC3 (8 μM) were incubated with 1 
mM MgCl2 and 0.2 mM DTT at 4 ºC in the presence or absence of 1 mM ATP. The reaction 
intermediate formation was followed at different times, either by SDS PAGE (A) or anti-ATG7 
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The entire system behaviour was checked by detection of the first reaction 
intermediates ATG7-LC3 and ATG3-LC3, before the lipidation occurred and triggered 
different membrane tethering or fusion events. Proteins bind through a thioester bond. 
Two different reactions were set up, one with the first two components of the system, 
ATG7 and LC3, and the next one with the addition of ATG3, both of them in the 
presence of ATP and MgCl2. The appearance of the ATG7-LC3 intermediate product at 
different time points was followed by non-reducing SDS-PAGE (Figure 3.5 A) and 
Western blotting (Figure 3.5 B) in the presence and absence of ATP. ATG7-LC3 was 
detected only in the presence of ATP, complex concentration increasing with time 
(Figure 3.5). The presence of ATG7 and LC3 in this band was also checked by mass 























Figure 3.6. ATG3-LC3 intermediates. ATG7 (2 μM), ATG3 (2 μM) and LC3 (8 μM) were 
incubated with 1 mM MgCl2 and 0.2 mM DTT at 4 ºC in the presence or absence of 1mM 
ATP. The second reaction intermediate formation was followed at different times, either by 






























When the third component of the system was added to the reaction under the 
same working conditions, an extra band appeared in the non-reducing SDS-PAGE 
(Figure 3.6 A) and Western Blot (Figure 3.6 B), corresponding to the ATG3-LC3 
















3.3.2. Reconstitution of the Lipidation Reaction 
After activation by ATG4B, covalent attachment of Atg8 to PE is mediated by a 
ubiquitin-like chain of enzymatic steps involving the E1-like ATG7 and the E2-like ATG3 
(Figure 3.7 C). These reactions can be reconstituted in vitro, using recombinant 
purified proteins, liposomes and ATP (Ichimura et al., 2004; Nakatogawa & Ohsumi, 
2012). In order to study the role of these protein-lipid complexes in membrane tethering 
and fusion processes, we first tried to reconstitute the enzymatically-driven lipidation 












Figure 3.7. In vitro reconstitution of the lipidation reaction. (A) Crystal structures of the 
indicated human Atg8 family members and ubiquitin. All Atg8s share a similar ubiquitin-like fold with 
two additional amino-terminal α helices. GATE-16 (Protein Data Bank (PDB): 1EO6), LC3B (PDB: 
1V49), GABARAP (PDB: 1KOT) and ubiquitin (PDB: 1UBI). Helix shape represents an α helix; 
arrow shape represents a β sheet; arrowhead represents the carboxyl termini of β sheets. (B) 
ClustalW sequence alignment of human GATE-16 (data base accession no. P60520), LC3B 
(Q9GZQ8) and GABARAP (Q6IAW1). The black arrow indicates the conserved glycine residue 
present at the C terminus of the processed forms of the Atg8-like proteins. (C) Outline 
representation of the enzymatic conjugation of LC3/GABARAP to PE. (D) Conjugation of 
recombinant LC3, GATE-16 and GABARAP with phosphatidylethanolamine (PE). Reaction media 
contain 1 μM ATG7, 1 μM ATG3, 10 μM Atg8 homologues, 1 mM DTT, 5 mM ATP and 0.4 mM LUV 
[PC/DOPE/bl-PI/NBD-PE (35/45/10/10 mol ratio)]. Each reaction mixture was incubated at 37 ºC for 
90 min, run on 12.5% SDS–PAGE gels and visualized by CBB-staining (top panels) or using a 
VersaDoc MP 4000 Imaging System (bottom panels). In CBB-stained gels lipidated forms of GATE-
16 and LC3 are undistinguishable from the adelynated intermediates (compare lanes 1, 3 and 5 
from the right). In the case of GABARAP, the adelynated intermediate appears immediately below 




































Reaction systems including ATG7, ATG3, ATP and liposomes led to the 
formation of a faster migrating band readily visualized by Coomassie Brilliant Blue 
(CBB)-staining (Figure 3.7 D, upper panels). The latter was particularly well-resolved 
for the GABARAP case. However for LC3 and GATE-16 this band was 
undistinguishable from the presumably adenylated form of the protein that appears in 
the presence of ATP and ATG7 (Nath et al., 2014) (Figure 3.7 D, upper panels). To 
confirm the lipidation reaction, conjugation reactions were prepared with liposomes 
containing 10% NBD-PE. In each case, reactions led to the formation of a fluorescent 
faster migrating band representing the lipidated products of LC3/GABARAP subfamilies 
(Figure 3.7 D, lower panels). 
Alternatively to the enzyme-driven reaction LC3 homologues can also be 
chemically lipidated (Nair et al., 2011; Weidberg et al., 2011) (Figure 3.7 E). Here the 
C-terminal glycine of the proteins is replaced by a cysteine residue and then linked to 
PE carrying a reactive maleimide on its headgroup (PEmal). Structurally this linkage 
differs from the native coupling by the addition of the maleimide ring, however, these 
maleimide-anchored conjugates have been reported to be functionally active and are 
generally considered as useful mimetic analogues to the naturally coupled proteins. 
Conjugation of the corresponding C-terminal mutants to PEmal-containing liposomes 
caused the appearance of a faster migrating band in SDS-PAGE, similar to the lipidated 
forms obtained using the enzymatic-conjugation machinery (Figure 3.7 F). 
Taken together these experiments indicate that the production of the lipidated 
products for the three proteins used in this study can be detected, in the context of the 
whole conjugation enzymatic system as well as using a chemically modified lipid.  
 
 
Conjugation of proteins to NBD-PE results in the appearance of a fluorescent faster migrating band 
corresponding to the lipidated form of the protein. Molecular masses are shown in kDa on the left-
hand side. For negative controls, Atg8 homologues lacking the reactive C-terminal glycine (ΔG) or 
reactions lacking either ATG7, ATG3, ATP or LUVs were used. (E) Outline representation of the 
chemical conjugation of LC3/GABARAP to PEmal. (F) Chemical conjugation of recombinant 
LC3BG120C, GATE-16G117C and GABARAPG117C. The indicated recombinant proteins (10 μM) 
were incubated at 37 ºC for 90 min with 0.4 mM LUV [PC/DOPE/PEmal/bl-PI (35/40/15/10 mol 
ratio)]. Cross-linking of the proteins to the maleimide-functionalized lipid results in the appearance 
of a faster migrating band corresponding to the lipidated form of the protein. For negative control 







Figure 3.8. Membrane tethering activities by human autophagic proteins. (A, C) Enzymatic 
conjugation reactions (maleimide-free) were performed as described in Figure 1 C followed by 
changes in absorbance at 400 nm, 37 ºC and observation under a light microscope (bar=10 
µm). Liposomes were composed of PC/DOPE/bl-PI (35/55/10 mol ratio). For a negative control, 
ATG7 was excluded from the reaction (grey trace). (B, D) Chemical conjugation to PEmal was 
performed as described in Fig. 1D followed by measurements of changes in the absorbance at 
400 nm, 37 ºC. Aggregate size distribution was measured by DLS at 37 ºC. In B and D 
liposomes were composed of PC/DOPE/PEmal/bl-PI (35/40/15/10 mol ratio). For negative 
controls, liposomes lacking PEmal were used (grey traces). 
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3.3.3. Effect of Human LC3 Homologues on Liposome Clustering in vitro 
In the course of autophagosome maturation membrane tethering should be 
essential both in the recruitment of vesicles targeting the expanding phagophore and in 
the closure of the autophagosome itself. In fact, yeast Atg8-PE was proven to induce 
liposome aggregation in vitro (Nakatogawa et al., 2007), shedding some light on the 
possible role of this protein during AP biogenesis. As an initial test for analyzing the 
functional activity of LC3 homologues, we evaluated their ability to induce liposome 
aggregation in vitro. As shown in Figure 3.8, of the three proteins tested, GATE-16 and 
GABARAP induced a marked liposome aggregation, measured as an increase in 
absorbance at 400 nm (Figure 3.8 A) and by visual observation under the light 
microscope (Figure 3.8 C). This effect was not observed in the absence of ATG7. LC3 




















We also evaluated the capacity of the PEmal-anchored homologues to induce 
liposome aggregation. Again only GATE-16-PEmal and GABARAP-PEmal were able to 
induce efficient liposome aggregation according to either turbidimetric (Figure 3.8 B) or 
dynamic light-scattering measurements (Figure 3.8 D). Interestingly, PEmal conjugates 
induce liposome aggregation at similar rates than their enzymatically conjugated 
counterparts, supporting the reliable use of this chemical model. 
These results are consistent with the growing number of evidences indicating a 
membrane tethering activity for autophagy-related ubiquitin molecules and might 
represent the first evidence of such an in vitro activity for the GABARAP homologue. 
LC3-PEmal was shown to efficiently induce membrane tethering in vitro (Weidberg et 
al., 2011). The fact that in our system this protein lacked this activity may result from 
differences in the experimental system, particularly differences in the lipidic composition 
of the LUVs that included phosphatidylserine and cholesterol in their case.  
 
3.3.4. Effect of Human LC3 Homologues on Membrane Fusion 
Liposome aggregation could simply represent membrane tethering, but it could 
also be an indication of hemifusion (i.e., fusion of the outer leaflets of adjacent 
membranes, while inner leaflets remain intact) or even of complete fusion (i.e., the 
merger of both inner and outer leaflets) of apposed membranes (Chernomordik & 
Kozlov, 2008). Previous studies with an in vitro reconstituted system similar to ours 
reported that yeast Atg8 mediates membrane hemifusion, but not complete fusion 
(Nakatogawa et al., 2007). In a different study, mammalian forms of LC3 and GATE-16, 
artificially linked to PEmal, were shown to induce full membrane fusion (lipid mixing) 
(Weidberg et al., 2011). In order to clarify the situation we initially used a intervesicular 
lipid-mixing assay based on fluorescence resonance energy transfer (FRET) from NBD-
PE to Rho-PE (Struck et al., 1981). When the two dyes are present at an appropriate 
concentration in the same liposome, the fluorescence of NBD is quenched by 
rhodamine. Upon fusion of these LUVs with unlabeled LUVs and subsequent probe 
dilution in the bilayer the distance between the two dyes increases, resulting in a 
dequenching of NBD fluorescence. As shown in Figure 3.9 A, when the two LUV 
populations were subjected to the conjugation reaction, a significant increase in 
fluorescence was observed with GATE-16-PE and GABARAP-PE proteins. Importantly, 
lipid mixing was not observed in the absence of ATG7. In agreement with the inefficient 
capacity of LC3-PE to tether liposomes, only a small increase in NBD fluorescence was 





We then investigated whether GATE-16/GABARAP-PE induced lipid mixing 
resulted from complete membrane fusion or membrane hemifusion. To this aim, we 
prepared asymmetrically labeled liposomes by adding the membrane-impermeable 
reductant sodium dithionite to the liposome suspension to selectively quench the 
fluorescence of NBD in the outer leaflet (Xu et al., 2005). Thus any observed lipid 
mixing arises from intervesicular mixing of inner monolayer lipids, i.e. from full 
membrane fusion. Both GATE-16-PE and GABARAP-PE stimulated NBD fluorescence 
of dithionite-treated liposomes in a time-dependent manner, indicating that fusion of the 
inner leaflets of apposed membranes, i.e., complete fusion of vesicles, had occurred 
(Figure 3.9 A). As expected, the intensity of the fluorescence signal corresponding to 
fusion of inner monolayer lipids is about one-half of the one indicating total lipid mixing. 
Note that fusion of inner monolayers exhibits a longer lag time than total lipid mixing 
which is particularly clear for GABARAP. The phenomenon occurs because total lipid 
mixing includes hemifusion, that is an obligatory step previous to inner monolayer 
mixing, i.e complete fusion (Basañez et al., 1996a; Ibarguren et al., 2010; Villar et al., 
2001). These results indicate that the observed membrane fusion elicited by human 
GATE-16 and by GABARAP in vitro, in the context of a minimal human conjugation 
machinery, consists of full membrane fusion events. Since in the process of vesicle-
vesicle fusion a pore connecting the vesicle inner spaces is opened, intervesicular 
mixing of aqueous contents should occur. This was tested, and confirmed, using the 
ANTS/DPX fluorescence quenching couple (Figure 3.9 B). Note that the extent of 
contents mixing corresponds roughly with that of inner monolayer lipid mixing (Figure. 
3.9 A) at a given time. Most biological fusion events occur in such a way that vesicle 
contents are not leaked out. This is also the case in our model fusion system (Figure 














Figure 3.9. Membrane fusion induced by enzymatically conjugated LC3/GABARAP-PE. 
(A) Time courses of total (●) and inner lipid (●) mixing induced by ATG7 (1 μM), ATG3 (1 μM) 
and the indicated Atg8 human homologues (10 μM) in liposomes (0.4 mM) composed of 
PC/DOPE/bl-PI (35/55/10 mol ratio). Lipid mixing was monitored by the NBD/Rhodamine lipid 
dilution assay. For inner monolayer lipid mixing NBD + Rho-liposomes were pre-treated with 
the appropriate amounts of sodium dithionite to quench NBD fluorescence of the outer leaflet. 
Unlabeled and (NBD + Rho)-labeled liposomes (9:1) were mixed and incubated for 5 min 
before ATP addition. The extent of lipid mixing was quantified on a percentage basis according 
to the equation: (Ft-F0/F100-F0) x100 where Ft is the measured fluorescence of protein-treated 
LUVs at time t, F0 is the initial fluorescence of the LUV suspension before protein addition, and 
F100 is the fluorescence value after complete disruption of LUVs by addition of 30 mM β-
octylglucoside (OG). Each curve represents the average and S.E. of three independent 
experiments. For negative controls, ATG7 was excluded from the reactions (○). (B) Time 
course of intervesicular aqueous content mixing. Proteins and lipids as in (A). Content mixing 
(●) was monitored by the ANT /DPX mixing assay; 100% mixing was determined using LUVs 
containing coencapsulated ANTS and DPX. ATG7 was excluded from the reactions for 
negative controls (○). (C) Time courses of fusion-related vesicle content leakage. Proteins and 
lipids as in (A). Vesicle leakage (●) was monitored by the ANT /DPX leakage assay; 100% 

































































+ ATG7 (- DTH)
+ ATG7 (+ DTH)






























Figure 3.10. Fusion-dependent increase in vesicle size analyzed by cryo-EM. Typical 
cryo-EM images of liposomes treated with human autophagic proteins. Enzymatic conjugation 
reactions including the indicated LC3 homologues (30 µM), ATG3 (3 µM), ATG7 (3 µM), and 3 
mM ATP were performed in conjugation buffer for 1 hour at 37 ºC and the products examined 
by cryo-EM. Liposome (LUVs) compositions: PC/DOPE/bl-PI (35/55/10 mol ratio), column 1 
and 2, or PC/DOPE/CL (35/55/10 mol ratio), column 3. In all cases, liposome concentration 
was 1.2 mM. In control experiments (column 1) ATG7 was excluded from the reaction. The 



















To obtain a morphological evidence of fusion, we analyzed the morphology of 
liposomes by cryo-EM. As shown in Figure 3.10, in the case of conjugation reactions 
including GATE-16 and GABARAP homologues, formation of much larger vesicles was 
observed at the end of the fusion reaction, clearly suggesting repetitive fusion events. 
These results strongly support our conclusion that GATE-16-PE and GABARAP-PE 
cause fusion of liposomes. In control experiments, no increase in liposome size was 
observed in the absence of ATG7. Moreover, consistent with the biochemical results 
suggesting that LC3 is a weaker inducer of membrane fusion in the in vitro system used 
here, liposome size increased less markedly. However, a significant number of 
liposomes lost their spherical shape and appeared as elongated structures that may 
derive from either deformation of single vesicles and/or fusion events between no more 





















3.3.5. The Role of Specific Lipids in LC3- and GATE-16/GABARAP-Promoted 
Fusion 
According to the widely accepted stalk-pore fusion model (Basañez et al., 
1996b, 1998; Chernomordik et al., 1995; Goñi & Alonso, 2000; Ibarguren et al., 2010; 
Villar et al., 2001), fusion is thought to start with the formation of a non-lamellar lipidic 
stalk, a local connection between the contacting monolayers of two membranes. The 
stalk then extends connecting the facing monolayers (hemifusion) before pore 
formation (fusion) occurs. The model predicts that addition of inverted cone-shaped 
lipids (i.e. positive curvature-inducing lipids) such as lyso-phosphatidylcholine (LPC) to 
contacting membrane leaflets should prevent formation of hemifused intermediates 
whereas cone-shaped lipids such as diacylglycerol (DAG) or cardiolipin (CL) (i.e lipids 
with a negative intrinsic curvature) should promote formation of hemifusion 
intermediates (Chernomordik et al., 1995). As shown in Figure 3.11 A, substituting bl-
PI for CL (10 mol%) strongly promoted GATE/GABARAP-PE-induced lipid mixing. 
Addition of DAG (10 mol%) further promoted intervesicular lipid mixing and LPC (10%) 
totally inhibited it (Figure 3.11 A).  
Furthermore fusion pore formation and content mixing occurred as well with 
lipidated GATE-16 and GABARAP proteins. Consistent with what it was observed in 
lipid mixing experiments, CL strongly potentiates mixing of aqueous contents (Figure 
3.11 B). Again vesicle fusion was accompanied by only a residual leakage of vesicular 
content (data not shown). For all lipid composition tested vesicle size was centered 
around 80 nm as assessed by DLS measurements (data not shown). 
Vesicle radius has been proven to modulate LC3/GABARAP lipidation in vitro 
(Nath et al., 2014). In their study, Melia and coworkers showed that ATG3 contains a 
membrane inserting, curvature-sensitive domain and that the conjugation of the Atg8-
family proteins occurs preferentially on highly curved membranes in vivo. In addition to 
promoting the lipidation process, membrane curvature may also facilitate the fusion 
process itself (Ahyayauch et al., 2005; de Arcuri et al., 1999), inducing autophagosome 
elongation on the curved edge of the growing isolation membrane. To address the 
effect of vesicle radius on the process of membrane fusion, we chose the maleimide 
system, as it allows the evaluation of membrane fusion elicited by LC3 homologues 
independently of ATG3.  To this aim, labelled and non-labelled PC/DOPE/bl-PI 
liposomes containing 15% PE-mal were prepared either by sonication (SUVs) or by 
extrusion through polycarbonate membranes 0.05 μm pore size (LUVs). As shown in 







Figure 3.11. Effect of lipids modifying the membrane intrinsic curvature on membrane 
fusion induced by LC3/GABARAP-PE conjugates. (A) Representative time courses (left 
panels) and comparison at t=2000 s (right panels) of intervesicular total lipid mixing induced by 
ATG7 (1 μM), ATG3 (1 μM) and the indicated Atg8 human homologues (10 μM) in liposomes 
(0.4 mM) with the basic lipid composition PC/DOPE (35/55 mol ratio) to which either bl-PI (+10 
mol ratio), CL (+10 mol ratio), CL+DAG (+10 +10 mol ratio ) or CL+LPC (+10+10 mol ratio ) was 
added. (B) Representative time courses (left panels) and comparison at t=2000 sec ( right panel) 
of aqueous contents mixing for the same reactions as in A. Lipid mixing and content mixing 
assays were performed as described in Fig. 3. ATG7 was excluded from the reaction in control 
experiments (grey traces). Liposomes and proteins were incubated for 5 min before ATP 
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Hardly a stimulatory effect was observed in the case of LC3-PEmal, although it 
was efficiently conjugated to PEmal. Consistent with what was observed previously for 
enzymatically-conjugated GATE-16 and GABARAP, substitution of PI by CL strongly 
enhances lipid-mixing induced by GATE-16-PEmal and GABARAP-PEmal (compare 
panels 3.12 B and C). Again inclusion of CL did not affect particle size (data not 
shown). These results add to the growing body of evidence supporting an important 
role of both vesicle radius and membrane intrinsic curvature during autophagosome 
biogenesis (Antonny, 2011; Fan et al., 2011; Knorr et al., 2014). 
 





Figure 3.12. Effect of vesicle diameter and lipid composition on membrane fusion 
elicited by LC3/GABARAP-PEmal conjugates. Time courses of total (●); and inner (●); lipid 
mixing induced by the indicated proteins (10 μM) in liposomes (total lipid 0.4 mM) of different 
sizes (sonicated A, or extruded, B and C) and different lipid compositions: 
PC/DOPE/PEmal/bl-PI (35/40/15/10 mol ratio) (A, B) or PC/DOPE/PEmal/CL (35/40/15/10 
mol ratio) (C). The arrow marks the moment of protein addition. Each curve represents the 
























































The fusogenic potential of Atg8-PEmal has been shown to be highly dependent 
on the concentration of PE in the target membrane (Nair et al., 2011). In that study, a 
reduction of PE concentration from 55 to 30% made Atg8-PEmal unable to fuse 
liposomes despite the fact that coupling of Atg8 to maleimide was equally efficient in 
both cases. We evaluated whether reducing the PE content in our liposomes had an 
impact on GABA/GATE-PE-dependent vesicle fusion. In agreement with the previous 
report, GATE-PEmal and GABA-PEmal were hardly able to fuse liposomes containing 





molecules such as CL or DAG promoted vesicle fusion, nearly to the extent observed 
with 55% DOPE. With enzymatically conjugated GATE and GABARAP proteins (Figure 
3.13 C-D) vesicle fusion is significantly impaired by reduction of DOPE to 30%, 
probably due to a drop in the efficiency of the lipidation reaction. However, 
incorporation of CL and DAG into the vesicles sustained potent vesicle fusion, even in 
the context of a limiting DOPE concentration. 
DAG and CL fatty acid composition could be an important factor influencing 
fusion. The beef heart CL used here is mainly tetra-linoleoyl, while egg DAG contains 
mainly saturated and mono-unsaturated fatty acids. In principle, for a given fatty acid 
composition, the intrinsic negative curvature of DAG is higher than that of CL, but this 
could be compensated by the different unsaturation in both lipids. We have resolved the 
ambiguity by assaying separately CL and DAG in our fusion assay (Figure 3.13 A-B). 
Both for GATE-16 and GABARAP, with either 30% or 55% PE, DAG is more potent 
than CL in increasing the fusion rate, thus the headgroup appears to be more important 





















Figure 3.13. CL- and DAG-sustained membrane fusion under PE limiting concentrations. 
Time courses of total lipid mixing induced by the indicated proteins (10 μM) in liposomes (0.4 
mM) of different lipid compositions. (A) and (B) panels (chemical conjugation): with the basic 
lipid composition PC/DOPE/PEmal (45/30/15 mol ratio, grey lines) to which either bl-PI (+10 
mol ratio), CL (+10 mol ratio)  or  DAG (+10 mol ratio) were used; or basic lipid composition of 
PC/DOPE/PEmal (35/40/15 mol ratio, black lines) to which either bl-PI (+10 mol ratio), CL (+10 
mol ratio) or DAG (+10 mol ratio) were used. (C) and (D) panels (enzymatic conjugation): with 
the  basic lipid composition of PC/DOPE  (60/30, grey lines) to which either bl-PI (+10 mol 
ratio), CL (+10 mol ratio) and CL+DAG (+10+10 mol ratio) were used or the basic lipid 
composition of PC/DOPE (35/55, black lines) to which either bl-PI (+10 mol ratio) or CL (+10 
mol ratio) were added. Liposomes and proteins were incubated for 5 min before ATP addition. 




































The Atg8 ubiquitin-like conjugation system plays a central role in autophagy. 
However, despite its likely importance during autophagosome formation, its mode of 
action is only incompletely understood. This is particularly true in the case of higher 
eukaryotes and information regarding mammalian LC3/GABARAP subfamilies is just 
recently starting to emerge (Mizushima et al., 2003; Tanida et al., 2002b, 2004; Yang & 





more about the molecular mechanisms by which human LC3 and GABARAP 
subfamilies trigger AP biogenesis. Using these simplified and biochemically accessible 
model systems, we systematically explored the membrane activities of human Atg8 
homologues in the context of different lipid compositions. Our data provide new insight 
into several aspects of the human autophagy machinery, namely on the nature of the 
fusion process leading to AP elongation, and the role of lipid instrinsic curvature in the 
process. From the methodological point of view, our results fully validate the use of 
chemically lipidated Atg8 homologue. 
 
3.4.1 The Fusion Mechanism 
According to the current view, phagophore expansion requires the supply and 
subsequent fusion of membranal material of yet uncharacterized origin. In this regard, 
several studies have involved both yeast Atg8 (Nakatogawa et al., 2007; Xie et al., 
2008) and human LC3 and GATE-16 (Weidberg et al., 2011) in the fusion processes 
underlying phagophore expansion. However the molecular mechanism is still obscure. 
The liposomal assays applied here allowed us to explicitly test the capacity of the 
different homologues for inducing membrane fusion in vitro, in the absence of other 
cellular proteins. 
The ensemble of the data is compatible with a fusion mechanism based on the 
“stalk hypothesis” (Basañez et al., 1996b, 1998; Chernomordik & Kozlov, 2008; 
Chernomordik et al., 1995; Goñi & Alonso, 2000; Ibarguren et al., 2010; Villar et al., 
2001; Xu et al., 2005), according to which the formation of a lipidic intermediate, the 
stalk, with a non-lamellar structure, is the limiting step in the fusion event. The 
canonical form of stalk-mediated fusion requires the independent demonstration of 
vesicle aggregation, intervesicular mixing of total membrane lipids, mixing of inner 
monolayer lipids and mixing of aqueous contents in the absence of vesicular content 
leakage or spill-out. Ideally aggregation, total lipid mixing, inner lipid mixing, and 
contents mixing should start in the said order, i.e should exhibit increasing lag times. All 
these predictions have been demonstrated in our case, particularly for GATE-16 and 
GABARAP (Figure 3.8 and Figure 3.9). Moreover the proposed stalk architecture 
demands that lipids with an intrinsic negative curvature (e.g. DAG, CL) must facilitate 
stalk formation, thus membrane fusion (Basañez et al., 1996b, 1998). This is also 
amply demonstrated by our data, as well as the opposite, inhibitory effect of positive 
intrinsic-curvature lipids (e.g lyso PC) (Figure 3.11). The same considerations on 
intrinsic lipid curvature apply to the requirement of high proportions of PE in the vesicle 




composition (Figure 3.13). We can thus conclude that, at least in the in vitro situation, 
Atg8 proteins induce AP growth via stalk-mediated fusion events.  
In the cell environment, the AP is seen to grow by elongation, i.e along a main 
axis. In our case the most effective Atg8 analogs, namely GATE-16 and GABARAP, 
give rise to a spectacular growth of vesicles, leading to roughly spherical structures 
(Figure 3.10), while LC3, a much less efficient fusogen, gave rise to elongated, peanut-
shaped structures, reminiscent of the growing AP in cell images. The reason why LC3 
is less effective than the other two, and why it originates elongated vesicles deserves 
further study. At least part of the answer will rely in the yet unknown mechanisms of AP 
growth regulation (Moreau et al., 2011; Nair et al., 2011). At the present time, we 
cannot rule out the possibility that, being less effective, LC3 is more physiologically 
relevant in AP elongation.   
 
3.4.2 Proteins and Lipids 
Both SNAREs and viral fusion proteins contain a transmembrane domain, which 
is critical for their fusion activity (Langosch et al., 2007; Xu et al., 2011, 2005). Atg8 
homologues do not present such a transmembrane domain and yet are capable of 
inducing full membrane fusion when anchored only to one membrane leaflet via PE. 
Several models have been proposed including that self-oligomerization of Atg8-PE 
molecules would drive membrane tethering and hemifusion through a yet 
uncharacterized mechanism (Nakatogawa et al., 2007). Alternatively, it has been 
shown that peptides representing the N-terminus of LC3 and GATE are sufficient to 
drive full membrane fusion when artificially linked to PEmal (Weidberg et al., 2011). An 
additional, non-exclusive possibility is that the asymmetric insertion of this N-terminal 
region would promote positive curvature and tension in the outer leaflet of the 
membrane thus promoting hemifusion and eventually fusion (Zimmerberg & Kozlov, 
2006). Amphipathic proteins devoid of transmembrane domains can induce vesicle 
fusion, e.g muscle glyceraldehyde 3-phosphate dehydrogenase (Morero et al., 1985). 
Determining membrane structures of LC3/GABARAP proteins, particularly at the 
fusogenic state, will likely broaden our understanding of Atg8-driven membrane fusion.  
According to a growing body of evidence, AP biogenesis is a lipid-modulated 
process (Chu et al., 2013; Dall’Armi et al., 2013; Sentelle et al., 2012; Vicinanza et al., 
2015). However, with the exception of the relatively well characterized role of PI3P, little 





of AP biogenesis. Here we obtained direct evidence that intrinsic-curvature modifying 
lipids (DAG, LPC, CL) act in concert with autophagic proteins to modulate the fusion of 
vesicles in vitro. This observation is compatible with a model in which the local 
generation or transfer of these lipids from the ER or mitochondria to the isolation 
membrane may regulate phagophore expansion in vivo. Interestingly the PLD1 
pathway, which produces phosphatidic acid (PA), a cone-shaped lipid, has been 
reported to promote autophagy (Dall’Armi et al., 2010). Furthermore, another study 
showed that DAG generation is required for the initiation of Salmonella-induced 
autophagy (Shahnazari et al., 2010). In both cases, however, the underlying 
mechanism is not known. What still needs to be determined is the lipid composition of 
the phagophore as well as the lipid changes that accompany AP biogenesis in vivo. In 
this regard, reliable autophagosome purification procedures in conjunction with 
lipidomic approaches should help to understand the specific roles of lipids in 
autophagy. 
In agreement with a recent report (Nath et al., 2014), we observe that both 
human LC3 and GABARAP subfamilies can be enzymatically lipidated in vitro (Figure 
3.7 D), even in the absence of the ATG12-ATG5-ATG16L1 complex. However both 
systems are essential for proper AP biogenesis in vivo, and several in vitro studies 
(Hanada et al., 2007; Sakoh-Nakatogawa et al., 2013) indicated that the ATG12-ATG5-
ATG16L1 complex functions, at least in part, facilitating the transfer of Atg8/LC3 from 
ATG3 to PE. Whether human ATG12-ATG5-ATG16L1 complex promotes lipidation of 
GABARAP subfamily in a similar manner to LC3 needs to be tested and will be 
addressed in future studies.  
As an alternative to the enzymatically-driven reaction the chemical conjugation 
approach enables direct conjugation of proteins to PE lipids (Figure 3.7 F), thus 
bypassing the requirement for the conjugation machinery. Although the enzymatic 
conjugation is more physiologically relevant, chemically-conjugated versions of 
LC3/GABARAP subfamilies are easily prepared and are increasingly being used in both 
mechanistic (Nair et al., 2011; Weidberg et al., 2011) and structural (Ma et al., 2010) 
studies. Here we report that PEmal conjugates faithfully recapitulate key features of 
their naturally conjugated homologues, supporting the reliable use of these artificial 
complexes. In fact PEmal conjugates show faster aggregation and fusion kinetics than 
the enzymatically-conjugated proteins, consistent with the fact that they are not 
conjugated through a relatively complex ubiquitin-like reaction comprising multiple steps 













4. Human ATG3 membrane 












Human ATG3 membrane association 







Macroautophagy is a bulk degradation pathway conserved among eukaryotic 
cells (Tooze et al., 2010).  A double membrane structure called autophagosome 
engulfs organelles or cytoplasmic portions and subsequently delivers the material into 
the lysosome for degradation (He & Klionsky, 2009). Autophagosome formation 
requires more than 30 proteins acting in a hierarchical manner (Lamb et al., 2013). 
Among these proteins an ubiquitin-like (UBL) system triggers the covalent attachment 
of Atg8 (LC3 and GABARAP subfamilies in mammals) to phosphatidylethanolamine 
(PE) in the autophagosomal membrane (Sou et al., 2006; Tanida et al., 2004). Atg8 
conjugation requires the involvement of additional enzymes such as Atg7 and Atg3. 
These proteins catalyze the mentioned process, Atg3 being responsible for transferring 
Atg8 to the membrane (Hong et al., 2011; Kaiser et al., 2012). Once in the membrane 
Atg8 participates in autophagosome formation, maturation and closure. It has been 
described that mammalian Atg8-like proteins (LC3, GATE-16 and GABARAP) induce 
membrane tethering and fusion in vitro (Landajuela et al., 2016; Nakatogawa et al., 
2007; Weidberg et al., 2011). 
Human ATG3, the E2-like enzyme for Atg8 conjugation, contains some 
disordered regions that allow its classification among the intrinsically disordered 





processes requiring quick responses such as autophagy. Atg3 shows two regions for 
its interaction with Atg7 and Atg8, respectively the HR and FR regions (Yamada et al., 
2007). These two domains act together with the catalytic cysteine (Cys264) to catalyse 
ATG3-LC3 binding and thus redirect LC3 to the membrane (Sakoh-Nakatogawa et al., 
2013). For this purpose, it was described that Atg3 N-terminus was the protein region 
responsible for membrane detection and interaction (Hanada et al., 2009). Specifically, 
a predicted N-terminal amphiphatic helix was indicated to be a membrane-curvature 
sensing domain (Nath et al., 2014). However, it was also proposed that the Atg5-
Atg12/Atg16 complex promotes a more efficient recruitment of Atg3 to membranes 
(Romanov et al., 2012; Walczak & Martens, 2013), due to the ability of Atg3 to interact 
with Atg12 (Metlagel et al., 2013; Radoshevich et al., 2010). Atg16 promotes 
localization of the Atg12-Atg5 conjugate to membranes in vivo (Fujita et al., 2008), in 
order to allow Atg8-PE conjugation and also tethering of GUV in vitro (Romanov et al., 
2012). Atg12-Atg5 complex induces a reorientation of Atg3 catalytic cysteine toward a 
threonine residue so that Atg3 conjugase activity is stimulated (Klionsky & Schulman, 
2014; Sakoh-Nakatogawa et al., 2013). Apart from its specific role in autophagy, the 
possible implication of Atg12 conjugation to Atg3 in the regulation of mitochondrial 
homeostasis and cell death has been proposed (Radoshevich et al., 2010). 
In this context, a question remains about what determines the movement of 
ATG3 to the membrane. Some proteins contain domains that detect specific membrane 
lipids, e.g. phosphoinositides, or membrane curvature (BAR and amphipathic helices) 
(Lemmon, 2008; McMahon & Gallop, 2005). An amphiphatic helix was proposed to be 
the responsible of the specific membrane recognition by ATG3 (Nath et al., 2014). 
Here we study the properties of ATG3 interaction with membranes in order to 
obtain a better understanding on how the lipidation process could be regulated by 
protein-lipid interactions. We show that human ATG3 interacts with PE-containing 
membranes through its N-terminal region and that this binding can be enhanced by the 
presence of negatively-charged phospholipids in the membrane. Furthermore, ATG3 
recognizes preferentially highly curved vesicles, but the presence of anionic 
phospholipids suppresses the necessity of this curvature. We also have demonstrated 








4.2 Experimental Techniques 
4.2.1 Materials 
QL22 and QF27 peptides were synthesized and purchased from ProteoGenix 
SAS (Schiltigheim, France). Egg phosphatidylcholine (PC) was purchased from Lipid 
Products (South Nutfield, UK). 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine 
(DOPE), bovine liver phosphatidylinositol (PI), heart cardiolipin (CL), brain 
phosphatydilserine (PS), egg phosphatidyldglycerol (PG), egg Phosphatidic Acid (PA), 
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) 
(Rho-PE), ovine wool cholesterol (Chol) and 1,2-dihexadecanoyl-sn-glycero-3-
phosphocholine (DPPC) were purchased from Avanti Polar Lipids, Inc. (Alabaster,AL). 
Anti-ATG3 antibody and goat anti-mouse IgG-HRP were from Santa Cruz 
Biotechnology, Inc. (Dallas, TX). Anti-GABARAP monoclonal antibody was from MBL 
International (Medical & Biological laboratories Co. Ltd.). Alexa Fluor® 488 dye was 
purchased from Molecular Probes (Eugene, OR). All other reagents were of analytical 
grade. 
 
4.2.2 DNA Constructs and Site-directed Mutagenesis 
Plasmids for expression of human ATG3 were kindly provided by Dr. Isei 
Tanida (National Institute of Infectious Diseases, Tokyo, Japan). A double mutant for 
Lys to Asp (ATG3 K9D/K11D) at positions 9 and 11 of ATG3 was made using 
QuikChange site-directed mutagenesis kit (Stratagene). Specifically designed ATG3 
primers purchased from Sigma Aldrich (Madrid, Spain) were used (See Table 2.1). 
Mutations were confirmed by DNA sequencing (Secugen S.L, Madrid, Spain). 
 
4.2.3 Recombinant Protein Expression and Purification 
All ATG3 variants were purified from soluble fractions of bacterial extracts 
obtained in the absence of detergents, and were >90% pure as evaluated by 
Coomassie-stained SDS-PAGE. E.coli BL21 (DE3) cells were transformed with 
appropriate plasmids, grown to OD600=0.8 and induced with 0.5 mM IPTG for 18 h at 
20 ºC. Following centrifugation at 4,500 xg for 15 min, the pellet was resuspended and 





After removal of cellular debris by centrifugation at 30,000 xg  for 30 min at 4 ºC, the 
sample supernatant fraction was incubated with 1 ml Glutathione Sepharose 4B (GE 
Healthcare) for 3 h at 4 °C to bind GST tagged proteins. Then, PreScission Protease 
(GE Healthcare) was added at 100 units/ml in 2 bed volumes of PreScission Buffer [50 
mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA] with freshly added 1 mM DTT and 
cleavage was performed for 4 h at 4 °C. Cleaved protein was eluted and purified 
proteins were stored in 20% glycerol at -80 °C. 
 
4.2.4 Monolayer Surface Pressure Measurements 
Lateral pressure experiments were carried out in a multi-well Delta Pi-4 
Langmuir balance (Kibron Inc., Helsinki, Finland) under constant stirring. Proteins 
induced changes in surface pressure at the air-water interface and protein-lipid 
monolayer interactions were studied at 25 ºC (same results were obtained at 37 ºC, 
data not shown). Monolayers were formed by spreading a small amount of the lipid 
mixtures in chloroform:methanol (2:1 v/v) solution on top of assay buffer, until the 
desired initial surface pressure was reached. Proteins were injected with a micropipette 
through a hole connected to the subphase. The assay buffer was 20 mM HEPES [4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid] (pH 7.4), 150 mM NaCl, 1 mM MgCl2, 
0.2 mM DTT. 
 
4.2.5 Liposome Preparation 
The appropriate lipids were mixed in organic solution and the solvent was 
evaporated to dryness under a N2 stream. Then the sample was kept under vacuum for 
2 h to remove solvent traces. The lipids were swollen in PreScission buffer, except in 
leakage assay experiments, where the corresponding buffer was used (see leakage 
assay section). Large unilamellar vesicles (LUVs) were prepared from swollen lipids, 
subjected to 10 freeze/thaw cycles, and then extruded using 0.1 µm pore size 
Nuclepore filters as described by Mayer et al., (1986). Small unilamellar vesicles 
(SUVs) were obtained by sonicating multilamellar vesicles (MLVs) with a probe tip 
sonicator (MSE Soniprep 150 (MSE, UK)) for 10 min (10 s on, 10 s off) on ice. Vesicle 
size was checked by quasi-elastic light scattering using a Malvern Zeta-Sizer 4 
spectrometer (Malvern Instruments, Worcestershire, UK). LUVs had an average 




diameter of 100 nm and SUVs an average diameter of 50 nm. Lipid concentration was 
determined by phosphate analysis (Böttcher et al., 1961). 
 
4.2.6 Sucrose Gradient Centrifugation of Liposomes 
ATG3 purified as indicated (10 µM) was incubated with 3 mM liposomes 
(containing 0.05% Rho-PE for detection) for 1 h at 37 ºC in 200 µl PreScission buffer. 
The protein/lipid mix was diluted to 300 µl in PreScission buffer containing 2.4 M 
sucrose. Then the reaction mix was transferred to a centrifuge tube. A 2.4 M sucrose 
layer was overlaid with 400 µl PreScission buffer containing 0.8 M sucrose and 300 µl 
PreScission buffer containing 0.5 M sucrose. Sucrose step gradients were centrifuged 
in a TLA-120.2 rotor at 100,000 xg for 3 h at 4 ºC. Four 250-µl fractions were pipette 
starting from the bottom. The top fraction (T) contained liposomes as determined by the 
rhodamine fluorescence, and the bottom fraction (B) contained the unbound protein. 
Both fractions were analyzed by SDS-PAGE and Western blotting. 
 
4.2.7 Aggregation Assays 
All assays were carried out at 37 ºC with continuous stirring, in a 1 ml cuvette 
with 600 μl of 50 mM Tris, 150 mM NaCl, 1 mM DTT buffer (pH 7.5). All experiments 
were performed at a vesicle concentration equivalent to 0.4 mM phosphate and 10 μM 
ATG3 were used unless otherwise stated. Lipid aggregation was monitored in an 
Uvikon 922 spectrophotometer (Kontron instruments, Groß-Zimmern, Germany) as an 
increase in turbidity (absorbance at 400 nm) of the sample. 
 
4.2.8 Alexa Fluor 488 Protein Labeling 
Purified proteins were first concentrated to 4-5 mg/ml (protein concentration 
should be at least 2 mg/ml for optimal results) and dialyzed against 0.1 M sodium 
bicarbonate pH 8.2, 150 mM NaCl buffer to remove any amine-containing substances 
that will interfere with the conjugation reaction. Then 10 µl of the reactive dye solution 
(10 mg/ml of the amine-reactive compound dissolved in dimethylsulfoxide) was slowly 
added to the protein solution. The reaction mixture was incubated for 2 h at 37 ºC with 





the conjugate from unreacted labelling reagent, with PreScission buffer as the eluent. 
The degree of labelling was determined measuring the absorbance of the protein-dye 
conjugate at 280 nm and at 488 nm for the dye. Labelled samples were subjected to 
SDS-PAGE and visualized using a VersaDoc MP 4000 Imaging System. 
 
4.2.9 Giant Unilamellar Vesicle (GUV) Preparation 
GUVs were prepared using the electroformation method developed by 
Angelova & Tsoneva, (1999). For direct visualization under the microscope a 
homemade chamber was used (Fidorra et al., 2006). Transferred GUVs were formed in 
a PRETGUV 4 chamber supplied by Industrias Técnicas ITC (Bilbao, Spain). Stock 
solutions of lipids (0.2 mM total lipid containing 0.2 mol% Rho-PE) were prepared in 
chloroform:methanol (2:1, v/v), 3 μl of the lipid stocks were added onto the surface of 
Pt electrodes and solvent traces were removed by evacuating the chamber under high 
vacuum for at least 2 h. 
 
4.2.10 Direct Visualization of GUVs 
The Pt electrodes were covered with 400 μl of 50 mM Tris-HCl, 150 mM NaCl, 1 
mM EDTA and 1mM DTT, pH 7.5. The Pt wires were connected to an electric wave 
generator (TG330 function generator, Thurlby Thandar Instruments, Huntington, UK) 
under alternating current (AC) field conditions (500 Hz, 0.031 VRMS for 6 min; 500 Hz, 
0.281 VRMS for 20 min, and 500 Hz, 0.623 VRMS for 1 h 30 min) at 37°C. After GUV 
formation, the chamber was placed on an inverted confocal fluorescence microscope 
(Nikon D-ECLIPSE C1, Nikon, Melville, NY). The excitation wavelengths were 488 nm 
for ATG3-Alexa488 and 561 nm for Rho-PE. The images were collected using band-
pass filters of 593 ± 20 nm for Rho-PE, and of 515 ± 15 nm for Alexa488. Then 1 μM 
ATG3-Alexa488 was added to study the ATG3 effect on the GUVs. All these 
experiments were performed at room temperature. Image treatment was performed 
using the EZ-C1 3.20 software (Nikon). 
 
4.2.11 Observation of Transferred GUVs 
The Pt electrodes were covered with 400 μl of a 300 mM sucrose solution, 
previously heated at 37 °C. The Pt electrodes were connected to a generator (TG330 




function generator, Thurlby Thandar Instruments) under AC field conditions (10 Hz, 1 
VRMS for 2 h, followed by 2.5 Hz, 1 VRMS, 1h 30 min) at 37 °C. Finally, the AC field 
was turned off and the vesicles (in 300 mM sucrose) were collected from the 
PRETGUV 4 chamber with a pipette and transferred to chambers pretreated with 
bovine serum albumin (BSA) (2 mg/ml) and containing an equiosmolar buffer solution 
of 50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA and 1mM DTT, pH 7.5. Due to the 
different density between the two solutions, the vesicles sedimented at the bottom of 
the chamber, and this facilitated observation under the microscope. Finally, ATG3-
Alexa488 at 1 μM was added to study the ATG3 effect on the GUVs. The excitation 
wavelengths were 488 nm for ATG3-Alexa488 and 561 nm for Rho-PE; and the 
emission was collected using 515 ± 15 nm and 593 ± 20 nm band-pass filters, 
respectively. All these experiments were performed at room temperature. Image 
treatment was performed using the EZ-C1 3.20 software (Nikon). 
 
4.2.12 Lipid Mixing Assay 
A fluorescence resonance energy transfer assay was used to monitor 
intervesicular membrane lipid mixing (Struck et al., 1981). 0.4 mM LUVs containing 1.5 
mol% NBD-PE and 1.5 mol% Rho-PE were mixed with 9-fold excess of unlabeled 
LUVs in 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA and 1mM DTT buffer. 
NBD-PE emission was monitored in a QuantaMaster spectrofluorometer (Photon 
Technology International, Birmingham, New Jersey) in a thermostatically controlled 1-
cm path length cuvette with constant stirring at 37 °C. NBD emission was monitored at 
530 nm with the excitation wavelength set at 467 nm (slits, 2 nm). A 515 nm cut-off 
filter was placed between the sample and the emission monochromator to avoid 
scattering interference. 10 μM ATG3 were used unless otherwise stated in 1 ml final 
volume. 
 
4.2.13 Vesicle Contents Leakage Assay 
Leakage of vesicle contents was monitored by the ANTS/DPX assay (Ellens et 
al., 1985). ANTS emission was monitored at 530 nm with the excitation wavelength set 
at 360 nm (slits, 2 nm). A 470 nm cut-off filter was placed between the sample and the 
emission monochromator to avoid scattering interference. To establish the 100% 
leakage signal, Triton X-100 was added to a concentration of 1%. Details for the 






4.3.1 ATG3 Interaction with Model Membranes 
ATG3 was proposed to direct human Atg8 homologues (LC3, GATE-16 and 
GABARAP) to the membrane to complete their lipidation process. Some studies 
demonstrated an important implication of the Atg3 N-terminal region in membrane 
recognition (Hanada et al., 2009). Particularly, a predicted N-terminal amphiphatic 
alpha-helix (Figure 4.1) would be responsible for this recognition and also acts as a 
membrane curvature sensor (Nath et al., 2014). Based on these observations, we 
decided to analyze the interaction of ATG3 with membranes in more detail. ATG3 
K9D/K11D mutant was created and analyzed to discern the involvement of this region 


















Figure 4.1. Predicted structure of ATG3 N-terminal amphiphatic α-helix. (A) Helical wheel 
representation of the predicted N-terminal amphipathic helix (amino acids 2–20) of human 
ATG3 (wheel generated in Heliquest). (B) Ribbon diagram of the hydrophobic (left) and 
hydrophilic (right) faces. Hydrophobic (Leu, Ala, Val), negatively-charged (Glu) and positively-
charged (Lys) residues are coloured grey, red and blue respectively. (B) Electrostatic surface 
diagram of the ATG3 N-terminal α-helix. Both hydrophobic and hydrophilic faces are 
represented, and the color code indicated below each image. 




To this aim, we first decided to explore the ability of ATG3 to interact and insert 
into lipid monolayers using a Langmuir balance. A rapid and dose-dependent increase 
of lateral pressure at the air-water interface was observed when ATG3 was injected 
into the aqueous phase (Figure 4.2 A left panel). This increase indicates that ATG3 is 
adsorbing onto the air-water interface and thus it is a surface-active molecule. A similar 
trend was observed for ATG3 K9D/K11D (Figure 4.2 A right panel). Both wild type and 
mutant ATG3 reach a similar plateau value of ~23 mN/m at 0.2 and 0.3 μM protein 
concentration, respectively. 
ATG3 was able to insert into lipid monolayers extended at an initial surface 
pressure ≥ 23 mN/m, above the maximum Δπ caused by adsorption of ATG3 at an air-
water interface. Compositions of PC:DOPE (70:30 mol ratio), PC:DOPE:CL (60:30:10 
mol ratio) and PC:DOPE:PA (50:30:20 mol ratio) were used to test the affinity of ATG3 
for monolayers containing different anionic phospholipids (Figure 4.2 C left panel). The 
protein (0.2 μM) was injected into the subphase and the increase in surface pressure 
was monitored in real time. A change in the lateral pressure at equilibrium (Δπ) was 
observed in all cases. The protein change in Δπ decreases linearly for both proteins 
with the increase in initial pressure (π0), i.e. insertion becomes more difficult when the 
initial lateral pressure is higher. In order to obtain a quantitative measure of ATG3 
insertion into lipid monolayers, critical surface pressure (πc) values were determined. 
Above a certain π0 value insertion is no longer observed (Figure 4.2 C). Extrapolation 
of the Δπ versus π0 lines to Δπ=0 provides the so-called critical surface pressure πc, 
above which no protein insertion occurs. πc values for wild type and mutant ATG3 are 
shown in Table 4.1. These values are close to or above the usually accepted average 
value of ∼30–35 mN/m for the lateral pressure of lipid monolayers in the cell 
membranes (Marsh, 1996). The increase in surface pressure obtained with 
PC:DOPE:CL and PC:DOPE:PA was considerably higher than that obtained with 
PC:DOPE monolayers. This result suggests a preference of ATG3 to insert into 
negatively-charged monolayers. Atg3 causes a larger surface pressure increase in PA-
containing monolayers as compared to CL-containing monolayers even though the net 
electrical charge must be the same in both cases (Figure 4.2 B left panel). However, 
ATG3 K9D/K11D (0.3 μM) did not show any preference for monolayers containing 









Figure 4.2.  ATG3 and ATG3 K9D/K11D insertion into lipid monolayers. (A) Representative 
time courses of adsorption of ATG3 (left) or ATG3 K9D/K11D (right) at an air-water interface. 
(B) Representative time courses of increase in lateral pressure after ATG3 (0.2 μM) insertion 
into PC:DOPE:CL (60:30:10 mol ratio) or PC:DOPE:PA (50:30:20 mol ratio) monolayers (left). 
Representative time courses of increase in lateral pressure after ATG3 or ATG3 K9D/K11D 
insertion into PC:DOPE:CL (60:30:10 mol ratio) monolayers (right). (C) Maximum increase in 
lateral pressure after ATG3 (left) or ATG3 K9D/K11D (right) insertion into lipid monolayers. 
Lipids were: [●] PC:DOPE (70:30 mol ratio), [▲] PC:DOPE:CL (60:30:10 mol ratio), [□] 





























Lipid Composition πc 
ePC:DOPE (70:30) 36.4 mN/m (± 1.23) 
ePC:DOPE:CL (60:30:10) 39.2 mN/m (± 1.67) 
ePC:DOPE:PA (50:30:20) 44.3 mN/m (± 1.94) 
ATG3 K9D/K11D (ePC:DOPE) 34.5 mN/m (± 0.81) 




The interaction of ATG3 with a simplified model, such as lipid bilayers, was 
assessed next. Using liposomes as model membranes, we can reproduce the 
composition and curvature of cell membranes. For this purpose we performed 
liposomal float up assays. A fixed concentration of ATG3 (10 μM) was incubated with 
liposomes (1:300 protein:lipid ratio) of different lipid compositions. Then the mixture 
was subjected to an equilibrium sucrose gradient centrifugation where the vesicles 
have the capacity to float up, and the amount of protein interacting with these 
liposomes was examined. Fractions from the top (T) and bottom (B) of the gradient 
were subjected to SDS-PAGE and Western Blot analyses. 
According to previous studies with the UBL system, 55% DOPE was required 
for get an optimal lipidation of LC3, and also aggregation and fusion of vesicles (Nair et 
al., 2011). As ATG3 is thought to be responsible for bringing over Atg8 homologues to 
the membrane, the preference of this protein for membranes with different DOPE 
amounts and the influence of negatively-charged phospholipids on this interaction was 
tested. ATG3 bound DOPE-containing membranes, but no significant difference was 
observed between 30% and 55% DOPE (Figure 4.3 A). However, when an anionic 
phospholipid (10% CL in this case) was included in the lipid composition, the affinity of 
ATG3 for the membrane increased significantly (Figure 4.3 A). Moreover, even in the 
presence of CL no difference between 30% and 55% of DOPE was observed. ATG3 
K9D/K11D was not able to bind vesicles of any composition tested (Figure 4.3 A). 
These results suggest that ATG3 has a marked preference to interact with negatively-
charged membranes, and that its N-terminal positively-charged residues play an 
important role in this interaction. 
Melia and coworkers (Nath et al., 2014) showed that mouse ATG3, basically 
identical to human (97.5% identity), contains a predicted N-terminal amphiphatic helix 
Table 4.1. Critical surface pressures (πc) of ATG3 interaction with lipid monolayers of 
different compositions. Data derived from experiments as shown in Figure 4.2 C. The 





that could be a membrane curvature sensor. In order to know if the human ATG3 
possesses this property, we compared the binding of ATG3 to vesicles of different 
sizes such as LUV (100 nm diameter) and SUV (50 nm diameter). We observed an 
increase in the binding of ATG3 to 30% or 55% DOPE-containing SUV as compared to 
LUV with the same electrically neutral composition (Figure 4.3 B). Nevertheless, in 
vesicles with anionic phospholipids present in the membrane no curvature preference 
of ATG3 was sensed (Figure 4.3 B). Hence, ATG3 could behave as a membrane 
curvature sensor when neutral membranes were present, however the incorporation of 
negatively-charged phospholipids could by-pass the curvature effect. 
Similar floatation experiments were performed to figure out whether or not 
ATG3 displayed the same affinity for any anionic phospholipid. In fact, ATG3 showed a 
very strong affinity for PA and CL, although the binding to liposomes with PI, PG or PS 
was also significantly higher than the one to neutral membranes (Figure 4.3 C). 
Considering that PA and CL, which gave the higher rates of binding, are the only 
conical shape phospholipids among those tested, we could suggest a dual requirement 
for ATG3 interaction with membranes, namely defects in lipid packaging generated by 
cone-shaped phospholipids, and net negative charges in the membrane. Insertion of 
proteins into pure lipid bilayers may also rely on the transient appearance of 
hydrophobic patches on the bilayer surface, which might provide access points. The 
occurrence of these patches may be promoted by the presence of lipids in the bilayer 
that promote negative curvature and facilitate the lamellar-to-inverted hexagonal phase 
transition such as PE, PA, DAG or CL. Aerolysin (Alonso et al., 2000), adenilate 
cyclase toxin (Martín et al., 2004) or CTP:phosphocholine cytidyltransferase (Jamil et 
al., 1993) interaction with membranes are favoured by the incorporation of this kind of 
lipids, as could also be in the case of ATG3. 
To evaluate the relevance of the electrostatic component in ATG3 binding to 
membranes the above experiments were carried out with increasing NaCl 
concentrations. For ATG3 we observed the same amount of binding to vesicles with 
NaCl concentrations from 150 mM to 1 M, further suggesting that the electrostatic 










Figure 4.3. ATG3 interacts with negatively-charged phospholipid vesicles. The liposome-
bound protein fraction was analyzed after floatation sucrose density gradient centrifugation by 
SDS-PAGE/immunoblot analysis and quantified by densitometric integration of the peaks.      
(A) 10 µM ATG3 was incubated with 3 mM LUVs composed of PC:DOPE (70:30 or 45:55 mol 
ratio) or PC:DOPE:CL (60:30:10 and 35:55:10 mol ratio). ATG3 K9D/K11D was also shown.  
(B) Effect of vesicle size reduction on ATG3 interaction. ATG3 (10 μM) incubated with  UV 
containing 30% or 55% DOPE with or without CL (C) Atg3 interaction with LUV containing 
different anionic phospholipids. (D) ATG3 (10 µM) binding to liposomes (3 mM) composed of 
PC:DOPE:CL after incubation with increasing NaCl concentration (150 mM to 1M). Molecular 
mass is shown in kDa on the left-hand side. Data shown as mean ± SEM (n = 3); **p = 0.001-
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In order to test to what extent could the ATG3 N-terminal predicted α-helix 
reproduce the behavior of the full protein in the interaction with model membranes, we 
designed two different peptides respectively of 22 (QL22) and 27 (QF27) amino acids 
corresponding to this helix. These peptides are predicted to fold into a helix in the 
protein. They are expected to be water-soluble (Figure 4.4 A). According to circular 






Figure 4.4. ATG3 N-terminal peptides do not reproduce ATG3 full length protein 
interaction with membranes. (A) Surface electrostatics of the predicted structures of QL22 
and QF27 peptides generated by QUARK. (B) Secondary structure analysis of both peptides 
analyzed by circular dichroism. (C) Maximum increase in lateral pressure after QL22 and QF27 
peptide insertion into lipid monolayers. Lipids were: [○] PC:DOPE (70:30 mol ratio) or [●] 
PC:DOPE:CL (60:30:10 mol ratio). Data reported as a function of initial lateral pressure πi. (D) 
QL22 and QF27 binding to liposomes. Lipid compositions are shown in the panel. The peptide 
position in the gel is indicated by the arrow. 
(Figure 4.4 B). Moreover, due to the capacity of some peptides to fold in the presence 
of membranes, Langmuir balance studies and floatation experiments were performed. 
Both peptides showed the ability to interact with neutral and anionic lipid monolayers 
although with critical pressures πc well below those found for the whole protein (Figure 
4.4 C) but they did not interact in any case with lipid bilayers (Figure 4.4 D). This may 
suggest that (a) the peptides were in the unfolded conformation, an in that 
conformation they cannot bind lipid bilayers, or (b) even if they could adopt the α-























To summarize, the above results suggest that human ATG3 interacts with 
membranes containing physiological concentrations of DOPE, binds preferentially to 
negatively-charged membranes, and the membrane association is improved by defects 
in the membrane structure. The presence of anionic phospholipids decreases or 
suppresses the preference for highly curved vesicles, whereas the anionic lipids with a 
negative intrinsic curvature clearly facilitate ATG3 interaction with membranes. 
Furthermore mutations of Lys residues 9 and 11 in the predicted N-terminal α-helix 
revealed their importance in the protein binding to lipid vesicles.  
 
4.3.2 ATG3 Induces Aggregation of Liposomes but no Intervesicular Lipid 
Mixing 
ATG7/ATG3/LC3 UBL system is involved in the autophagosome elongation. In 
this process vesicle tethering and fusion is essential. It is usually understood that the 
full responsibility of the latter processes falls on the last reaction component, LC3. The 
other components (ATG7 and ATG3) are considered to act only in the previous 
conjugation reactions. However, since ATG3 interacts with membranes this protein 
could contribute, to some extent, to the aggregation and fusion of vesicles. This 
hypothesis was tested as detailed below. 
First, vesicles of different lipid compositions were incubated in presence of 
ATG3. Aggregation was monitored continuously in a spectrophotometer as an increase 
in sample turbidity (absorbance at 400 nm) (Goñi et al., 2003). ATG3 was observed to 
cause vesicle aggregation of electrically neutral vesicles [PC:DOPE (70:30 mol ratio)] 
and, at higher rates, of negatively-charged liposomes (containing PA, CL or PI) (Figure 
4.5 C). Just as in the interaction of ATG3 with vesicles assay (Figure 4.3) this protein 
showed the best tethering rate with PA-containing liposomes. In all cases, aggregation 
is ATG3 concentration dependent, at least between 1 μM and 10 μM. Furthermore, the 
activity of ATG3 K9D/K11D was tested in parallel experiments and no vesicle 
aggregation was observed even with anionic vesicles (Figure 4.5 B). 
Confocal images of liposome aggregates confirmed the turbidity results. 10 μM 
ATG3 was incubated with liposomes of different lipid compositions, and after 1 h 
images were taken in a confocal microscope. Very little aggregation was observed with 
the PC:DOPE composition, while extensive liposome aggregation was seen with CL- or 
PA-containing vesicles (Figure 4.5 A). Our negative controls, buffer only or ATG3 






Figure 4.5.  ATG3-promoted vesicle aggregation. (A) Representative images of ATG3-
induced LUV aggregation of different lipid compositions PC:DOPE (70:30 mol ratio), 
PC:DOPE:CL (60:30:10 mol ratio) and PC:DOPE:PA (50:30:20 mol ratio). (B) Time-course of 
ATG3 (10 μM) LUV aggregation. PC:DOPE:CL (60:30:10 mol ratio) lipid composition was used.  
Arrow indicates time of ATG3 addition. Each curve is the mean ± SE of three experiments. (C) 
Effect of different lipid composition and ATG3 concentration on LUV aggregation. Lipid 
compositions are indicated for each bar. Bars represent mean ± SE (n = 3) of ΔA400. ∗∗∗P ≤ 






























Figure 4.6. (A) Time courses of total lipid mixing induced by ATG3 (10 μM) in liposomes 
(0.4 mM) composed of PC:DOPE:CL (45:55:10 mol ratio). Lipid mixing was monitored by the 
NBD/Rhodamine lipid dilution assay. Unlabeled and (NBD + Rho)-labeled liposomes (9:1) were 
mixed and incubated for 5 min before ATG3 addition. The extent of lipid mixing was quantified on 
a percentage basis according to the equation: (Ft-F0/F100-F0) x100 where Ft is the measured 
fluorescence of protein-treated LUVs at time t, F0 is the initial fluorescence of the LUV 
suspension before protein addition, and F100 is the fluorescence value after complete disruption 
of LUVs by addition of 30 mM β-octylglucoside. (B) Time courses of vesicle content leakage 
induced by ATG3 (10 μM). Lipid compositions are shown in the panel.  Vesicle leakage was 
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Once aggregation was monitored, lipid mixing and release of vesicle contents 
assays were performed in order to assess the possible contribution of this protein to 
the fusion processes in autophagosome elongation, but ATG3 did not exhibit any of 














The above results demonstrate a novel activity for ATG3, namely vesicle 
tethering. This new activity would be in part performed by its N-terminal α-helix as a 
membrane anchor, but some other region of the protein might also be involved. Further 
investigation is required to discern the regions of the protein involved. Our observations 
could suggest a possible contribution of ATG3 to the tethering of vesicles preceding 
fusion events in autophagosome elongation, while the fusion ability would only remain 
in the final effector of the UBL system, Atg8. These aggregation and fusion processes 
could occur in negatively-charged and highly curved membrane regions such as the 







4.3.3 ATG3 Interaction with Negatively-charged GUV 
Giant unilamellar vesicles (GUVs) constitute a cell-sized model membrane 
system that allows direct visualization of particular membrane-related phenomena, 
such as domain formation or protein interaction, at the level of single vesicles using 
fluorescence microscopy-related techniques. We used this method to know whether 
ATG3 was able to interact with GUVs of different lipid compositions, had any lipid 
preference when binding GUVs, and could reproduce the aggregation activity with 
much larger vesicles. 
GUVs with different lipid compositions were electroformed in sucrose solution 
and then transferred to a visualization chamber with an equiosmolar buffer. Then 
Alexa488-labeled ATG3 or ATG3 K9D/K11D (1 μM) was incubated with Rho-PE-
labeled GUVs and the mixture was observed under the microscope. ATG3-Alexa 488 
was clearly seen bound to the membranes (Figure 4.7 A). In GUV containing some 
other negatively-charged phospholipids colocalization of Rho-PE and ATG3-Alexa 488 
was also detected, indicating the interaction of ATG3 with all these vesicles (Figure 
4.8). A preferential association of ATG3 to the GUV-GUV contact sites was observed 
(Figure 4.7 B). In contrast, no ATG3 interaction was observed in the absence of 
anionic phospholipids (electrically neutral vesicles) (Figure 4.7 A). To further analyse 
the preference of ATG3 for anionic phospholipids, GUV with segregated domains were 
electroformed. Asymmetric distributions of CL within the membrane of single vesicles 
were engineered by incorporating CL into lipid mixtures that are known to phase 
separate into two distinct liquid phases. Ternary mixtures of DOPC/DPPC/cholesterol 
have a large region of their phase diagram wherein these membranes demix to form 
liquid-ordered (Lo) and liquid-disordered (Ld) domains (Veatch & Keller, 2003). The Ld 
phase of these model membranes is rich in DOPC due to its unsaturated hydrocarbon 
tails, and the Lo phase is rich in the saturated DPPC. Cholesterol partitions into both 
phases but is slightly enriched in the Lo domains compared to the Ld phase. GUVs 
composed of DOPC:DPPC:cholesterol (37.5:37.5:25 mol ratio) at 22 °C are within this 
region of liquid-liquid phase separation. Domains of these two liquid phases coalesce 
to form two large domains on the vesicle surface, one of each phase. 10 mol% DOPC 
for 10 mol% CL were exchanged based upon two assumptions: that CL, due to its high 
degree of chain unsaturation, will also prefer to partition into the Ld phase, and that 
despite such a significant change in lipid composition, the membrane will still be in a 
region of phase space for liquid-liquid phase coexistence (Beales et al., 2011). ATG3-
Alexa488 bound preferentially to regions of the membrane that are rich in CL (labeled 





Figure 4.7. Confocal microscopy of representative GUVs. (A) ATG3 interaction with CL-
containing or non-containing GUV. Membrane labelled with Rho-PE and protein represented as 
ATG3-Alexa 488.  Merge: yellow indicates colocalization of both probes. Lipid composition is given 
at the left-hand side. (B) ATG3 preferential localization in GUV contact sites. (C) ATG3 binding to 
GUV with segregated domains. Two different lipid domains are clearly seen, one of them 
containing CL and labelled with Rho-PE. (D) ATG3 K9D/K11D does not interact with PC:DOPE:CL 




with Rho-PE) (Figure 4.8 C). Thus, ATG3 interaction with GUVs is determined by the 
presence of negatively-charged lipids on their surface.  
However, GUV containing CL were not labeled with ATG3 K9D/K11D-Alexa 
488. In fact, the vesicles were seen as dark objects against a green (Alexa) 





































ATG3 aggregation experiments could also be reproduced in GUV. A different 
methodology was used to form GUV in order to obtain them as close as possible to 
allow the protein-induced tethering. In this case, PC:DOPE:CL (60:30:10 mol ratio) 
GUV were electroformed and directly visualized in a Nikon confocal microscope. Upon 
addition of ATG3-Alexa 488 (1 μM) GUV tended to aggregate and precisely the 
flattened areas between tightly aggregated GUV appeared enriched in ATG3-Alexa 
488 (Figure 4.9 upper panels). Controls made with ATG3 K9D/K11D-Alexa 488 and 
buffer did not show any event of GUV tethering (Figure 4.9 lower panels). 
These results suggest that ATG3 interaction with membranes does not require 
a high vesicle curvature (GUV curvature is practically zero), instead the electrostatic 
interaction with anionic phospholipids and the intrinsic negative membrane curvature 






Figure 4.8. ATG3 interaction with negatively charged GUVs. Different anionic phospholipids are 
incorporated to GUVs (labeled with Rhodamine-PE) and protein (labeled with Alexa-488) 
incorporation to them was observed by confocal microscopy. Merge: yellow indicates colocalization 
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4.3.4 ATG3 Interaction with Membranes could Govern GABARAP 
Lipidation 
Atg3 was proposed to direct LC3 to the membrane for lipidation in vitro and also 
to act together with the Atg5-Atg12/Atg16 system to perform the same task in vivo 
(Hanada et al., 2007; Walczak & Martens, 2013). In this context, lipid composition 
changes could modify the lipidation rate of Atg8 homologues (Ichimura et al., 2004; 
Nath et al., 2014; Sou et al., 2006). The effect of adding negatively-charged lipids, or 
lipids with a negative intrinsic curvature, that facilitate ATG3 binding to membranes, on 
GABARAP lipidation was analysed. For this purpose in vitro lipidation assays 
incubating ATG7, ATG3 and GABARAP in the presence of liposomes, ATP and MgCl2 
were performed. The lipidation product was followed by SDS-PAGE gels and its 
subsequent CBB staining or Western blotting. GABARAP was used as the human Atg8 
homologue in this experiments because the lipidated band of LC3 and GATE-16 was 
undistinguishable from the presumably adenylated form of the protein. The increased 
affinity of ATG3 for anionic monolayers (Figure 4.10 A) and vesicles (Figure 4.10 B) 
was also associated to an enhanced lipidation as observed in Figure 4.10 C-D. 
Moreover higher lipidation ratios were observed when lipids such as PA and CL, with a 
high negative intrinsic curvature, were incorporated to the liposomes. This suggests 
that ATG3 membrane interaction could govern the lipidation efficiency of the Atg8 
homologues. This does not rule out a similar involvement of ATG7 in the regulation of 







Figure 4.9. ATG3-induced GUV aggregation. PC:DOPE:CL (60:30:10 mol ratio) vesicles 
stained with Rho-PE were used. After ATG3-Alexa488 addition (t=10 s) vesicle aggregation 
was observed (upper panels). Protein (labeled in green) is localized preferentially to vesicle 
contact sites. Merge: yellow indicates colocalization of both probes. ATG3 K9D/K11D-
Alexa488 or buffer do not induce any effect on the GUVs. 
 





























Figure 4.10. ATG3 governs GABARAP lipidation ratio. (A) ATG3 binding to lipid monolayers. 
Data from Figure 4.2 C normalized to the PC:DOPE value (B) ATG3 binding to liposomes of 
different lipid compositions. Data from Figure 4.3 C normalized to PC:DOPE. (C) GABARAP 
lipidation ratio using different lipid compositions. Data obtained from gels as shown in D normalized 
to the PC:DOPE value. Average values of two experiments. (D) Coomassie blue staining (upper 
panel) and anti-GABARAP Western blotting (lower panel) of the in vitro lipidation reaction using 
different lipid compositions. Lipid compositions are detailed in each panel. Red arrows indicate 
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The autophagy machinery is the subject of study in several contexts due to its 
essential role in cell life survival and its controversial function in apoptosis. A large 
amount of proteins have been discovered that participate in autophagy control, more 
precisely in the formation, elongation and closure of the autophagosome. In this 
process, the protein Atg8 (and its mammalian homologues LC3, GATE-16 and 
GABARAP) triggers the aggregation and fusion of vesicles with the nascent 
autophagosome. The way in which Atg8 is brought to the membrane has been studied 
but little is known on how the proteins involved in this process recognize specific sites 
in the membrane. Some studies showed that Atg3 is the protein involved in the 
transport and recognition of PE as Atg8 substrate (Oh-oka et al., 2008), and also that 
another UBL system involved in autophagy, Atg5-Atg12/Atg16, interacts with 
membranes and improves the rate of Atg8 lipidation through interaction with Atg3 
(Romanov et al., 2012).  
According to a growing body of evidence, changes in membrane properties 
such as surface charge or lipid packaging directly affect protein binding. The physical 
properties of different lipid acyl chains or headgroups can favor different membrane 
curvatures (McMahon & Boucrot, 2015; McMahon & Gallop, 2005). For example, 
lysophosphatidic acid (LPA) and phosphatidic acid (PA), which are interconverted by 
lysophosphatidic acid acyl transferase and phospholipase A2 activity respectively, 
favour opposite curvatures (Kooijman et al., 2003). In addition, flippases (that transfer 
lipids from one leaflet to the other) give rise to membrane asymmetry (Pomorski & 
Menon, 2006), and enzymes that change lipid headgroup size will influence the area 
occupied by the lipids and thus affect membrane curvature. The access to the 
membrane could also be favoured by inverted cone-shaped lipids that impart negative 
curvature to bilayer leaflets and as the result they lower the surface pressure at the 
interface, i.e. aerolysin-membrane interaction (Alonso et al., 2000). In addition, lipid 
headgroups are the attachment sites for peripheral membrane proteins. The main 
acidic phospholipids in mammalian cell membranes are phosphatidylserine, 
phosphatidic acid and phosphatidylinositol. These negatively-charged lipids are 
particularly important directing the membrane association of phospholipid-binding 
domains. At least 10 different globular domain types bind phospholipids at the 
membrane surface. The interactions of these domains with the membrane surface fall 
into two broad classes: some are highly specific and involve stereospecific recognition 
of particular membrane components; others are non-specific and involve a general 




physical property of the membrane (such as charge, amphiphilicity, or curvature) 
(Antonny, 2011). 
For Atg3 it was demonstrated to interact with membranes in part through its N-
terminal region. It was also suggested that the predicted N-teminal amphiphatic helix 
would be responsible for this attachment, and also that this helix would be a membrane 
curvature sensor (Nath et al., 2014).   
 
4.4.1 ATG3-membrane Interaction 
This work was focused on a better understanding of ATG3-membrane 
interaction. Using Langmuir balance measurements (Figure 4.2) and liposome 
floatation assays (Figure 4.3) we show that ATG3 binds to PE-containing membranes 
and in particular to negatively charged membranes. Incorporation of anionic 
phospholipids to the liposome compositions substantially increases ATG3 binding to 
these vesicles (Figure 4.3 A). It was reported by Nath et al., (2014b) that ATG3 
contains a membrane curvature sensor in its structure. We report here that curvature 
recognition by ATG3 is only noticed when neutral membranes are present, because no 
change is observed in ATG3 binding when the size of anionic-lipid containing 
liposomes decreases (Figure 4.3 B). Furthermore, ATG3 attachment to membranes 
relies on two components, electrostatic and hydrophobic interactions due to membrane 
defects. This result is consistent with the notion that mutations in the N-terminal 
amphiphatic helix, including polar and hydrophobic residues, alter ATG3 interaction 
efficiency (Nath et al., 2014). Our results with ATG3 K9D/K11D mutant (Figure 4.3 A) 
strongly support the idea that these two lysines, located between the hydrophobic and 
polar faces of the helix represent an important anchor for ATG3 binding, probably 
related to the increased binding capacity in the presence of anionic phospholipids. 
Moreover, comparing the different negatively-charged phospholipids we observe that 
lipid packaging defects in the membrane may be important for ATG3 interaction 
(Figure 4.3 C). Both CL and PA possess a high negative intrinsic curvature, and when 
incorporated to bilayers they create membrane defects where ATG3 can easily insert. 
According to this, the electrostatic component would favor protein binding but it would 
not be the only force driving this association.  
Furthermore, when approaching to a cell system using cell-sized model 
membranes (GUV), where no membrane curvature is present, ATG3 recapitulates the 





BAR domains and amphiphatic α-helices are considered to be the best 
examples of membrane curvature-sensing domains in proteins. BAR domains sense 
membrane curvature by insertion of an amphiphatic helix to membrane defects and 
also by electrostatic interactions with negative charges in the membrane (Madsen et 
al., 2010), whereas amphiphatic α-helices such as ALPS motifs just insert their 
hydrophobic face into lipid packing defects (Bigay et al., 2005; Mesmin et al., 2007). In 
this case ATG3 exhibits both requirements, electrostatics and intrinsic curvature of the 
membrane lipids. According to the snorkel model, lysines at the interface of the polar 
and nonpolar faces of the helix favor the association to flat membranes and the 
electrostatic interaction with them (Mishra et al., 1994), and this would also explain 
ATG3 ability to bind negatively-charged vesicles. Hence, mutations of lysine residues 
to aspartic acid in ATG3 K9D/K11D mutant cause an electrostatic repulsion between 
these amino acids and the negative charges of the membrane (lipid polar head groups 
and phosphate). The same Lys mutated to Ala just causes a decrease in binding to 
anionic vesicles but not to neutral membranes. In the autophagy context, ATG3 would 
not be the only protein that is proposed to sense membrane curvature through an 
amphiphatic helix, also Barkor is involved in detecting this curvature in PI3P-enriched 
membranes (Fan et al., 2011; Wilz et al., 2011). 
Moreover, in an attempt to extrapolate our in vitro findings to physiological 
conditions in cells, there are evidences suggesting that autophagosome biogenesis is a 
lipid-modulated process (Dall’Armi et al., 2013). While the role of phosphoinositides 
(PI3P) in autophagy progression is well known (Dooley et al., 2014; Vicinanza et al., 
2015), little information on the participation of other lipid species during the different 
steps of autophagosome biogenesis is reported (Chu et al., 2013; Sentelle et al., 
2012). A combined action between lipids and autophagic proteins should lead to 
phagophore expansion. The participation of PA and other cone-shaped lipids (DAG) in 
autophagy and also in membrane fusion/fission processes has been proposed 
(Ibarguren et al., 2010). Previous studies in our group have suggested a possible role 
of intrinsic-curvature modifying lipids such as CL, DAG and LPC in promoting GATE-16 
and GABARAP mediated vesicle fusion in vitro (Landajuela et al., 2016). DAG 
generation was shown to be required for the initiation of Salmonella-induced autophagy 
(Shahnazari et al., 2011). Moreover, the PLD1 pathway, that produces PA, a cone-
shaped lipid, has been also reported to promote autophagy (Dall’Armi et al., 2010). The 
lipid composition of the pre-autophagosomal membrane is not yet known but further 
efforts to discern it would open a new window to understand how elongation would 
occur.  




4.4.2 ATG3 Aggregation 
During autophagosome formation and elongation, a large amount of vesicles 
containing proteins and lipidic material are fused with the forming autophagosome. In 
this process some Atg and other proteins are involved, i.e the Atg7/Atg3/Atg8 UBL 
system. Atg8 homologues are the final effectors of the system and are well studied that 
mediates the tethering and fusion of liposomes in vitro (Landajuela et al., 2016). It is 
also known that other proteins e.g. SNARES participate in this action (Moreau et al., 
2013). Here, we report a novel function for ATG3, namely the vesicle aggregation 
capacity. We demonstrate that Atg3 can tether vesicles when it binds them (Figure 4.5 
and 4.9). The aggregation potential would be related to the anionic charge and intrinsic 
curvature of the membrane, but further work has to be performed to find the specific 
protein regions involved in this activity. In this context, ATG3 might be cooperating with 
Atg8 in the aggregation process before vesicle fusion in the pre-autophagosome 
elongation. 
Other studies have reported a regulation of the lipidation ratio of Atg8 and their 
mammalian homologues by changes in the lipid composition of the membrane 
(Ichimura et al., 2004; Landajuela et al., 2016; Nath et al., 2014; Sou et al., 2006). 
According to this, we suggest in this work that ATG3 would be the responsible for 
bringing Atg8 homologues the membrane in vitro. As we have shown, the incorporation 
of CL, PA or PI to the liposomes improves ATG3 association to the membrane and also 
enhances the lipidation ratio of GABARAP (Figure 4.10). Nevertheless, other proteins 
participate in this process in vivo such as the Atg5-Atg12/Atg16 system, and further 
experiments with these other partners should be performed to discern the precise role 
of each protein. 
In conclusion, the data shown on ATG3 interaction with membranes should 
clarify the mechanism by which the lipid composition of the autophagosomal 
membrane could facilitate the redirection of the autophagy machinery to some regions, 
in order to undertake the elongation process. However, the lipid composition of the 
phagophore and the number of proteins recruited to it should be further investigated for 
a better understanding of how phagophore elongates. This would allow discovering 
new potential targets implicated in macroautophagy that could also be explored in 
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Cellular homeostasis requires equilibrium between protein degradation and 
protein synthesis. For this purpose, eukaryotic cells have two main different 
mechanisms for degrading components, the ubiquitin-proteasome system in order to 
degrade proteins, and autophagy for degrading proteins and organelles. Autophagy is 
responsible to maintain energy levels and provide amino acids under starvation or 
cellular stress, thus it is involved in several disorders such as cancer, Parkinson´s or 
Alzheimer´s diseases. 
The main event in autophagy is the formation of a double-membrane 
compartment, named autophagosome, which engulfs the unnecessary material. After 
that, fusion with the lysosome occurs to degrade the sequestered contents. Despite the 
identification of more than 30 Atg proteins required for normal autophagy there are still 
many key questions open (Lamb et al., 2013). For instance, the origin of the membrane 
that gives rise to autophagosome formation and the way in which this newly formed 
structure elongates and closes have to be elucidated (Tooze & Yoshimori, 2010). 
Among the Atg proteins Atg9 is the only transmembrane protein essential for 
autophagosome formation (Lang et al., 2000; Noda et al., 2000). It is composed by six 





cytoplasm (Tooze, 2010). An N-glycosilation site was described in the first luminal loop 
(Young et al., 2006) (Figure 5.1). As the only multispanning membrane protein in this 
system so far, Atg9 is considered to play a key role in the trafficking of membrane 
material along the autophagosome formation and elongation process. In yeast, Atg9 
can be observed as punctate structures scattered through the cytoplasm and partially 
colocalizing with a perivacuolar site, known as the PAS (Mari & Reggiori, 2007; 
Reggiori et al., 2005). These puncta correspond to highly motile Atg9-containing 
vesicles of 30-60 nm and they are increased upon rapamycin treatment (Yamamoto et 
al., 2012). Furthermore, Atg23 and Atg27 are required for Atg9 trafficking through the 
Golgi (Backues et al., 2015; Yen et al., 2007), and under starvation Atg9 was 
demonstrated to be embedded in the autophagosomal outer membrane (Yamamoto et 
al., 2012). Another evidence of the Atg9 involvement in autophagosome elongation 
resides in the upregulation of Atg9 expression when a protein as Atg16 (essential for 
phagophore growth) is not present in Dictyostelium discoideum. This indicates that 
cells overexpress other proteins involved in the elongation process such as Atg9 to 
compensate the lack of Atg16 (Xiong et al., 2015). Moreover, a recent publication 
shows the participation of Atg9 in the phagophore nucleation through its interaction 
with proteins such as Atg13 or Atg17, which are members of the Atg17-Atg29-Atg31 
complex, probably involved in fusion processes that give rise to the autophagosome 
nucleation and elongation (Ragusa et al., 2012; Sekito et al., 2009; Stanley et al., 2014; 
Suzuki et al., 2015) 
In contrast, human ATG9 (hATG9) resides in the trans-Golgi Network (TGN), 
and late and recycling endosomes under basal conditions (Orsi et al., 2012). When 
autophagy is induced, it redistributes from the TGN to endosomal membranes, where 
LC3 is present, in a ULK1-dependent manner (Young et al., 2006). Despite this fact, 
ATG9 does not completely colocalize with autophagosomes but it transiently interacts 
with them. The latter would be a difference between the yeast and mammalian 
homologues, and it could be explained because hATG9 is rapidly recycled from the 
autophagosome. 
Taking this into account, ATG9 vesicles could contribute to the regulation of 
autophagosome size, thus participating in the delivery of lipid material and/or proteins 
in the elongation step to the forming autophagosome. The continuous movement of 
these vesicles in the cytoplasm and their transient incorporation to the autophagosome 
would recapitulate a process of material delivery. Moreover, due to the high hATG9 C-
terminal domain size (almost half of the entire protein), this could be the region through 
which ATG9 performs its function. Here we have made a first approach to purify 




hATG9 and its C-terminal domain in E. coli to test their possible participation in lipid or 
vesicle delivery during autophagosome formation. In a preliminary study, we have 
observed the presence of phospholipids in ATG9 C-terminal-enriched fractions. In 
addition a eukaryotic system was also used to purify the above-cited two versions of 
ATG9 with improved results, thus opening a possibility to obtain the protein in sufficient 
amounts to perform in vitro experiments. 
 
5.2 Materials and Methods 
5.2.1 Materials 
NaCl, Tris Base, MgCl2, Triton X-100 and n-octyl-β-D-glucopyranoside were 
obtained from Calbiochem (Darmstadt, Germany). Dithiothreitol (DTT) and Tris(2-
carboxyethyl)phosphine (TCEP) were purchased from Sigma-Aldrich (St. Louis, MO). 
Anti-ATG9 FL (STO219) and anti-ATG9 CT (STO215) antibodies were kindly provided 
by Dr. Sharon Tooze (Cancer Research UK, London Research Institute, London, UK). 
Goat anti-rabbit and anti-6xHis antibodies were from Clontech (Mountain View, CA). Ni-
NTA Agarose was purchased from Qiagen (Hilden, Germany). 
 
5.2.2 DNA Constructs 
Plasmids for expression of human ATG9 (pCMV6XL4-hATG9) were kindly 
provided by Dr. Sharon Tooze (Cancer Research UK, London Research Institute, 
London, UK). ATG9 C-terminal domain was generated as a deletion mutant from 
ATG9. Specifically designed ATG9 primers for mutations, cloning and sequencing, 
purchased from Sigma Aldrich (Madrid, Spain) were used (See Section 2.3.5). 
Mutations were confirmed by DNA sequencing (Secugen S.L, Madrid, Spain). 
 
5.2.3 Expression and Purification of Recombinant Proteins 
hATG9 C-terminal (ATG9 CT) fragment was purified from soluble fractions of 
bacterial extracts obtained in the absence of detergents, and purity was evaluated by 
Coomassie-stained SDS-PAGE. Full length ATG9 (ATG9 FL) and ATG9 CT were also 
expressed by baculoviral infection of HighFive (H5) insect cells. ATG9 FL and ATG9 





DH10Bac E. coli for transposition into the bacmid. Blue/white colony selection was 
used to identify colonies containing the recombinant bacmid and they were confirmed 
by PCR. The recombinant bacmid was then isolated and purified using Macherey 
Nagel endotoxin-free DNA purification kit. H5 insect cells were transfected with purified 
bacmid using Lipofectamine from Invitrogen (Waltham, MA) in TC-100 insect media 
(Sigma-Aldrich) supplemented with the appropriate antibiotics. When the transfected 
cells demonstrated signs of late stage infection (typically around 72 h), the medium 
containing the free virus was collected. Repeated cycles of transfection and virus 
collection were performed to amplify the viral stock. Cells were collected after 48 h 
infection followed by centrifugation at 5,000 xg for 10 min. The pellet was resuspended 
and sonicated in a breaking buffer consisting of 50 mM Tris pH 8, 150 mM NaCl and 
freshly prepared 1mM TCEP and protease inhibitors. The lysate was cleared by 30 min 
centrifugation at 30,000 xg and loaded on cobalt resin (Clontech, Mountain View, CA) 
for 3 h at 4 ºC. Protein was eluted with a gradient of 0-500 mM imidazole.  
ATG9 CT plasmid was transformed onto E. coli one shot BL21 Star (DE3) cells. 
Cells were grown to OD600=0.6 and induced with 0.5 mM IPTG overnight at 18 ºC. 
Following centrifugation at 5,000 xg for 10 min, the pellet was resuspended and 
sonicated in breaking buffer [50 mM sodium phosphate, 300 mM NaCl, 1 mM DTT, 0.1 
mM PMSF, 1 mg/ml lysozyme and EDTA-free protease inhibitors (Roche), pH 8.0]. The 
lysate was cleared by 30 min centrifugation at 30,000 xg, loaded on Ni-NTA beads 
(Sigma-Aldrich) and incubated for 3 h at 4 ºC. Proteins were eluted with elution buffer 
(50 mM sodium phosphate, 525 mM NaCl, 250 mM imidazole, pH 6.0 and freshly 
added 1 mM DTT). The eluted fractions were loaded onto SDS-PAGE gels and 
subjected to CBB-staining and Western blotting. Then these fractions were dialyzed 
against 20 mM Pipes, 137 mM NaCl, 3 mM KCl (pH 6.8) and loaded into a Hiload 
16/600 Superdex-75 size exclusion column. The protein was eluted with the same 
buffer used for the dialysis. 
 
5.2.4 Lipid Extraction from Protein Samples 
Lipid extraction for mass spectrometry analysis was performed as follows: 500 
μl protein sample was mixed with 6 ml chloroform:methanol (2.5:1) in a glass tube and 
kept on ice. The mixture was sonicated for 10 s at 22 microns and kept at room 
temperature for phase stabilization. The sample was filtered using 0.22 μm filters (GV 
filters, Millipore) and transferred to glass centrifuge tubes with 0.2 volumes of K4EDTA 
(pH 6). The mix was subjected to 200 rpm, 15 min at 4 ºC centrifugation. After that, two 




different phases were observed, aqueous (top) and organic (bottom), the latter 
containing the extracted lipids. The organic phase was transferred to another glass 
tube and dried under N2 at 37 ºC. Then the sample was resupended in 100 μl 
chloroform:methanol:water (5:5:1), transferred to an HPLC vial with 40 μl lipid standard 
and dried under N2 gas flow. Finally, the sample was resuspended in 18 μl 
chloroform:methanol:water (90:9.5:0.5) for its application to HPLC and mass 
spectrometry. 
5.2.5 Mass Spectrometry Analysis of Lipids 
Mass spectrometry was used for the lipid analysis of ATG9 CT and PITPα protein 
samples. Samples obtained from lipid extraction and a control sample containing only 
the lipid standards were subjected to the mass spectrometer-associated HPLC, in 
order to separate the different compounds and proceed to mass spectrometry analysis. 
The HPLC solvents were: 
A: 135 ml chloroform, 14 ml methanol, 1 ml water and 51 μl ethylamine. 
B: 30 ml chloroform, 35 ml methanol, 5 ml water, 30 ml acetonitrile and       
45 μl ethylamine. 
2 μl samples were used for each mass spectrometry analysis, and the following 
analyses were performed for each sample: 
Analysis Number Analysis Name Observations 
1 Q1- Solvent A equilibration 
2 Q1- Solvent A equilibration 
3 Q1- Solvent A equilibration 
4 Q1- PIP Standards 
5 Q1+ Standards 
6 241 PI Standards 
7 184 PC Standards 
8 153 PA Standards 
9 196 PE Standards 
10 87 PS Standards 
11 Q1- Solvent A wash 
12 Q1- Solvent A wash 
13 
Repeat 4-10 for each 
sample 
Analysis 4-10 for each 
extracted sample 





Analysis Number Analysis Name Observations
1 Q1- Solvent A equilibration
2 MI-PG Standards
3 Q1- Solvent A equilibration
 In order to detect the presence of PG in the analysed samples, a different 
program was used. A new PG standard was incorporated to the samples and the 






Mass Spectrometry analysis was performed on a Shimadzu IT-TOF LC/MS/MS 
system hyphenated with a five-channel online degasser, four-pump, column oven and 
autosampler with cooler (Prominence HPLC, Shimadzu). To identify and quantify 
molecular species we used accurate mass (mass accuracy 5 ppm) and tandem MS, as 
well as comparison with appropriate lipid standards. IT-TOF mass spectrometer 
operation conditions: ESI interface voltage +4.5kv for positive ESI and -4kv for negative 
ESI, heat block temperature 230 ºC, nebulising gas flow 1.4 L/min, CDL temperature 
210 ºC, drying gas pressure 100 psi. All solvents used for lipid extraction and 
LC/MS/MS analysis are LC-MS grade from Fisher Scientific. 
 
5.2.6 Cell Inmunofluorescence 
Hi5 cells were plated on 12 mm glass disks and infected as detailed in Section 
2.3.6. At 24, 48 or 72 h post-infection cells were washed twice with PBS 1X and fixed 
with 3% p-formaldehide solution for 10 min. After fixation cells were permeabilised 
using 0.01% (v/v) Triton-X-100 in PBS 1X for 3 min and blocked with 10% FCS in PBS 
1X for 1 h at room temperature. Following this step, the glasses were incubated with 
anti-6xHis, anti-ATG9 FL or anti-ATG9 CT for 1 h at 37 ºC. After 6 washes with PBS 
1X, they were incubated with Alexa-488 conjugated goat anti-rabbit or anti-mouse 
antibodies under the same conditions. Nuclei were stained using 4’,6- Diamidino-2-
phenilindol (DAPI, Sigma) and the glasses were fixated to the glass slides with 
ProLong (Invitrogen). The samples were visualized using a confocal fluorescence 
microscope (Nikon D-ECLIPSE C1, Nikon, Melville, NY). Image treatment was 
performed using the EZ-C1 3.20 software (Nikon). 
Table 5.2.Specific program for PG detection by mass spectrometry. 





5.3.1 ATG9 CT Bacterial Expression, Purification and Lipid Mass 
Spectrometry Analysis 
 hATG9 is a multispanning membrane protein required for normal autophagy. As 
stated in the Introduction section, ATG9 might deliver lipids as membrane material 
for autophagosome formation and elongation. As ATG9 consists of 6 transmembrane 
domains a difficult expression and purification was envisaged. In order to manage this 
issue, a construct was designed containing the C-terminal domain which covered 
almost half of the protein (36.9 kDa) (Figure 5.1). This C-terminal domain does not 
contain any putative transmembrane domain, so it could be predicted as a large 









Many different constructs, plasmids, tags, bacterial strains and expression 
conditions were tested for ATG9 FL and CT expression, but just one of them was 
considered as relatively satisfactory. No expression of ATG9 FL was detected under 
any condition tested, perhaps because this protein may be toxic when overexpressed 
in a bacterial system. However, the ATG9 CT construct cloned in a pEXP11085-
HisMBP plasmid was slightly expressed in E. coli One shot BL21 Star (DE3), although 
high degradation was observed. This HisMBP tagged ATG9 CT fragment was affinity 
purified using Ni-NTA beads and a subsequent pass through a size exclusion column. 
The eluted fractions were loaded onto SDS-PAGE gels and protein was detected by 
CBB-staining and Western blotting (Anti-His and Anti-ATG9 CT antibodies) (Figure 5.2 
A-B). Together with a large amount of degraded protein some ATG9 CT remained 
intact in certain fractions but probably not in its monomeric state, because the protein 
 
Figure 5.1. Outline of Atg9 FL and CT proteins. The orange sections correspond to the 





eluted as a larger protein in the column. Finally, a monoQ chromatography was 
performed to obtain some purer fractions of the ATG9 CT fragment (Figure 5.2 C-D). 
Further modifications of the expression conditions and purification protocol were tested 
















A preliminary study of the presence of lipids associated to the ATG9 CT domain 
was performed by mass spectrometry. To this aim we divided the elution fractions from 
the size exclusion and monoQ chromatography into ATG9 CT-containing and non-
containing fractions, subjecting both types of samples to a modified Folch lipid 
extraction. At the end of the lipid extraction a mix of lipid standards was added to the 
samples to have an internal standard and an estimation of the detection quality and 
lipid quantity. Phosphatidylglycerol was the only lipid class found associated to ATG9. 
Different species of phosphatidylglycerol were detected in all the ATG9 CT-containing 
fractions (Figures 5.3 and 5.4), the mol% distribution of each species being the same 
 
Figure 5.2. ATG9-CT purification steps. (A) Gel filtration chromatography SDS-PAGE 
stained with coomassie blue. A small band between 76 and 102 kDa markers corresponds to 
ATG9 CT. (B) Anti-6xHis Western blot of the gel filtration chromatography fractions. Protein 
degradation could be observed. (C) MonoQ chromatography of ATG9 CT-containing fractions 
selected from the gel filtration. Anti-ATG9 CT Western blot. (D) MonoQ chromatography of 
ATG9 CT-containing fractions selected from the gel filtration. Anti-6xHis western blotting. The 
square brackets with a positive sign are the ATG9 CT-containing fractions subjected to mass 
spectrometry, whereas those that are indicated with a negative sign are the ATG9 CT-non 
containing fractions. Molecular weight markers are shown at the left-hand side of each panel. 
The ATG9 CT position in the gel is indicated by a red arrow. Molecular masses are shown in 
kDa on the left-hand side. 
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in all the fractions (Figures 5.4 and 5.5). Nevertheless, the ATG9 CT-non-containing 
fractions did not show any presence of phospholipids (Figures 5.3 and 5.4). Detection 
of PG in the sample could be explained because it is the predominant phospholipid in 
bacterial membranes. Moreover in order to have a positive control of a lipid carrier 
protein, we purified PITPα (Phosphatidylinositol Transfer Protein alpha) and, as 
described (Garner et al., 2012), phosphatidylglycerol and phosphatidylserine were 
detected (Figure 5.6). Taking this into account, we would suggest that the ATG9 CT 
might be in contact with membranes either continuously or transiently. The presence of 
lipids in the protein sample might indicate, as in the case of PITP, a lipid carrier 
function, and the ATG9 CT-associated lipids might recapitulate some contacts with the 
membrane. However further improvements in the expression and purification of ATG9 


















Figure 5.3. Mass spectrometry analysis of phospholipids in ATG9 CT protein sample. 
(A) Two different ATG9 CT-containing fractions were analysed and the main PG species 
detected. (B) Two different ATG9 CT-non-containing fractions analysed by mass 
spectrometry. Only trace amounts of phospholipids were detected. 12:0/12:0 PG species 


































Figure 5.4. PG species detected by mass spectrometry.  Main species detected in samples 
from gel filtration (A) and monoQ chromatography (B) containing and non-containing ATG9 CT 
(C) nmoles detected and the % of the total of the sample for each species are detailed. 








































































Figure 5.5. PG species detected in ATG9 CT fractions. Each bar corresponds to a different 
sample analysed by mass spectrometry. PG species are coloured and ordered according to 


































Lipid mass area ug mole %
12:0/12:0 609 8.08E+07 4 6.56814E-09
14:0/18:2 717 6.28E+07 3.108910891 4.336E-09 6.171791688
14:0/18:1 719 2.57E+08 12.72277228 1.76951E-08 25.1869166
14:0/18:0 721 5.91E+07 2.925742574 4.0579E-09 5.775944178
16:0/18:2 745 2.15E+08 10.64356436 1.42867E-08 20.33541118
16:0/18:1 747 1.94E+08 9.603960396 1.28567E-08 18.30003411




Lipid mass area ug mole mole %
12:0/12:0 622 1.56E+06 4 6.43087E-09
14:0/18:2 730 6.14E+06 15.74358974 2.15666E-08 21.99162172
18:2/20:4 806 2.52E+06 6.461538462 8.0168E-09 8.174802039
18:1/20:4 808 2.96E+06 7.58974359 9.39325E-09 9.578380733
14:0/18:2aa 716 1.04E+07 26.66666667 3.72439E-08 37.97799759







5.3.2 ATG9 FL and CT Expression in Insect Cells 
 The results of ATG9 CT expression in bacteria and its possible association with 
membranes encouraged us to try other expression systems in order to reproduce and 
pursue our observations. The human origin of ATG9 indicates that we would get the 
best expression in a mammalian system, but the good results obtained for ATG7 
expression (Chapter 3) led us to use insect cells. The Baculovirus expression system 
incorporates more post-translational modifications in proteins than the prokaryotic cells. 
ATG9 FL and ATG9 CT were cloned into pFastBac1 and pFastBacHta plasmids 
respectively for overexpression in insect cells. Both of them were successfully 
expressed and optimization of the infection time and MOI were performed (Figures 5.7 











Then ATG9 CT containing a His-tag in its N-terminal end was subjected to 
purification using cobalt beads. Unfortunately the protein was insoluble and remained 
almost completely in the pellet fraction after cell disruption (Figure 5.8 B). Some 
attempts with lower expression temperatures and the use of detergents in the 
purification process were tried in order to obtain soluble ATG9 CT but no improvements 
were observed. The insolubility of the protein would reside in the incorporation to 
inclusion bodies or the association to cell membranes that would bring it the pellet 
fraction upon cell disruption. 
 
Figure 5.7. ATG9 FL expression in insect cells. Infection time and MOI optimization for 
ATG9 FL expression. ATG9 FL expression was followed by SDS-PAGE (A) and Western 
blotting anti-Atg9 FL (B), under different infection times and MOI. ATG9 FL is observed as a 
band around 90 kDa. Molecular masses are shown in kDa on the left-hand side. 
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Figure 5.8. ATG9 CT expression and purification from insect cells.  (A, B) Infection time 
and MOI optimization for ATG9 CT expression. ATG9 CT expression was followed by SDS-
PAGE (A) and anti-ATG9 CT Western blotting (B), under different infection times and MOI. 
(C) SDS-PAGE gel of ATG9 CT purification using Ni-NTA beads. (D) Anti-ATG9 CT Western 
blotting of the nickel affinity purification of ATG9 CT. ATG9 CT is observed as a band around 
45 kDa. Molecular masses are shown in kDa on the left-hand side. (FT: Flow-Through; P: 
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With the purpose of detecting the localization of the protein within the cell after 
overexpression, cell immunofluorescence was performed. Anti-His and anti-ATG9 CT 
antibodies were used to visualize the protein and DAPI for the nuclei. It could be 
observed that ATG9 CT was located mainly associated to cell membranes which partly 
explained its behaviour as an insoluble protein during its purification (Figure 5.9 upper 
panels). ATG9 FL-expressing insect cells were also subjected to immunofluorescence 
to know where the protein was located. ATG9 FL showed the same behaviour as the 
CT fragment, appearing associated to membranes, with only a small fraction in the 






Figure 5.9. ATG9 FL and CT cells inmunofluorescence. ATG9 CT (green, upper panels), 
and ATG9 FL (green, lower panels) expressed in Hi5 insect cells were immunofluorescence 
labelled. The localisation of both proteins in cells was detected by confocal microscopy. Cell 




















In light of the above results we conclude that the use of insect cells as a more 
sophisticated system to express ATG9 may be satisfactory, but the purification of the 
full length or C-terminal fragment would need some modifications and improvements 











 ATG9 is an essential and scarcely studied protein involved in cell 
macroautophagy. The role of this protein has been mainly explored in vivo, but little 
information about its function is available. Yeast autophagy is the most used system for 
the study of Atg9, revealing important results about the movement of the protein from a 
pool of very motile vesicles around the cytoplasm to the outer autophagosomal 
membrane (Yamamoto et al., 2012). Atg9 function in mammals has been less 
investigated, although some studies about the trafficking of Atg9 between TGN and 
recycling endosomes (Young et al., 2006), and the transient association to the 
autophagosome have been emerged. Because of this lack of knowledge on Atg9 
function in vivo, and complete absence of data on Atg9 in vitro, this protein is an 
interesting object in the field of cell autophagy.  
 As mentioned in the Introduction section, Atg9 is the only transmembrane 
protein described so far in autophagy (Lang et al., 2000; Noda et al., 2000). The 
cytosolic C-terminal domain of the protein covers almost 40 kDa (Figure 5.1), which 
might indicate that the protein would act through this region. Furthermore, according to 
the published data Atg9 might be involved in the delivery of membrane material to the 
autophagosome nucleation and growth through fusion events of ATG9 vesicles 
(Stanley et al., 2014; Suzuki et al., 2015). 
In this chapter, we have contributed to the in vitro study of ATG9 function. We 
first tried to express the full length and the C-terminal domain of ATG9 in E. coli, in 
order to perform studies with model membranes. Unfortunately we only got low 
expression levels of ATG9 CT with some degradation of the protein and purification of 
ATG9 CT was poor (Figure 5.2). Thus, we were unable to use the protein for the 
assays with model membranes, instead it was checked whether this fragment of 
protein could really be associated to membranes and perhaps could contain bound 
lipids. For this purpose, mass spectrometry of the lipids extracted from ATG9 CT-
containing fractions was performed and compared with PITPα as a positive control of a 
lipid carrier protein (Figure 5.6). The results showed that PG was present in the 
samples where ATG9 CT domain was present (Figures 5.3-5) which might indicate a 
possible association of this region to the membrane or even that the fragment acts as a 
lipid carrier, in the way of the PITPα protein. However, the lack of purity of the samples 
does not allow us to establish a more solid conclusion about how ATG9 could 





We also tried to express and purify ATG9 FL and CT from insect cells, a more 
evolved organism that incorporates some more post-translational modifications to the 
proteins. High expression of both variants was achieved (Figures 5.7 and 5.8 A-B) but 
ATG9 CT was not soluble for its purification (Figure 5.8 C-D). Despite of the insolubility 
of the protein, further attempts to solubilise ATG9, either with detergents or otherwise, 
must be performed in order to obtain an appropriate amount of protein to carry out in 
vitro studies. Moreover, extraction or purification of ATG9-containing vesicles directly 
from cells could reveal the lipid composition of these vesicles and shed light on how 
this could contribute to the autophagosome membrane lipidome. 
To sum up, ATG9 is an interesting and important protein to be studied both in 
vivo and in vitro due to its transmembrane character. In the present study we have 
taken the first steps in the recombinant ATG9 expression and purification for its future 
use with model membranes in order to perform aggregation or fusion assays.  
Moreover we have also obtained preliminary results on the presence of 
phosphatidylglycerol associated to the C-terminal domain of ATG9. Future experiments 



















6. Overview and Conclusions 









CHAPTER 6:  






Cell homeostasis requires a correct balance between catabolic and anabolic 
processes. Many different pathways are involved in biosynthetic functions or possess 
catabolic responsibilities. Autophagy can participate in both kinds of pathways, being 
essential to degrade unnecessary or damaged organelles (catabolism) and also to 
produce new building blocks through mobilization of diverse cellular energy and 
nutrient sources such as lipids, carbohydrates or iron (anabolism) under normal or 
starvation conditions. Autophagy participates also in a large variety of physiological 
processes such as viral infection, cell differentiation and development, or immunity, 
causing certain disorders when it is deregulated (Wirawan et al., 2012). 
As a regulation process of many housekeeping events in the cell, autophagy is 
connected to several human disorders, especially to neurodegenerative diseases such 
as Huntington´s, Parkinson´s and Alzheimer´s diseases (Lynch-Day et al., 2012; 
Martinez-Vicente et al., 2010; Nixon et al., 2005). These disorders are related to the 
accumulation of protein aggregates that would not occur under normal autophagy 
conditions. Moreover, cancer, aging and other metabolic disorders are somehow 
regulated by autophagy and therefore it is a promising target for the prevention and 
treatment of these conditions (Choi et al., 2013; Levine & Kroemer, 2008).  
In the autophagy signalling pathway several proteins are involved, mainly 
participating in complexes that regulate specific steps in the formation of a double 





autophagy, although the lipid source for this newly formed membrane is still unknown 
(Tooze & Yoshimori, 2010). Mitochondria, plasma membrane, Golgi or ER are 
postulated to supply materials for the initial nascent membrane (Mari et al., 2011). The 
material susceptible to be degraded is enclosed in this pre-formed compartment which 
grows by adhesion and fusion of other membrane structures. Finally, autophagosome 
closes in a recently described scission process (Knorr et al., 2015) and fuses with the 
lysosome to degrade the trapped material. Several studies have proposed the specific 
participation of two UBL systems (Atg8/Atg3/Atg7 and Atg5-Atg12/Atg16), among the 
various Atg proteins, in vesicle fusion processes that give rise to the phagophore 
extension (Nair et al., 2011; Romanov et al., 2012; Walczak & Martens, 2013; 
Weidberg et al., 2011). Others have described the presence of a unique autophagic 
transmembrane protein (Atg9) that is essential for autophagy in yeast and mammalian 
organisms (Noda et al., 2000; Webber et al., 2007).  
However how the autophagosome grows and is finally sealed are key open 
questions that are now being studied. For this reason the subject of study in this thesis 
has been to contribute to a better understanding of the autophagosome elongation 
process and also to reproduce its growth in vitro. To this aim, biophysical techniques 
and model membranes have been handled to (i) analyze the role of the human 
Atg8/ATG3/ATG7 UBL system in vesicle tethering and fusion processes and how they 
can be modulated by lipids, and (ii) to characterize the lipid-protein interactions of the 
autophagic protein ATG3. Moreover a preliminary study of ATG9, a promising 
transmembrane protein probably involved in lipid delivery for autophagosome growth, 
has been performed. 
 
Lipid Regulation of Fusion Events Triggered by a Reconstituted Minimal 
Protein System (Atg8/Atg3/Atg7) Involved in Autophagosome Elongation 
In the current autophagy model, the most accepted hypothesis about 
phagophore elongation proposes that small vesicles reach the forming organelle and 
fuse so that it grows. According to that, yeast Atg8, the final effector of the UBL system, 
has been demonstrated to participate in vesicle tethering, hemifusion and fusion events 
in vitro (Nair et al., 2011; Nakatogawa et al., 2007). However human Atg8 homologues 
(LC3 and GATE-16) have only shown fusogenic activity in their artificially conjugated 
forms (Weidberg et al., 2011). All of them catalyze these processes through their 





Taking this into account we have shown here the in vitro fusogenic activity of the 
complete human UBL system comparing it with the artificial one, and demonstrated the 
lipid geometry and bilayer curvature modulation of the LC3, GATE-16 and GABARAP-
induced fusion. 
Human Atg8 homologues reproduce the in vitro enzymatic lipidation reaction 
similarly to what was described for yeast (Figure 3.7 D). However the lipidation 
reaction efficiency is apparently lower than in yeast. This fact could be due to the 
necessity of specific lipid compositions or the presence of the Atg5-Atg12/Atg16 UBL 
system as it occurs in vivo. It might also be due to the fact that 7 human homologues 
exist versus only one in yeast, a lower activity of each one of them being perhaps 
required. Furthermore, as recently reported (Nath et al., 2014), a presumably 
adenylated form of the Atg8 homologues is observed and hampers the detection of 
LC3-PE and GATE-16-PE conjugates in SDS-PAGE gels by CBB staining or Western 
blotting. Accordingly we have developed the use of NBD-labeled PE to solve this issue 
and to allow a correct detection (Figure 3.7 D). The chemical lipidation of these 
proteins resembles closely the enzymatic one. 
To gain information on the initial steps of the fusion process, vesicle tethering 
assays were performed. According to the commonly accepted stalk-fusion pore model 
(Basañez et al., 1998; Chernomordik & Kozlov, 2008; Chernomordik et al., 1995; 
Khattari et al., 2015; Siegel, 1999), membranes first approach and make local contacts 
in order to remove the water in between. GATE-16 and GABARAP, in our experimental 
context, show a high membrane aggregation activity in both the enzymatic and 
chemical conjugation systems, whereas LC3 is less active than its homologues (Figure 
3.8). 
The vesicle tethering activity itself does not recapitulate hemifusion nor fusion of 
membranes. Prior in vitro studies with the recombinant yeast Atg8 reported that this 
protein mediates membrane hemifusion, but not complete fusion (Nakatogawa et al., 
2007). Closer to our system, Weidberg et al., (2011) showed that mammalian LC3 and 
GATE-16, artificially attached to PEmal, induced full membrane fusion, and moreover 
Nair et al., (2011) showed that Atg8 and LC3 require high contents of DOPE to drive 
membrane hemifusion. In our enzymatic system both GATE-16 and GABARAP induce 
intervesicular total lipid mixing, inner lipid mixing and aqueous content mixing, that 
correlates with the capacity of these proteins to mediate full membrane fusion (Figure 
3.9). Similar results display the chemically lipidated forms of GATE-16 and GABARAP 





the chemical conjugation and faithfully reproduce the activity of the wild type forms. As 
previously suggested and shown in our experiments, not all the different human Atg8 
homologues display the same in vitro activity. This could indicate the participation of 
each protein at different time points during phagophore growth or even under different 
physiological conditions. These results indicate perhaps the first evidence of the in vitro 
fusion activity of GABARAP, and also provide a complete in vitro study of the fusogenic 
potential of three human Atg8 homologues acting through their corresponding 
enzymatic machinery. 
As other membrane-related processes, vesicle fusion can be notably regulated 
by lipids. Many evidences on how lipids with different morphologies and intrinsic 
curvatures modulate fusion events have been described (Basañez et al., 1996b, 1998). 
In Atg8-driven membrane fusion the incorporation of cone-shaped lipids with a negative 
intrinsic curvature such as cardiolipin or diacylglycerol stimulates intervesicular lipid 
mixing and the mixing of aqueous contents, whereas the addition of inverted cone-
shaped lipids completely inhibits both processes (Figure 3.11). These results are 
consistent with the stalk-fusion pore model which assumes that the inclusion of lipids 
with negative intrinsic curvature favours the hemifusion intermediate and thus fusion 
event progression. In this context and in contrast to studies that suggest that non-
physiological DOPE concentrations (55%) are necessary to promote fusion by these 
proteins (Nair et al., 2011), our chemical conjugation system shows vesicle fusion 
under physiological amounts of DOPE (30%) supplemented by 10% of a conical-shape 
lipid (Figure 3.13). Furthermore, the predicted fusion events that govern 
autophagosome elongation would take place in highly curved regions on the edge of 
the isolation membrane, perhaps with a specific lipid composition, or enriched in 
fusogenic proteins, and small vesicles would participate. Consistent with this GATE-16 
and GABARAP promote membrane fusion to a greater extent when vesicle size 
decreases (Figure 3.12). Interestingly a spectacular growth of liposomes shown by 
cryo-EM is promoted by our human Atg8 homologues-induced membrane fusion 
events, thus providing a rough visual reproduction of the autophagosome elongation 
process in vitro (Figure 3.10). Further experiments combining our system with Atg5-








ATG3, the E2-like Enzyme of the UBL System, Interacts with and Tethers 
Negatively-charged Membranes, Possibly Governing the Human Atg8-
Homologue Lipidation 
Given the participation of the human Atg8 homologues in vesicle fusion 
processes involved in autophagosome elongation, the question arises of how these 
proteins sense or are recruited to this forming membrane. Previous studies have 
suggested that both Atg3, the last enzyme involved in the Atg8 UBL system, and the 
Atg5-Atg12/Atg16 system are involved in membrane recognition and catalyze the 
lipidation process in vivo (Nath et al., 2014; Romanov et al., 2012; Sakoh-Nakatogawa 
et al., 2015). Other proteins involved in autophagy have been described to recognize 
specific lipids or features in the membrane, such as phosphoinositides (WIPI1-2) 
(Dooley et al., 2014) or membrane curvature (Barkor) (Fan et al., 2011), that facilitate 
the lipidation or fusion processes respectively. In this context, a recent paper has 
shown that mouse ATG3 possesses a predicted N-terminal amphiphatic α-helix that 
would act as a membrane curvature sensor, and that mutations in this region modulate 
the lipidation ratio of GABARAP-L1 in vitro and in vivo (Nath et al., 2014). This provides 
evidence that ATG3 participates in membrane recognition in order to cause Atg8 
lipidation. According to this, we have used biophysical techniques to assay the affinity 
of human ATG3 to model membranes in order to gain further knowledge of how this 
protein detects and interacts with the membrane previously to Atg8 lipidation. 
ATG3 shows a strong affinity to negatively-charged membranes compared to 
neutral ones as the Langmuir balance, floatation and GUV studies reveal (Figures 4.2, 
4.3 and 4.8). In addition the presence of anionic phospholipids in the membrane 
eliminates the high DOPE (55%) and small-sized vesicle requirements for ATG3 
binding proposed by Nath et al., (2014) (Figure 4.3 A-B). Additionally a high 
preference for cone-shaped and negatively-charged lipids such as CL and PA is 
observed (Figure 4.3 C), suggesting a dual component in ATG3-membrane interaction, 
electrostatics (negative charge) and membrane defects (created by lipids with negative 
intrinsic curvature). Consistent with these results and assuming that human ATG3, 
almost identical to mouse ATG3, contains the same predicted amphiphatic helix in its 
N-terminal region, the implication of this α-helix in the membrane association was 
assessed. Two lysines (K9 and K11) delimiting the hydrophobic and hydrophilic faces 
of the helix might accommodate in between the polar headgroups (near the 
phosphates) and the hydrophobic tails of the phospholipids in the membrane, i.e. at the 





protein to bind neutral or anionic vesicles, probably due to charge repulsion with the 
negative environment in the region mentioned above (Figure 4.3 A). However, 
peptides covering this ATG3 N-terminal helix do not reproduce the complete protein 
activity (Figure 4.4), as a likely consequence of the involvement of other regions of the 
protein, or perhaps because the isolated peptides do not exhibit an α-helical 
conformation. 
There are publications indicating that the presence of negatively-charged 
phospholipids (i.e. PI, PS or PG) in model membranes favours the lipidation ratio of 
Atg8 in vitro (Ichimura et al., 2004; Oh-oka et al., 2008). Nevertheless, only one 
associates ATG3 binding to membranes with the efficiency of Atg8-PE conjugation 
(Nath et al., 2014). Consistent with these evidences, we also proposed the role of 
ATG3 in directing Atg8 homologues to the membrane through insertion of the predicted 
α-helix, and moreover suggest that the ATG3 affinity for negatively-charged cone-
shaped lipids might govern GABARAP lipidation efficiency at least in vitro (Figure 
4.10). Some other components have been related to the conjugation machinery in vivo 
(Fujita et al., 2008; Hanada et al., 2007; Romanov et al., 2012). 
Different proteins including human Atg8 homologues, as we have 
demonstrated, participate in tethering and fusion processes along the AP growth (Diao 
et al., 2015; Landajuela et al., 2016; Romanov et al., 2012). Additionally, as shown 
above (Chapter 3), these events can be modulated by the lipid composition of specific 
regions in the membranes. In this context ATG3 might participate in the vesicle fusion 
processes that accompany phagophore elongation. This proposal is based on the 
novel ATG3 activity proposed in this work, vesicle tethering. ATG3 promotes 
aggregation of anionic membranes and, to a lesser extent, of neutral membranes 
(Figure 4.5). Just as in ATG3-membrane interaction, the tethering activity is modulated 
by lipids that generate inverted hexagonal phases in the membrane (CL or PA) (Figure 
4.5 C), and does not require highly curved membranes. However intervesicular lipid 
mixing or leakage is not observed (Figure 4.6) suggesting that ATG3 would help only 
in the vesicle approaching step that precedes full fusion.  
From a different perspective, in the autophagosome elongation pathway the 
continuous arrival of new vesicles or even of lipids alone is currently proposed. For this 
purpose one or a few proteins should manage the movement of these vesicles to the 
growing organelle. ATG9 has been proposed to participate in this process and further 





our preliminary results on recombinant human ATG9 expression and lipid binding by 
ATG9 C-terminal domain (Figures 5.3-8). 
In summary the findings in this thesis shed light on the role of three different 
human Atg8 homologues in the fusion events taking place during autophagosome 
elongation. The enzymatically PE-conjugated forms of LC3, GATE-16 and GABARAP 
induce liposome fusion and this process can be modulated by the lipid geometry and 
membrane curvature, features that could be present in the edge of the nascent 
phagophore and rightly match with the proposed stalk-fusion model. Additionally ATG3, 
a component of the enzymatic reaction that produces the PE-conjugated forms, 
interacts specifically with anionic membranes, appears to modulate the lipidation 
efficiency and shows vesicle-tethering activity, all of which might be related to the 
fusion steps in autophagosomal growth catalyzed by the above-mentioned Atg8 
homologues. Finally, preliminary results might suggest a possible involvement of the 













1) LC3, GATE-16 and GABARAP human Atg8 homologues, enzymatically or 
chemically PE-conjugated, induce complete vesicle-vesicle fusion events 
modulated by the lipid geometry and membrane curvature. This process 
constitutes a minimal in vitro reconstitution model of the human autophagosome 
elongation process. 
 
2) ATG3, the E2-like enzyme in the Atg8 conjugation system, strongly interacts 
with negatively-charged membranes through its predicted N-terminal 
amphiphatic α-helix, and also induces tethering of anionic vesicles. ATG3 
governs GABARAP lipidation efficiency through its preferential interaction with 
anionic and cone-shaped lipids in vitro. 
 
3) Recombinant ATG9 and ATG9 C-terminal domain can be expressed in insect 
cells associated to cell membranes. Mass spectrometry analysis of the 
recombinant ATG9 C-terminal domain-containing fractions shows the presence 
of phosphatidylglycerol. This might indicate the attachment of this domain to the 















La homeostasis celular requiere un correcto balance entre los procesos 
catabólicos y anabólicos, en los cuales están involucradas diferentes rutas de 
señalización celular. La autofagia puede participar en ambos tipos de señalización, y 
es esencial tanto en la degradación de orgánulos innecesarios o dañados 
(catabolismo), como en la producción de nuevos elementos básicos a través de la 
movilización de energía celular y fuentes de nutrientes como lípidos, carbohidratos o 
hierro (anabolismo). La autofagia también esta implicada en una gran variedad de 
procesos fisiológicos tales como la inmunidad, la protección frente a infecciones 
virales, la diferenciación y el desarrollo celular, y puede causar incluso diversas 
patologías cuando está desregulada (Wirawan et al., 2012). 
La autofagia es un proceso mediante el cual se regulan muchos eventos 
esenciales en la célula, por lo que está implicada en el desarrollo de varias 
enfermedades humanas, especialmente neurodegenerativas, como son el Alzheimer, 
la enfermedad de Huntington y el Parkinson (Lynch-Day et al., 2012; Martinez-Vicente 
et al., 2010; Nixon et al., 2005). Los desajustes que se producen en estas 
enfermedades están relacionados con la acumulación de agregados proteicos que no 
ocurrirían en condiciones normales de autofagia. Además, el cáncer, envejecimiento y 
otras alteraciones metabólicas están también reguladas en mayor o menor medida por 
la autofagia, lo que la convierte en una prometedora diana para la prevención y 
tratamiento de estos procesos. (Choi et al., 2013; Levine & Kroemer, 2008). 
Se han descrito muchas proteínas involucradas en la ruta de señalización de la 





etapas específicas en la formación de un orgánulo de doble membrana denominado 
autofagosoma. Éste es considerado el evento principal que tiene lugar en la autofagia, 
y aunque aún se desconoce la procedencia del material lipídico de esta nueva 
membrana (Tooze & Yoshimori, 2010), se han propuesto la membrana plasmática u 
orgánulos como la mitocondria, el retículo endoplasmico o el Golgi como donantes. 
(Mari et al., 2011). El material susceptible de ser degradado es atrapado dentro del 
nuevo orgánulo, el cual crece gracias a la adhesión y fusión de otras estructuras 
membranosas en forma de vesículas. Finalmente, el autofagosoma se cierra mediante 
un proceso de escisión recientemente descrito (Knorr et al., 2015), y se fusiona con el 
lisosoma tras lo cual se degrada el material contenido en su interior. Varios estudios 
han propuesto que, de entre todas las proteínas Atg, dos sistemas UBL 
(Atg8/Atg3/Atg7 y Atg5-Atg12/Atg16) participan en los procesos de fusión que dan 
lugar a la extensión del fagóforo (Nair et al., 2011; Romanov et al., 2012; Walczak & 
Martens, 2013; Weidberg et al., 2011). Por otro lado, también se ha descrito la 
presencia de una única proteína Atg con carácter transmembrana (Atg9), que es 
esencial para la autofagia tanto en levaduras como en mamíferos (Noda et al., 2000; 
Webber et al., 2007). 
Sin embargo, la manera en la que el autofagosoma crece y finalmente se cierra 
es todavía una pregunta sin resolver, y continúa siendo objeto de profundo estudio. 
Por este motivo, el objetivo de esta tesis ha sido contribuir a conocer mejor el proceso 
de elongación del autofagosoma, así como reproducir su crecimiento in vitro. Para ello 
se han empleado técnicas biofísicas y membranas modelo para (i) analizar el papel del 
sistema UBL humano Atg8/ATG3/ATG7 en los procesos de agregación y fusión de 
vesículas, y cómo estos pueden ser modulados por lípidos, y (ii) caracterizar las 
interacciones lípido-proteína de la proteína autofágica ATG3. Además, se ha realizado 
un estudio preliminar de ATG9, una prometedora proteína transmembrana 
probablemente involucrada en el transporte de lípidos necesario para el crecimiento 
del autofagosoma. 
 
Regulación lipídica de los eventos de fusión catalizados por el sistema mínimo 
proteico reconstituido (Atg8/Atg3/Atg7) involucrado en la elongación del 
autofagosoma 
En el modelo actual de autofagia, la hipótesis más aceptada sobre la 
elongación del fagóforo propone que pequeñas vesículas llegarían al orgánulo 




demostrado que Atg8 de levaduras, el efector final del sistema UBL, participa en 
eventos de agregación, hemifusión y fusión in vitro (Nair et al., 2011; Nakatogawa et 
al., 2007). Sin embargo, los homólogos humanos de Atg8 (LC3 y GATE-16) solo han 
mostrado actividad fusogénica en sus formas unidas químicamente, o sea, 
artificialmente a PE (Weidberg et al., 2011). Es importante señalar que todas estas 
proteínas catalizan los procesos mencionados a través de su forma lipidada, unida a 
PE, lo cual constituye su principal manera de asociarse a la membrana. Teniendo todo 
esto en cuenta, en este trabajo hemos descrito la actividad fusogénica in vitro del 
sistema UBL completo, la hemos comparado con el artificialmente lipidado, y hemos 
demostrado que la geometría lipídica y la curvatura de la membrana modulan la fusión 
inducida por LC3, GATE-16 y GABARAP. 
Los homólogos humanos de Atg8 sufren la reacción de lipidación enzimática de 
manera similar a lo descrito en levaduras (Figura 3.7 D). Sin embargo, la eficiencia de 
la reacción es aparentemente menor que en el sistema de levaduras. Este hecho 
podría deberse a la necesidad de una composición lipídica específica o a la presencia 
del sistema UBL Atg5-Atg12/Atg16, tal y como sucede in vivo. Por otro lado, existen 7 
homólogos humanos de Atg8 mientras que en levaduras solo existe uno, por lo que la 
baja eficiencia podría deberse a que quizá se requiera la presencia de varios 
homólogos, con una menor actividad de cada uno de ellos. Además, recientemente se 
ha descrito (Nath et al., 2014) una posible forma adenilada de los homólogos de Atg8, 
la cual dificulta la detección de los conjugados LC3-PE y GATE-PE en los geles SDS-
PAGE. Para solucionar este problema y conseguir una correcta detección hemos 
desarrollado el uso de PE marcada con NBD (Figura 3.7 D). La lipidación química de 
estas proteínas es semejante a la enzimática. 
Con el objetivo de obtener más información acerca de los primeros momentos 
del proceso de fusión, se han realizado ensayos de agregación de vesículas. Según el 
modelo de fusión actualmente aceptado, denominado “modelo de tallo” (del inglés 
stalk) (Basañez et al., 1998; Chernomordik & Kozlov, 2008; Chernomordik et al., 1995; 
Khattari et al., 2015; Siegel, 1999), las membranas inicialmente se aproximan y 
establecen contactos locales para eliminar las moléculas de agua que se encuentran 
entre ellas. En nuestras condiciones experimentales, GATE-16 y GABARAP muestran 
una alta actividad de agregación tanto en el sistema de conjugación enzimática como 
en el químico. LC3 posee una actividad menor en ambos sistemas (Figura 3.8). 
La capacidad de agregación de vesículas por sí misma no es indicativa de que 





proteína recombinante de levaduras Atg8 demostraron que ésta es capaz de producir 
hemifusión, pero no se pudo observar fusión completa (Nakatogawa et al., 2007). Más 
cercano a nuestro sistema, Weidberg et al., (2011) mostró que LC3 y GATE-16 de 
mamíferos, artificialmente conjugadas a PEmal, inducen fusión completa de 
membranas, y además Nair et al., (2011) demostró que Atg8 y LC3 requieren un alto 
contenido de DOPE en la membrana para inducir hemifusión. En nuestro sistema 
enzimático tanto GATE-16 como GABARAP inducen mezcla total de lípidos 
intervesicular, así como mezcla de lípidos de la hemicapa interna y mezcla de 
contenidos acuosos, lo cual se correlaciona con la capacidad de estas proteínas para 
producir fusión completa (Figura 3.9). Las formas químicamente lipidadas de GATE-
16 y GABARAP muestran resultados similares (Figura 3.12). Este hecho nos permite 
concluir que las proteínas están correctamente plegadas después de su conjugación 
química y reproducen fielmente la actividad de las proteínas salvajes. Como se ha 
mostrado y sugerido previamente en nuestros experimentos, no todos los homólogos 
humanos de Atg8 presentan la misma actividad in vitro. Esto puede indicar que cada 
proteína participaría en el crecimiento del fagóforo en distintos momentos o en 
condiciones fisiológicas diferentes. Estos resultados indican quizá la primera prueba 
de la actividad fusogénica de GABARAP, y también proporcionan un estudio completo 
in vitro del potencial fusogénico de estos tres homólogos de Atg8 actuando a través de 
su correspondiente mecanismo enzimático. 
Al igual que otros procesos relacionados con las membranas celulares, la 
fusión de vesículas puede estar considerablemente regulada por lípidos. Existen en la 
bibliografía muchas pruebas de cómo lípidos con distintas morfologías y curvaturas 
intrínsecas modulan eventos de fusión (Basañez et al., 1996b, 1998). En la fusión 
mediada por Atg8, la incorporación de lípidos con forma de cono y curvatura intrínseca 
negativa (como la cardiolipina o el diacilglicerol), estimula la mezcla intervesicular de 
lípidos y contenidos acuosos. Por el contrario, la adición de lípidos con forma de cono 
invertido inhibe ambos procesos (Figura 3.11). Estos resultados están de acuerdo con 
el modelo de fusión de tallo, el cual supone que la inclusión de lípidos con curvatura 
intrínseca negativa favorece el intermediario de hemifusión y por lo tanto la progresión 
del proceso de fusión. En este contexto, y en contra de estudios que sugieren que son 
necesarias concentraciones no fisiológicas de DOPE (55%) para promover la fusión 
desencadenada por estas proteínas (Nair et al., 2011), nuestro sistema de conjugación 
química muestra fusión de vesículas con cantidades fisiológicas de DOPE (30%) 
suplementadas con un 10% de un lípido con forma cónica (Figura 3.13). Además, 




autofagosoma tendrían lugar en las regiones altamente curvadas que se generan en el 
borde de la membrana emergente, las cuales estarían enriquecidas en proteínas y 
lipidos fusogénicos, y cuya aparición podría incluso verse favorecida por la unión de 
vesículas pequeñas. De acuerdo con esto último, la fusión observada para GATE-16 y 
GABARAP es mayor cuanto menor es el tamaño de las vesículas (Figura 3.12). Por 
último, nuestros experimentos de cryo-EM muestran el espectacular crecimiento de 
liposomas promovido por los procesos de fusión inducidos por nuestros homólogos 
humanos de Atg8, y ofrecen una reproducción visual aproximada de la elongación del 
autofagosoma in vitro (Figura 3.10). Futuros experimentos combinando nuestro 
sistema con el sistema Atg5-Atg12/Atg16 proporcionarán un mejor entendimiento de 
las características del proceso in vivo. 
 
ATG3, la enzima homóloga de E2 del sistema UBL, interacciona y agrega 
vesículas cargadas negativamente, probablemente dirigiendo la lipidación de los 
homólogos humanos de Atg8 
Una vez establecido que los homólogos de Atg8 participan en los procesos de 
fusión que provocan la elongación del autofagosoma, se plantea la pregunta de cómo 
detectan las proteínas la membrana emergente y son dirigidas hacia ella. Estudios 
previos en este campo sugieren que tanto Atg3 (la última enzima implicada en el 
sistema UBL de Atg8), como el sistema Atg5-Atg12/Atg16 están involucrados en el 
reconocimiento de la membrana y catalizan el proceso de lipidación in vivo (Nath et al., 
2014; Romanov et al., 2012; Sakoh-Nakatogawa et al., 2015). También se ha descrito 
que otras proteínas implicadas en la autofagia reconocen lípidos específicos, como 
fosfatidilinositoles (WIPI1-2) (Dooley et al., 2014), o características específicas de la 
membrana, como la curvatura (Barkor) (Fan et al., 2011). De esta manera, dichas 
proteinas facilitarían la lipidación o los procesos de fusión respectivamente. En este 
contexto, un artículo reciente ha indicado que la proteína ATG3 de ratón posee una 
posible -hélice N-terminal anfipática que actuaría como sensor de curvatura de 
membrana. Mutaciones en esta región modulan la lipidación de GABARAP-L1 in vitro 
e in vivo (Nath et al., 2014). Estos estudios proporcionan una prueba de que ATG3 
participa en el reconocimiento de la membrana para promover la lipidación de Atg8. De 
acuerdo con esto, hemos empleado técnicas biofísicas para analizar la afinidad de 
ATG3 humana por membranas modelo, con el objetivo de entender cómo esta 
proteína detecta la membrana e interacciona con ella durante el paso previo a la 





Nuestros estudios con la balanza de Langmuir, de flotación de liposomas y 
GUV muestran que ATG3 tiene una fuerte afinidad por membranas cargadas 
negativamente en comparación con membranas neutras (Figuras 4.2, 4.3 y 4.8). 
Además, la presencia de fosfolípidos aniónicos en la membrana elimina el 
requerimiento, propuesto por Nath et al., (2014), de altas concentraciones de DOPE 
(55%) y vesículas de pequeño tamaño para la unión de ATG3 (Figura 4.3 A-B). 
Además, se observa una alta preferencia por lípidos con forma cónica y cargados 
negativamente, como son CL y PA (Figura 4.3 C), lo que sugiere un doble 
componente en la interacción de ATG3 con la membrana: fuerza electrostática (carga 
negativa) y defectos en la membrana (creados por lípidos con curvatura intrínseca 
negativa). De acuerdo con estos resultados y suponiendo que ATG3 humana (casi 
idéntica a ATG3 de ratón) contiene la misma α-hélice anfipática predicha en su 
extremo N-terminal, se estudió la implicación de esta hélice en la interacción de la 
proteína con la membrana. Las dos lisinas (K9 y K11) que delimitan las caras 
hidrofóbica e hidrofílica de la hélice se acomodarían entre los grupos polares (cerca de 
los fosfatos) y las colas hidrofóbicas de los fosfolípidos en la membrana, es decir, en la 
interfase membrana-agua. El mutante de ATG3 K9D/K11D pierde la capacidad de 
unirse a vesículas tanto neutras como aniónicas, probablemente por la repulsión de 
carga con el ambiente negativo en la región mencionada anteriormente (Figura 4.3 A). 
Sin embargo, los péptidos sintéticos que cubren la secuencia de esta hélice N-terminal 
de ATG3 no reproducen la actividad de la proteína completa (Figura 4.4), ya sea 
porque la proteína necesita otras regiones para interaccionar, o quizá porque los 
péptidos no adoptan la conformación α-hélice. 
Diferentes publicaciones indican que la presencia de fosfolípidos cargados 
negativamente (por ejemplo PI, PS o PG) favorece el rendimiento de la lipidación en 
membranas modelo in vitro (Ichimura et al., 2004; Oh-oka et al., 2008). Sin embargo, 
sólo un estudio asocia esta unión de ATG3 con membranas a la eficiencia  de la 
conjugación de Atg8 a PE (Nath et al., 2014). A este respecto, en este trabajo 
proponemos que ATG3 adquiere un papel en la dirección de los homólogos de Atg8 
hacia la membrana a través de la inserción de la mencionada α-hélice. Además, 
sugerimos que la afinidad de ATG3 por lípidos cargados negativamente y con forma 
cónica podría ser la responsable de la eficiencia de la lipidación de GABARAP in vitro 
(Figura 4.10). Otros componentes que participan en el proceso de autofagia celular 
formarían parte de la maquinaria de conjugación in vivo (Fujita et al., 2008; Hanada et 




Distintas proteínas, incluídos los homólogos humanos de Atg8, participan como 
hemos demostrado en procesos de agregación y fusión a lo largo del crecimiento del 
AP (Diao et al., 2015; Landajuela et al., 2016; Romanov et al., 2012). Además, como 
se ha demostrado (Capítulo 3), estos eventos pueden ser modulados por la 
composición lipídica de regiones específicas en las membranas. En este contexto, 
podría ser que ATG3 participase en los procesos de fusión de vesículas que 
acompañan a la elongación del fagóforo. Esta hipótesis está basada en la nueva 
actividad de ATG3 que hemos observado en este trabajo, la agregación de vesículas. 
ATG3 promueve la agregación de membranas aniónicas, y en menor medida, de 
vesículas neutras (Figura 4.5). Al igual que ocurre en la interacción de ATG3 con la 
membrana, la actividad de agregación está modulada por lípidos que generan fases 
hexagonales invertidas en la membrana (CL o PA) (Figura 4.5 C), y no requiere 
membranas altamente curvadas. Sin embargo, no se observa mezcla de lípidos 
intervesicular o liberación de contenidos (Figura 4.6), lo cual sugiriere que ATG3 
únicamente favorecería el paso de aproximación de las vesículas que precede a la 
fusión completa. 
Desde una perspectiva diferente, se ha propuesto que en el proceso de  
elongación del autofagosoma se da una llegada continua de vesículas o incluso sólo 
de lípidos. Una o varias proteínas deberían controlar el movimiento de estas vesículas 
hacia el orgánulo emergente, y se ha propuesto ATG9 como candidata. Sin embargo, 
en el futuro deberían realizarse experimentos con membranas modelo in vitro para 
validar nuestros resultados preliminares sobre la expresión y unión de lípidos del 
dominio C-terminal de ATG9. (Figuras 5.3-8). 
En resumen, los resultados de esta tesis sirven para aclarar el papel de tres 
homólogos humanos diferentes de Atg8 en eventos de fusión que tienen lugar durante 
la elongación del autofagosoma. Las formas de LC3, GATE-16 y GABARAP 
conjugadas enzimáticamente a PE inducen fusión de liposomas y este proceso puede 
estar modulado por la geometría lipídica y por la curvatura de membrana, 
características que podrían estar presentes en el borde del fagóforo naciente y que se 
ajustan debidamente al modelo propuesto de fusión tipo tallo. Además ATG3, uno de 
los componentes de la reacción enzimática que induce las formas conjugadas a PE, 
interacciona específicamente con membranas aniónicas, parece modular la eficiencia 
de la lipidación y muestra actividad de agregación de vesículas, lo cual puede estar 
relacionado con los eventos de fusión catalizados por los arriba mencionados 





preliminares pueden sugerir una posible implicación de la proteína transmembrana 







1) Los homólogos humanos de Atg8, LC3, GATE-16 y GABARAP, conjugados a 
PE enzimáticamente o químicamente, inducen eventos de fusión completa de 
vesículas lipídicas, modulados por la geometría lipídica y la curvatura de la 
membrana. Éste constituye el más sencillo modelo reconstituido del proceso 
humano de elongación del autofagosoma. 
 
2) ATG3, la enzima homóloga de E2 en el sistema de conjugación de Atg8, 
interacciona fuertemente con membranas cargadas negativamente a través de 
una hipotética α-hélice anfipática N-terminal, y también induce agregación de 
vesículas aniónicas. ATG3 dirige la eficiencia de la lipidación de GABARAP a 
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